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The incidence of lymphoid neoplasms has been rising steadily over the 
past decades in Singapore, and there were no apparent reasons to account for 
its highest lymphoma rate in Asia.  The aims of this thesis are to explore the 
influence of temporal variations on lymphoma rates and understand the 
aetiology factors including occupation, sun exposure behaviours as well as 
smoking and drinking habits which could be related to its rise in Singapore. 
 
Study I – Trends of lymphoma in Singapore (1968-2007) 
 
We describe changes in lymphoma cancer incidence based on various 
classifications using aggregate, non-identifiable lymphoma incidence data from 
the Singapore Cancer Registry for the period 1968 to 2007.  Age-period-cohort 
(APC) modelling was performed on 7,217 individuals aged 15 to 79 years with 
lymphoid neoplasms using Poisson regression.   
 
Our analysis of non-Hodgkin lymphoma indicated that the full APC model 
provided the best fit.  Apart from age, both period and cohort effects have 
significant impacts on the population trend.  When Hodgkin lymphoma was 
grouped as part of lymphoid neoplasms, the period effect disappeared from the 
model.  Our study is the first analysis on incidence trends using the updated 
WHO classifications of lymphoid neoplasms, and the results suggested both age 
and birth cohort effect contributed to the rise.   
 
vii 
Study II to IV : Singapore Lymphoma Study (2004-2008) 
 
In studies II to IV, a hospital-based case-control study of 541 incident 
cases of lymphoid neoplasms and 830 controls aged 18 years and above were 
recruited between 2004-2008.  Participants were interviewed using structured 
questionnaire to elicit information on occupational history, lifestyle factors such 
sun exposure histories cigarette smoking and alcohol drinking.  Information on 
basic demographics and potential confounders were also collected.  The effect 
of various risk factors on lymphoma were quantified using odds ratios (OR) and 
95% confidence intervals (CI) via the unconditional logistic regression. 
 
Study II examines the association between occupational history and the risk of 
lymphoma.  There was no association with any occupational groups except the 
teaching profession.  As compared with those who were never employed in 
teaching profession, teachers who taught <10 years had increased NHL risk 
[OR 2.43, 95%CI 1.11-5.33].  
 
Study III investigates the association between sun exposure and the risk of 
lymphoma.  Regular leisure sun exposure on non-school days during childhood 
[OR 0.62, 95%CI 0.46-0.83] and non-working days in adulthood [OR 0.70, 
95%CI 0.51-0.97] reduced the risk of NHL.  The protective effect was more 
evident among females.  
 
Study IV examines the smoking and drinking behaviours and risk of lymphoma.  
Compared with non-drinkers, alcohol drinkers had a lower risk of NHL overall 
[OR 0.68, 95%CI 0.48-0.97], regardless of beverages types.  The protective 
effect was observed in those started drinking after 19 years old [OR 0.47, 
viii 
95%CI 0.28-0.79], and in those drank at least 40 standard drinks per week [OR 
0.50, 95% 0.27-0.93].  No relations between cigarette smoking and lymphoma 




Age and cohort effects have contributed to the rise of lymphoid 
neoplasms over the years.  Lifestyles such as sunlight exposure and alcohol 
drinking might be inversely associated with NHL risk, while teaching occupation 
increased its risk.  Future epidemiology studies with bigger sample size are 
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Chapter 1 
Background of lymphoid malignancies 
 
 
Lymphoid neoplasms (LN), which generally called lymphoma, are 
heterogeneous groups of malignancies in the immune system.  The major 
neoplastic groupings of the lymphoid neoplasms are known as Hodgkin 
lymphoma (HL) and non-Hodgkin lymphoma (NHL).  Both malignancies 
occur in B- or T-lymphocytes which normally protects us from infection and 
disease.  Different lymphomas have various origins, and they derived at various 
stage of cell differentiation.  Precursor B-lymphocytes arise from bone marrow, 
and differentiate into mature lymphocytes at lymph nodes (across marginal zone, 
mantle zone, and germinal centre), and recirculate around the body.  Similarly 
the precursor T-lymphocytes bypass to thymus, before it enters lymph nodes or 
other extra-nodal tissue.  Majority of lymphomas are B-cell lymphomas. 
 
Since lymphocytes travel along the lymphatic system, most lymphomas 
have nodal involvement, i.e. lymphoma found in lymph nodes such as cervical, 
infraclavicular, occipital, axillary, mediastinum, retroperitoneal, hilar, mesenteric, 
para-aortic, iliac, inguinal, or even epitrochlear and brachial or popliteal lymph 
nodes.  Locations including Waldeyer ring, tonsil, thymus, spleen, or bone 
marrow are also common in lymphoma.  Other common sites found outside of 
lymphatic systems, i.e. extra-nodal involvement, including central nervous 
system, stomach, lung, small intestine, or skin.  It is therefore lymphoma 
presented in both solid phase as solid tumour in extra-nodal organs, and 
leukemic phase in bone marrow and circulating blood.   
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1.1 Signs and symptoms  
 
Some types of lymphoma are slow-growing, i.e. indolent, or low-grade 
lymphomas, it is usually asymptomatic unless it caused compression at organs, 
and treatments may not be needed urgently.  Others are fast-growing and 
causing rapid deterioration, i.e. aggressive, or high-grade lymphomas.  
Treatments are needed as soon as possible after diagnosis, most are respond 
well to treatment and hence curable.  Once there are signs and symptoms, it is 
important to have physical examination by medical doctors to rule out the 
possibility, since some of the symptoms are common between infections, 
autoimmune diseases and lymphoma.  Depends on the aggressiveness of 
lymphoma, symptoms may last from weeks to months, or even years 
(Emmanouilides & Casciato 2004; UK). 
 
Local symptoms are generally related to the disease of presentation, 
including 1) enlarged but usually painless lymph nodes (i.e. lymphadenopathy) 
in the neck, armpits or groin area; 2) chest symptoms - coughing, 
breathlessness or chest pain; 3) abdominal symptoms – pain or discomfort may 
be due to organomegaly, any swellings, indigestion, change in bowel habit e.g. 
diarrhoea; 4) pain or ache in bones may reflect localized area of bone 
destruction; 5) back pain due to massive retroperitoneal nodal involvement; 6) 
brain and nerve symptoms: dizziness, numbness, tingling, weakness in limb, 
visual problem, memory problems; 7) skin problem – lumps, redness or itchy 
patches; or 8) lumps in other unusual places e.g. in the breast, testicle, nose, 
jaw etc.   
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Other symptoms are affecting overall, i.e. systematic symptoms, 
including unexplained weight loss >10% in the past 6 months, fever >38oC, 




1.2 Diagnosis and staging 
 
To order to confirm involvement of lymphoma, a biopsy (fine needle 
biopsy or excision biopsy) at the site of presentation is needed.  Lymphomas 
are distinguished by the cell of origin and morphology, immunologic phenotyping, 
location of tumour, and genetic approach such as polymerase chain reaction.  
Other clinical evaluation are including physical examination, blood test e.g. 
lactate dehydrogenase (LDH) and human immunodeficiency virus (HIV), bone 
marrow biopsy, imaging techniques e.g. x-ray, computer topography (CT), 
magnetic resonance imaging (MRI), positron emission tomography (PET).  
 
The extent to where the cancer has spread in the body is called the 
stage of disease.  The performance status of patients is measured by ECOG 
score (Table 1.1), a score introduced by the Eastern Cooperative Oncology 
Group, which indicate how well a patient is function at the time of presentation.  
This is one of the predictive variables for prognosis of lymphoma.  
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Table 1.1 ECOG score 
Grade ECOG 
0 • Fully active, able to carry on all pre-disease performance without 
restriction. 
1 • Restricted in physically strenuous activity but ambulatory and able to 
carry out work of a light or sedentary nature, e.g., light house work, office 
work. 
2 • Ambulatory and capable of all self-care but unable to carry out any work 
activities. Up and about more than 50% of waking hours. 
3 • Capable of only limited self-care, confined to bed or chair more than 50% 
of waking hours. 
4 • Completely disabled. Cannot carry on any self-care. Totally confined to 
bed or chair. 
5 • Dead. 
 
 
The tumour stage of patients is usually determined by the Ann Arbor 
staging system (Lister et al. 1989), which was originally developed for Hodgkin’s 
disease (Table 1.2).  Under the system, there are designations applicable to 
any disease stage based on the symptoms presented, called A, B, E, and X.  
High fever, night sweats, weight loss are called “B symptoms”, which is 
associated with poor prognosis.  For example, if a stage 2 patient presented 
with the above symptoms, it will be called “Stage 2B”, or else will be called 
“Stage 2A”.  “E” stands for single isolated site of extra-nodal disease or extra-
nodal extension, i.e. lymphoma has spread to organ or area outside lymphatic 
system.  “X” refers bulky disease, a mediastinal mass exceeding 1/3 the 
maximum transverse thoracic diameter, or the presence of nodal mass greater 
than 10cm.   
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Table 1.2 Cotswolds Modification of Ann Arbor Staging system (Lister et al. 
1989) 
Stage Area of involvement 
I (early) • Single lymph node group 
II (early) • Multiple lymph node groups and/or an organ on the same side of 
diaphragm  
III (advanced) • Multiple lymph node groups and/or an organ on both sides of 
diaphragm and/or an organ or other area both above and below 
the diaphragm 
IV (advanced) • Multiple extra-nodal sites or lymph node and extra-nodal disease 
e.g. bone marrow, lungs, liver and skin 
 
 
Since the patterns of disease spread in HL and NHL are different, the 
Ann Arbor classification is not very sensitive to predict prognosis of patients with 
aggressive NHL.  A new system incorporated with clinical features called 
International Prognostic Index (IPI) was developed (1993) to identify 4 risk 




Table 1.3 International Prognostic Index (IPI) (1993) 
Prognostic factors for all patients  IPI   
• Age >60 years 
• Serum LDH >1xnormal 
• Performance status 2-4 
• Stage III-IV 
• Extra-nodal involvement >1 site 






0 or 1 
2  
3 
4 or 5 
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1.3 Classification of lymphoid neoplasms 
 
Hodgkin’s disease or Hodgkin lymphoma: In 1832, a rare disease was first 
described by Thomas Hodgkin (1798-1866) as “some morbid appearance of the 
absorbent glands and spleen”. The disease was named Hodgkin’s disease 
(HD) in 1865.  The Rye Classification for Hodgkin Disease was developed by 
Lukes and Butler, modified and presented at the conference in Rye, New York 
in 1966.  There were 4 subtypes called lymphocyte predominant (LP), nodular 
sclerosis (NS), mixed cellularity (MC), and lymphocyte depletion (LD), with 
decreasing prognosis from most favourable to least favourable respectively.  
The abnormal B-lymphocyte called Reed-Sternberg cell, which derived from B-
cell germinal centre, is particularly found in this type of lymphoma.  This cell is 
the standard diagnosis of Hodgkin disease (NCI).  This classification has been 
used for another 30 years, before an additional subtype lymphocyte-rich 
classical Hodgkin lymphoma (LR) was proposed in Revised European-American 
Lymphoma (REAL) classification in 1994, and renamed as Hodgkin 
Lymphoma in 2001. HL accounts for about 10% of all lymphoid neoplasms, all 
other types of lymphomas are called non-Hodgkin’s lymphoma (Melbye et al. 
2008).   
 
Non-Hodgkin lymphoma – The classification of NHL has been evolving in the 
past few decades in Europe and the United States.  A new classification was 
launched in almost every decade.  Table 1.4 summarizes the early 
classifications of lymphoid neoplasms.  The Rappaport system, which was 
based only on the morphology of cell differentiation, was one of the earliest 
systems used until mid-70s.  In Europe, Karl Lennert developed the Kiel system 
in 1974, which was based on cellular morphology and immunologic 
characteristics of T- and B-lymphocytes; while similar systems called the Lukes 
Ch.1 - Background 
7 
and Collins Classification were used in the United States.  In 1982, the Working 
Formulation was introduced by the National Cancer Institute.  The classification 
was further modified based on cell differentiation, cell size, and whether or not 
the cell was cleaved.  This led to the distinction between low-grade and high-
grade cancers.   
 
In 1994, the International Lymphoma Study Group (ILSG) proposed that 
lymphomas should be grouped as clinical-pathologic entities based on 
morphologic, immunologic and genetic characteristics according to cell origin.  
This led to the development of the REAL classification, which was further 
revised in 2001 and became the new international standard for NHL worldwide 
today.  The World Health Organization (WHO) classification was based on cell 
appearance, growth pattern of cancerous cells and genetic features.  Table 1.5 
summarizes the entities of WHO classification, and the equivalents in the 
updated Kiel and REAL classification systems (Chan 2001; Gallus et al. 2004; 
Jaffe et al. 2001; Network).  The latest updated version was released in 2008 
(Campo et al. 2011; Jaffe 2009) and presented in Table 1.6.   
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Table 1.4 Early classifications of NHL a) The Rappaport classification, b) 
Working Formulation. 
 
a) The Rappaport classification (1960s) 
Description 
• Well-differentiated cells, or small lymphocytic lymphoma 
• Poorly differentiated cells, or follicular centre cell lymphoma with a 
large component of small-cleaved cells 
• Histocytic cells, or large cell lymphoma 
 
b) Working Formulation (1982) 
Description 
Low grade 
A. Small lymphocytic; plasmacytoid 
B. Follicular, small cleaved cell 
C. Follicular, mixed (small cleaved and large cell) 
Intermediate 
grade 
D. Follicular, large cell 
E. Diffuse, small cleaved cell 
F. Diffuse, mixed (small cleaved and large cell) 
G. Diffuse, large cell 
High grade 
H. Immunoblastic (large cell) 
I. Lymphoblastic 
J. Small, noncleaved (Burkitt, non-Burkitt) 
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Table 1.5 Entities of the WHO classification for lymphoid neoplasms and their 
equivalents in the updated Kiel classification and the REAL classification. (NCI) 
Kiel (1974) REAL (1994) WHO (2001) ICD-O 3rd Ed 
 HODGKIN’S DISEASE HODGKIN LYMPHOMA  














 • Nodular sclerosis • Nodular sclerosis 9663/3 
 • Lymphocyte-rich 
classical HD 
• Lymphocyte-rich 9651/3 
 • Mixed cellularity • Mixed cellularity 9652/3 
 • Lymphocyte depletion • Lymphocyte-depleted 9653/3 
B-CELL LYMPHOMAS B-CELL NEOPLASMS B-CELL NEOPLASMS  
 Precursor B-cell neoplasm Precursor B-cell neoplasm  
Acute lymphoblastic B-
cell leukaemia 
Precursor B lymphoblastic 
leukaemia/ lymphoma 





  9728/3 































 Splenic marginal zone 
lymphoma (±villous 
lymphocytes) 




Hairy cell leukaemia Hairy cell leukaemia Hairy cell leukaemia 9940/3 
Plasmacytic lymphoma 
(Plasmacytoma) 
Plasmacytoma / Plasma 
cell myeloma 
Plasma cell neoplasms  
• Plasma cell myeloma 9732/3 
  • Solitary plasmacytoma of 
bone 
9731/3 
  • Extraosseous 
plasmacytoma 
9734/3 
  Extranodal marginal zone B-
cell lymphoma of mucosa-





Marginal zone B-cell 
lymphoma, nodal 
(±monocytoid B cells) 
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Table 1.5 (cont.)  
Kiel (1974) REAL (1994) WHO (2001) ICD-O 3rd Ed 
 Peripheral B-cell neoplasms Mature B-cell neoplasms  
Centroblastic-centrocytic 
lymphoma, Follicular, 
follicular and diffuse - 
with an increased no of 
centroblasts 
Follicle centre lymphoma, 
follicular 
Follicular lymphoma 9690/3 
• Grade I • Grade 1  
• Grade II • Grade 2  
• Grade III • Grade 3a  
Centroblastic lymphoma, 
follicular 
 • Grade 3b  
Centroblastic-centrocytic 
lymphoma, diffuse 
Follicle centre lymphoma, 
diffuse, small cell 
Diffuse follicle centre 
lymphoma 
 
Centrocytic (mantle cell) 
lymphoma 
Mantle cell lymphoma Mantle cell lymphoma 9673/3 
Centroblastic lymphoma,  
  centrocytoid 
   
Centroblastic lymphoma, 
diffuse  
Diffuse large B-cell 
lymphoma 






 • centroblastic 
 • immunoblastic 
B-cell large anaplastic 
lymphoma 
 • anaplastic  
 • T-cell/histiocyte rich  
  • plasmablastic  
  • with expression of full 
length ALK (IgA+) 
 
 DLBCL subtype:  Primary 
mediastinal (thymic) large 
B-cell lymphoma 






Diffuse large B-cell 
lymphoma 
 
Intravascular large B-cell 
lymphoma 
9680/3 
 Diffuse large B-cell 
lymphoma 
Primary effusion lymphoma 9678/3 
Burkitt lymphoma (BL) Burkitt’s lymphoma Burkitt lymphoma (BL) 9687/3 
• BL with 
intracytoplasmic 
immunoglobulin 
DLBCL subtype:  
High-grade B-cell 
lymphoma, Burkitt-like 
BL with plasmacytoid 
differentiation atyptical BL / 
Burkitt-like 
 
 Burkitt leukaemia 
 
• Burkitt leukaemia 9826/3 
  
















Ch.1 – Background 
11 
Table 1.5 (cont.) 
Kiel (1974) REAL (1994) WHO (2001) ICD-O 3rd Ed 
T-CELL LYMPHOMAS T-CELL AND PUTATIVE NK-CELL NEOPLASMS 
T-CELL AND NK-CELL 
NEOPLASMS  







Precursor T lymphoblastic 
leukaemia / lymphoma 
Precursor T lymphoblastic 
leukaemia / lymphoma 
9837/3 
9729/3 
  Blastic NK-cell lymphoma 9727/3 
 Peripheral T-cell and NK-cell neoplasms 













T-cell chronic lymphocytic 
leukaemia (azurophilic-
type) 
Large granular lymphocyte 
leukaemia (LGL) of T-cell 
type 
T-cell large granular 
lymphocytic leukaemia 
9831/3 
Large granular lymphocyte 





T-cell lymphoma, small 
cell type, pleomorphic 
medium and large cell 
type (HTLV-1+) 








lymphoma, nasal type 
9719/3 










 Subcutaneous panniculitis 
T-cell lymphoma 
Subcutaneous panniculitis-
like T-cell lymphoma 
9708/3 
Small cell cerebriform 
(mycosis fungoides/ 
Sezary syndrome) 
Mycosis fungoides Mycosis fungoides 9700/3 
Sezary syndrome Sezary syndrome 9701/3 
Primary cutaneous 
anaplastic large cell 
(CD30+) lymphoma 
Primary cutaneous 











T-zone lymphoma  • T-zone variant  
Lymphoepithelioid 
(Lennert’s) lymphoma 











T-cell large anaplastic 
(Ki-1+) lymphoma 
Anaplastic large cell 
lymphoma, CD30+ (T-
/null-cell types) 
Anaplastic large cell 
lymphoma 
9714/3 




  Lymphomatoid papulosis 9718/1 
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Table 1.6 WHO classification of tumors of hematopoietic and lymphoid tissues 
(updated in 2008)  (Swerdlow et al. 2008) 
 
Mature B-cell neoplasms 
• Chronic lymphocytic leukemia/small lymphocytic 
lymphoma 
• B-cell prolymphocytic leukemia 
• Splenic marginal zone lymphoma 
• Hairy cell leukemia 
• Splenic lymphoma/leukemia, unclassifiable* 
− Splenic diffuse red pulp small B-cell lymphoma* 
− Hairy cell leukemia variant* 
• Lymphoplasmacytic lymphoma 
− Waldenström macroglobulinemia 
• Heavy chain diseases 
− Alpha heavy chain disease 
− Gamma heavy chain disease 
− Mu heavy chain disease 
• Plasma cell myeloma 
• Solitary plasmacytoma of bone 
• Extraosseous plasmacytoma 
• Extranodal marginal zone lymphoma of mucosa-
associated lymphoid tissue (MALT lymphoma) 
• Nodal marginal zone lymphoma 
− Pediatric nodal marginal zone lymphoma* 
• Follicular lymphoma 
− Pediatric follicular lymphoma* 
• Mantle cell lymphoma 
• Diffuse large B-cell lymphoma (DLBCL), NOS 
− T-cell/histiocyte rich large B-cell lymphoma 
− Primary DLBCL of the CNS  
− Primary cutaneous DLBCL, leg type 
− EBV-positive DLBCL of the elderly* 
• DLBCL associated with chronic inflammation 
• Lymphomatoid granulomatosis 
• Primary mediastinal (thymic) large B-cell 
lymphoma 
• Intravascular large B-cell lymphoma 
• ALK-positive large B-cell lymphoma 
• Plasmablastic lymphoma 
• Large B-cell lymphoma arising in HHV8-
associated multicentric Castleman disease 
• Primary effusion lymphoma  
• Burkitt lymphoma 
• B-cell lymphoma, unclassifiable, with features 
intermediate between DLBCL and Burkitt 
lymphoma 
• B-cell lymphoma, unclassifiable, with features 
intermediate between DLBCL and classical 
Hodgkin lymphoma 
 
Mature T-cell and NK-cell neoplasms 
• T-cell prolymphocytic leukemia 
• T-cell large granular lymphocytic leukemia 
• Chronic lymphoproliferative disorder of NK-cells* 
• Aggressive NK-cell leukemia 
• Systemic EBV-positive T-cell lymphoproliferative 
disease of childhood 
• Hydroa vacciniforme-like lymphoma 
• Adult T-cell leukemia/lymphoma 
• Extranodal NK/T-cell lymphoma, nasal type 
• Enteropathy-associated T-cell lymphoma 
• Hepatosplenic T-cell lymphoma 
• Subcutaneous panniculitis-like T-cell lymphoma 
• Mycosis fungoides  
• Sézary syndrome 
• Primary cutaneous CD30+ T-cell 
lymphoproliferative disorders 
− Lymphomatoid papulosis 
− Primary cutaneous anaplastic large cell 
lymphoma 
• Primary cutaneous gamma-delta T-cell lymphoma 
• Primary cutaneous CD8+ aggressive 
epidermotropic cytotoxic T-cell lymphoma* 
• Primary cutaneous CD4+ small/medium T-cell 
lymphoma* 
• Peripheral T-cell lymphoma, NOS 
• Angioimmunoblastic T-cell lymphoma 
• Anaplastic large cell lymphoma, ALK-positive 
• Anaplastic large cell lymphoma, ALK-negative* 
 
Hodgkin lymphoma 
• Nodular lymphocyte predominant Hodgkin 
lymphoma 
• Classical Hodgkin lymphoma 
• Nodular sclerosis classical Hodgkin lymphoma  
• Lymphocyte-rich classical Hodgkin lymphoma 
• Mixed cellularity classical Hodgkin lymphoma 
• Lymphocyte-depleted classical Hodgkin lymphoma 
 
Histiocytic and dendritic cell neoplasms 
• Histiocytic sarcoma 
• Langerhans cell histiocytosis 
• Langerhans cell sarcoma 
• Interdigitating dendritic cell sarcoma 
• Follicular dendritic cell sarcoma 
• Fibroblastic reticular cell tumor 




• Early lesions 
− Plasmacytic hyperplasia 
− Infectious mononucleosis-like PTLD 
• Polymorphic PTLD 
• Monomorphic PTLD (B- and T/NK-cell types)† 
• Classical Hodgkin lymphoma type PTLD† 
* These histologic types are provisional entities for which the WHO Working Group felt there was 
insufficient evidence to recognise as distinct diseases at this time. 
 † These lesions are classified according to the leukemia or lymphoma to which they correspond. 
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The features of more common lymphoid neoplasms are summarised in the 
followings (Aster 2003; Campo et al. 2011) : 
 
a) Low grade B-cell lymphomas  
 
• Follicular lymphoma (FL) is one of the most common indolent 
lymphoma in the world.  It constitutes ~40% of adult lymphomas.  
These tumours express B-cell markers (CD10, CD19, and CD20) and 
BCL2 protein. FL is determined by Follicular Lymphoma International 
Prognostic Index (FLIPI) (Solal-Celigny et al. 2004). It is generalized 
lymphadenopathy and occurs in older age. Due to its slow growing 
nature, it does not respond to chemotherapy very well, treatments may 
be delayed for years, and replaced by ‘watch and wait’ management if 
patients are clinically stable with no symptoms (LFA 2011).  
 
• Chronic lymphocytic leukaemia/Small lymphocytic lymphoma (CLL/SLL) 
is a lymphoid leukaemia expressed as both lymphoma (3-4%) and 
leukaemia (30%).  It expresses both pan-B-cell makers (CD19, CD20 
CD23) and T-cell-associated antigen (CD5). CLL is staged by Rai 
classification, and uncommon in Asians.  It behaves similar to FL but 
usually involves bone marrow. (Foon & Casciato 2004; Rai et al. 1975). 
 
• Plasma cell myeloma (PCM) / Multiple myeloma (MM) are formed by 
clonal expansion of a single homogenous immunoglobulin, often 
referred as M component. They occur mainly in middle-aged to elderly 
persons, with bone marrow and skeletal destruction.  PCM is usually 
asymptomatic and does not require immediate treatment, unless organ 
damage is present.  
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b) Intermediate and high grade B-cell lymphomas: 
 
• Diffuse large B-cell lymphoma (DLBCL) is the most common NHL 
(<50%). These are the mature B-cell tumours that express pan-B-cell 
antigens (CD19, CD20, and CD79a). It is an aggressive tumour with 
higher frequency of spreading to extra-nodal, visceral and bone marrow. 
Prognosis is poor but up to 50% are curable. 
 
• Mantel cell lymphoma (MCL) is predominantly in older males, 
disseminated disease in nodes, spleen, and bone marrow. It is an 
aggressive and difficult to cure tumour. Similar to CLL/SLL, the tumour 
cells expressed pan-B-cell antigens, and surface IgM and IgD, and high 
level of cyclin D1 protein.  
 
• Burkitt lymphoma (BL) is endemic in Africa but sporadic in other 
countries. BL expresses surface IgM and pan-B-markers (CD19) and 
CD10 antigen.  It is well-known its relation with immunosuppression 
(e.g. HIV/AIDS). Extranodal visceral involvement but responsive to 
therapy. 
 
c) T/NK-cell lymphomas 
 
• Mycosis Fungoides (MF) / Sézary syndrome (SS) is the most common 
type of cutaneous lymphoma, with expression of CD4 T-cells.  It is very 
indolent and presents with local or generalized skin involvement.  
 
• Peripheral T-cell lymphoma (PTCL) is a common T-cell lymphoma 
(CD3+) in adults, generally with poor prognosis.  
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d) Hodgkin lymphoma 
 
• HL, nodular sclerosis (HL NS) is the most common form of HL.  Usually 
pan-B-cell markers and T-cell markers are not expressed, and it is 
identified by Reed-Sternberg cell.  It affects mostly in young women, and 
presented with cervical or mediastinal lymphadenopathy. 
 
• HL, mixed cellularity (HL MC) is the second most common HL. It is 
identified by the classic Reed-Sternberg cell, CD15 and CD30 positive, 
in a mixed inflammatory background. Most common in men, presented 
with advances stage disease, and 70% of cases EBV positive. 
 
 
1.4 Changes in incidence of lymphoid neoplasms  
 
The GLOBOCAN project used the most recent cancer data available 
from the International Agency for Research on Cancer (IARC) to provide the 
estimates of the incidence and mortality of major types of cancers for 184 
countries in the world (Ferlay et al. 2010).  According to the GLOBOCAN 
estimation in 2008, of the 12.6 million new cancer cases (52.4% males, 47.6% 
females), 2.8% were non-Hodgkin lymphoma (3.0% males, 2.6% females), 0.8% 
multiple myeloma (0.8% males, 0.8% females), and 0.5% Hodgkin lymphoma 
(0.6% males, 0.5% females).  Since we cannot separate the acute 
lymphoblastic lymphoma (i.e. a subtype of lymphoid neoplasms under WHO 
classification, previously grouped as leukaemia) from acute myeloid leukaemia 
under the “Leukaemia” category, therefore they were not included in the 
followings. 
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a) Variation in incidence across countries and gender  
 
Lymphoid neoplasms, in terms of HL, NHL and MM subtypes, vary 
across countries.  Across all racial and ethnic groups in these countries, cultural 
and genetic factors may play a role in the cancer incidence.  The age 
standardized rate (ASR) of incidence and mortality of LN is universally higher in 
men than women.  The estimated age-standardized (world) rates of NHL, HL 
and PCM by gender were presented in Figure 1.1.   
 
Non-Hodgkin lymphoma: When the world is divided into 6 major regions, the 
ASR per 100,000 person-years (py) of NHL in 2008 was the highest in North 
America (16.2 per 100,000 py in males, 11.5 per 100,000 py in females), 
followed by the Oceania (i.e. Australia/New Zealand) (13.6 per 100,000 py in 
males, 9.6 per 100,000 py in females), and Europe (8.5 per 100,000 py in males, 
5.8 per 100,000 py in females).  The lowest ASR was in Asia (3.9 per 100,000 
py in males, 2.6 per 100,000 py in females), despite the number of incidence 
being the largest (n=75,866 in males and n=52,233 in females).  Considering at 
country level, the ASR of NHL was the highest in Israel (18.5 per 100,000 py in 
males, 14.9 per 100,000 py in females); followed by the United States of 
America.  The estimates in Singapore (9.6 per 100,000 py in males and 5.9 per 
100,000 py in females) were higher than most of the European countries (Ferlay 
et al. 2010).  
 
Hodgkin lymphoma: The pattern of HL was similar to NHL, where higher rates 
were reported in the Western countries.  The highest and lowest ASR of HL was 
in North America (2.6 per 100,000 py in males, 2.2 per 100,000 py in females), 
and Asia (0.8 per 100,000 py in males, 0.5 per 100,000 py in females) 
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respectively.  When comparing at country levels, Israel, Cyprus and Lebanon 
are the countries with highest ASR of HL (Ferlay et al. 2010).   
 
Multiple myeloma: The incidence of MM is the most prevalent in Europe, but 
the ASR is still the highest in North America (4.8 per 100,000 py in males and 
3.0 per 100,000 py in females), and the lowest in Asia (0.8 per 100,000 py in 
males and 0.6 per 100,000 py in females).  France and Luxembourg are the 
countries with the highest ASR of MM in males and females respectively (Ferlay 
et al. 2010). 
 
b) Variation in incidence across age  
 
HL, NHL and PCM have very different incidence pattern in terms of age 
at diagnosis (Figure 1.2).  HL is bimodal, the incidence is low in childhood but 
increases during adolescence to peak in young adulthood (i.e. first peak), the 
rate decrease gradually and then increases steadily again from 40 years old 
onwards (i.e. second peak).  As for NHL, the rate increased exponentially with 
age from adolescence, and MM commonly occurred after age 40 years and its 
rate increased with age. 
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Figure 1.1 Estimated ASR of incidence per 100,000 person years of NHL, HL 
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c) Changes in lymphoma trends over the years 
 
Non-Hodgkin lymphoma: Many studies reported that the incidence of NHL has 
risen dramatically in the past few decades.  Majority of the reports from the 
West, including US Connecticut (1935-1991) (Polednak 1994), SEER (1973-
1995) (Varterasian et al. 2000), Canada (1970-1996) (Liu et al. 2003), Denmark 
(1943-1989) (Hjalgrim et al. 1996), Italy (1974-1993) (Broccia et al. 2001), Spain 
(1973-1991) (Pollan et al. 1998), UK (1984-1993) (McNally et al. 1999), and 7 
countries across Europe (1985-1992) (Cartwright et al. 1999) suggested at least 
3% increase per year in NHL incident rates.  The rate of increase started to level 
off in early 1990s in Sweden/Denmark (1960-2003) (Sandin et al. 2006), Austria 
(1991-2000) (Mitterlechner et al. 2006) and Kuwait (1998-2006) (Ameen et al. 
2010).  Decreasing NHL trend was observed in Tunisia (1993-2006) (Missaoui 
et al. 2010) and Egypt (1995-2004) (Abdel-Fattah & Yassine 2007), although 
increasing trend was still observed in Pakistan between 1995-2002 (Bhurgri et 
al. 2005).  
 
Hodgkin lymphoma : Adamson et al (2007) reported the time trends of HL in 
13 European countries from 1953 to 2000, and found the incidence increased 
up to 1970s and tended to decline afterwards (Adamson et al. 2007).  The 
observed downward trend was supported by the analysis of IARC cancer 
registries (1973-1997) (Katanoda & Yako-Suketomo 2008), and a UK study 
between 1984-1993 which reported a 2.4% annual decrease (McNally et al. 
1999).  Decreased incidence of HL was observed for those above 40 years old, 
but a significant increase among adolescents and young adults was reported in 
Israel (Ariad et al. 2009), Connecticut (Chen et al. 1997), Nordic countries 
(Hjalgrim et al. 2001) and Singapore (Hjalgrim et al. 2008). 
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d) Trends of lymphoid neoplasms in Singapore 
 
The Singapore Cancer Registry has been collecting and reporting 
cancer statistics in Singapore every 5 years since 1968.  In the first few reports, 
the age-standardized rate of lymphomas were reported separately for: 
 
• Non-Hodgkin lymphoma (ICD-9: 200, 202/ICD-O-2: C00-C80 with M9590-
9595, M9670-9723 and M9740-9741),  
• Hodgkin lymphoma (ICD-9: 201/ICD-O-2: C00-C80 with M9650-9667),  
• Plasma cell tumours and immunoproliferative neoplasm (ICD-9:203 / ICD-
O-2:C42 with M9731-9732 and M9760-9768) and  
• Lymphoid leukaemia (ICD-0: 204 / ICD-O-2: C42).   
 
Since 2003-2007, the term Lymphoid neoplasms was used instead, 
and this included non-Hodgkin lymphomas (precursor lymphoid neoplasms, 
mature B-cell neoplasms, mature T-cell and NK-cell neoplasms, 
immunodeficiency associated lymphoproliferative disorders, and histocytic and 
dendritic cell neoplasms) and Hodgkin lymphoma based on the WHO 
classification. 
 
Table 1.7 shows lymphoid neoplasms was the 6th most common cancer 
in males, and 7th in females in 2003-2007, consisting of 1,309 cases (ASR 14.4 
per 100,000) in males and 973 cases (ASR 10.0 per 100,000) in females 
respectively (M:F=1:1.3).  As compared to Chinese, Malays had a higher risk of 
developing lymphoid neoplasm (RR 1.13 in males and 1.44 in females), and 
Indians the lowest risk (RR 0.75 in males and RR 0.87 in females). 
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Table 1.7 Incidence of lymphoid neoplasms, 2003-2007.  Source: Singapore 
Cancer Registry Report (NRDO 2010) 
 Rank No of incidence 




 c RR (95%CI) d 
Male       
• Alla 6 1309 6.0 15.2 14.4  
• Chinese 7 1029 5.5 15.8 14.5 1.0 
• Malay 3 178 10.2 14.8 16.9 1.13 (0.96-1.32) 
• Indian 4 80 8.3 10.7 11.4 0.75 (0.60-0.94) 
       
Female       
• Alla 7 973 4.2 11.1 10.0  
• Chinese 9 747 3.8 11.2 9.6 1.0 
• Malay 4 156 7.2 13.0 13.6 1.44 (1.21-1.71) 
• Indian 5 54 5.5 7.6 8.5 0.87 (0.66-1.14) 
a All ethnicity included Chinese, Malay, Indian and others. 
b Crude rate per 100,000 per year 
c ASR: Age-standardized rate (per 100,000 per year) to World population. 
d RR: Relative risk, adjusted for age and ethnic group using generalized linear 
regression model for binary data with the Chinese as the reference population. 
 
Figure 1.3 Age-specific incidence of lymphoid neoplasms in Singapore, 2003-
2007. Source: Singapore Cancer Registry Report (NRDO 2010).  
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Comparatively, the risk of lymphoid neoplasms increased slightly in early 
childhood and adolescence, and declined in young adults before increasing 
steadily from age 40 years onwards.  The risk of lymphoma was consistently 
higher in males as compared with females across all age groups (Figure 1.3). 
 
According to the Singapore Cancer Registry report 2003-2007, the 
average annual change in lymphoid neoplasms was 2.4% in males and 4.0% in 
females respectively during the period  1998 to 2007 (Table 1.8).  Lymphoid 
neoplasms was ranked the third highest in children under 15 years old, 
comprising 14.9% and 11.1% for males and females respectively of all cancers 
recorded in this age group.  A striking increase of 9.7% per year was noted in 
young females, which could not be accounted for.   
 
While most of the HL increases around the world was noted in 
adolescence and young adults, previous study on HL in Singapore showed the 
peak increase at age 15-19 and 20-24 years (Hjalgrim et al. 2008), which may 
account for the rise in the 15-34 age groups.  
 
Table 1.8 Lymphoid neoplasms according to different age groups, 1998-2007.  
Source: Singapore Cancer Registry Report (NRDO 2010). 
Age groups 
Males   Females  
Rank 
% of all 





% of all 
cancers in this 
age group 
AAPCa 
0-14 years 3 14.9 +2.46  3 11.1 +9.66 
15-34 years 1 21.1 +3.58  4 11.0 +6.26 
35-64 years 6 6.3 +1.97  7 3.4 +4.18 
65+ years 7 4.0 +2.42  7 3.6 +0.67 
All age   +2.37    +4.04 
a Average annual percent change, at 1998-2007. 
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Figure 1.4 shows the age-standardized rates per 100,000 per year by 
major subtypes of lymphoid neoplasms in Singapore.  The incidence of NHL 
increased significantly from 1968 to 2002 in both males and females, while 
those of HL, plasma cell and lymphoid leukaemias remained stable across all 
years.  Although these subtypes were all classified as lymphoid neoplasms 
based on the latest WHO classification, they behaved very differently across the 
years.  It is important to understand the secular trends in order to provide clues 
to the underlying risk factors.  
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1.5 Aetiology of lymphoid malignancies 
 
Two major factors that influence the incidence of cancer are hereditary 
and environmental factors.  Hereditary factors are inherited from our ancestors 
and cannot be modified.  Environmental factors, such as tobacco use, poor 
nutrition, inactivity, obesity, certain infectious or cancer-causing agents naturally 
occurring or existing as pollutants are potentially modifiable.  The followings are 
the major environmental risk factors investigated in this thesis:  
 
 
a) Occupational exposures 
 
At present, no consistent pattern of causal relations between 
occupational agents and increased lymphoma risk exists (Alexander et al. 2007).  
Overall, studies on exposures based on occupational job title and industry have 
many limitations.  Lack of specific individual-level exposure information is the 
main reason, and there were multiple-exposures in many occupations.  Possible 
etiological agents suggested from literatures were teaching profession, chemical 
exposures e.g. organic solvents, pesticides and insecticides, exposure to fumes, 
textile or printing environment, and viral infection (Alexander et al. 2007; Boffetta 




Numerous studies examined the relation between the teaching 
profession and the risk of NHL (Baker et al. 1999; Boffetta & de Vocht 2007; 
Cano & Pollan 2001; Costantini et al. 2001; Ji & Hemminki 2006; Miligi et al. 
1999; Svec et al. 2005; Zheng et al. 2002).  Findings from a meta-analysis of 19 
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studies showed an elevated relative risk amongst teachers (RR 1.47, 95%CI 
1.34-1.61) (Boffetta & de Vocht 2007).  No difference in risk was observed 
between primary / secondary school teachers, theoretical or arts teacher, nor 
principals or headmasters in a Swedish cohort study (Cano & Pollan 2001).  The 
detailed literature review on teaching profession and the risk of lymphoma is 
presented in Chapter 5.  
 
b) Ultraviolet (UV) radiation  
 
Solar UV radiation (wavelengths 100-400nm, divided into UV-A, UV-B 
and UVC) is a known carcinogen (El Ghissassi et al. 2009).  UV-B is also crucial 
to humans as it is our major source of vitamin D which is produced in our skin 
upon sun exposure.  There are several factors influencing UV radiation levels 
reaching Earth.  These include geographical latitude and altitude, cloud cover, 
ozone level, seasons and  time of day etc (Kimlin 2008).   
 
Cartwright et al (1994) reported parallel increases in the incidence of 
both NHL and non-melanoma skin tumours in various populations using registry 
data from the IARC (Cartwright et al. 1994).  Large population-based studies 
also observed an increased risk of subsequent NHL among patients with skin 
cancer, or vice versa (Adami et al. 1995; Hu et al. 2005).  These findings led to 
the suggestion that solar UV irradiation may be a common risk factor, possibly 
through immunosuppression (Elwood & Jopson 1997).  However in studies on 
individual-level sun exposures suggested an inverse association between sun 
exposure and risk of NHL, which may be explained by increased serum vitamin 
D level resulting from sun exposures (Hughes et al. 2004).   The detailed 
literature review on sun exposure and the risk of lymphoma is presented in 
Chapter 6.  
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c) Alcohol drinking  
 
Some epidemiological studies on alcohol drinking and risk of NHL have 
reported an inverse association (Kanda et al. 2009; Klatsky et al. 2009; Lim et al. 
2007; Monnereau et al. 2008), others did not (Benedetti et al. 2009; Besson et 
al. 2006b; Chang et al. 2010b; Chang et al. 2004; De Stefani et al. 1998; 
Deandrea et al. 2007; Polesel et al. 2007; Tavani et al. 2001; Troy et al. 2010; 
Willett et al. 2007; Willett et al. 2004).  The inverse relationships between 
alcohol drinkers and NHL risk were reported in moderate drinkers (Morton et al. 
2005b) and wine drinkers only (Briggs et al. 2002b; Morton et al. 2003b); other 
studies showed no change in risk estimates in any types of alcoholic drinks 
(Morton et al. 2005b; Nieters et al. 2006).  The detailed literature review on 
alcohol drinking and the risk of lymphoma is presented in Chapter 7.  
 
d) Cigarette smoking 
 
Tobacco smoke has been classified by WHO as carcinogenic to human 
(IARC 2012). Conflicting study on cigarette smoking were showing an elevated 
NHL risk (Freedman et al. 1998; Linet et al. 1992; Morton et al. 2005a; Talamini 
et al. 2005), while others reporting no association (Besson et al. 2006b; De 
Stefani et al. 1998; Fernberg et al. 2006; Herrinton & Friedman 1998; 
Monnereau et al. 2008; Nieters et al. 2008; Willett et al. 2004; Zahm et al. 1997).  
A large pooled analysis involving 6,594 cases and 8,892 controls, found a 
slightly elevated NHL risk with ever smokers (OR 1.07, 95%CI 1.00-1.15), and 
current smokers (OR 1.10 95%CI 1.00-1.20) (Morton et al. 2005a).  Compared 
with non-smokers, heavy smokers and those who smoked for a longer duration 
had an increased NHL risk (Freedman et al. 1998; Morton et al. 2005a; Talamini 
et al. 2005). 
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Most of the studies on cigarette smoking consistently showed increased 
risk of HL (Besson et al. 2006a; Briggs et al. 2002a; Glaser et al. 2004; Hjalgrim 
et al. 2007; Nieters et al. 2006; Nieters et al. 2008; Willett et al. 2007).  A meta-
analysis of 17 studies reported an elevated risk of HL in current smokers (OR 
1.35, 95%CI 1.17-1.56, p<0.001), but not former smokers (Castillo et al. 2011).  
The detailed literature review on cigarette smoking and the risk of lymphoma is 
presented in Chapter 7.  
 
e) Other potential confounders and risk factors 
 
Family history of cancer: An important familial component in the development 
of lymphoma has been reported in many studies. The risk of different LN 
differed according to gender and the familial relationship of the affected 
relative.  A study from Swedish Family Cancer Database reported a 3-fold 
increase risk in developing HL in relatives of patients with HL (Goldin et al. 
2004). In a separate study by InterLymph, they reported elevated NHL risk 
for individuals who had a brother with NHL (OR 2.8, 95%CI 1.6-4.8), a 
parent with HL (OR 1.7, 95%CI 1.0-2.9), or in women whose sister were 
diagnosed with leukaemia (OR 3.0, 95%CI 1.6-5.6) (Wang et al. 2007). 
 
Social economic status (SES): Study on social economic status represents an 
indirect measure of known and unknown environmental risk factors.  
Education level is one of the contributing factors on the understanding of 
SES.  Limited studies about educational level or other SES indicators and 
lymphoma risk have been published (Boffetta et al. 1989; Clarke et al. 2005; 
Hermann et al. 2010).  In a large prospective EPIC cohort study, high 
education level (e.g. subjects with university degree) was positively related 
to women subjects diagnosed with B-NHL (HR 1.31, 95%CI 1.02-1.68); but 
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inversely to incidence of DLBCL (HR 0.46, 95%CI 0.27-0.79) (Hermann et 
al. 2010).  In another study of 3,794 HL incidence from California cancer 
registry, using residential address to determine neighbourhood SES, high 
SES was associated with the risk of young HL (aged 15-44) (male: RR 1.22, 
95%CI 1.05-1.42; female: 1.44, 95%CI 1.22-1.70), and the finding was 
consistent in Whites and Hispanic populations.   
 
BMI/Obesity: Obesity, defined as body mass index (BMI) of 30kg/m2 or 
above, was associated with elevated risk of NHL incidence (Pan et al. 2005; 
Rapp et al. 2005; Willett et al. 2005; Wolk et al. 2001) in some studies but 
not in others (Britton et al. 2008; Chang et al. 2005; MacInnis et al. 2005; 
Willett et al. 2008).  In a meta-analysis on 9 prospective studies, Renehan 
et al (2008) reported a weak positive association between 5 kg/m2 increase 
in BMI and NHL incidence in both sexes (men: OR 1.06, 95%CI 1.03-1.09, 
p-trend<0.0001; women: OR 1.07, 95%CI 1.00-1.14, p-trend=0.05).  
Increased BMI at early adulthood was a better predictor variable than recent 
BMI (Kanda et al. 2010; Maskarinec et al. 2008; Pylypchuk et al. 2009). 
 
 
In conclusion, lymphoid neoplasms are a group of complex disease more 
than 40 entities based on the latest classification in 2008, and there is a 
possibility of increasing subtypes in future due to the advance in genetic 
diagnosis.  LN may be presented in any parts of the body, an extensive clinical 
investigations are needed to carry out in order to confirm a diagnosis.  Disease 
progression depends on the subtype entities, as aggressive subtypes may 
present with signs and symptoms within weeks. Indolent entities may stay low or 
even asymptomatic for years, until it presents clinically or discovered by chance 
(Figure 1.5).  Disease prognosis is usually good for NHL and HL as compared 
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with the other cancers.  Based on the subtypes of lymphoma, prognostic scores, 
stage of lymphoma at presentation, there are clinical guidelines for 
recommendation on standard treatment, such as chemotherapy, radiotherapy 
etc. (National 2006a; National 2006b) 
 
The WHO classification of lymphoid neoplasms suggested both Hodgkin 
lymphoma and non-Hodgkin lymphoma are belonged to one big family. 
However, in terms of cancer rates across the world, clinical presentation and 
involvement (Table 1.9), response to treatment, as well as the etiological factors 
trigger the on-set of disease are different between HL and NHL.  There are still 
a lot of questions about lymphoid neoplasms that need to be answered.   
 
Table 1.9 Comparison of Hodgkin and Non-Hodgkin lymphomas 
(Emmanouilides & Casciato 2004) 
Characteristic In Hodgkin lymphoma 
In Non-Hodgkin lymphoma 
Low Grade Others 




Nodal distribution Centripetal 
(axial) 
Centrifugal Centrifugal 
Nodal spread Contiguous Non-contiguous Non-
contiguous 
CNS involvement Rare (<1%) Rare (<1%) Uncommon 
(<10%) 
Hepatic involvement Uncommon Common 
(>50%) 
Uncommon 









Yes No Yes 
Curable by chemotherapy Yes No Yes 
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1.6 Aims of study and outline of thesis  
 
The lymphoma rate in Singapore is the highest in Asia, and it is close to 
those of Western countries.  It has been increasing consistently over the years 
with no apparent reasons to account for the rise. In Chapter 1, we presented 
the complex diagnosis of lymphoma, literature review on the different 
classifications adopted in the world in the past few decades, and the patterns of 
lymphoma incidence across countries.  Since most of the studies on aetiology 
factors were conducted in the West, there is a knowledge gap regarding its 
association with the development of lymphoma in Asian populations.  In 
Chapter 2, we provided an overview on the different study designs, with the 
strengths and limitations, and discussions on the best study design for the 
following studies. The aims of study in this thesis are :  
 
1) To examine the trends of lymphoma in Singapore under REAL and WHO 
classification systems using the age-period-cohort analysis.  In Chapter 3, 
using incidence data over 40 years from the national cancer registry, we 
decompose the individual effect of age, period and cohort on the secular 
trends of lymphoma in Singapore.  
 
2) In order to understand the unique aetiology factors in Singapore, we 
conducted a hospital-based multi-ethnic case-control study, and presented 
its detailed study design and histological subtypes in Chapter 4. The aim of 
this hospital based case-control study is to:  
 
a. To provide an overall understanding of the associations of common 
occupations in Singapore with the risk of lymphoma, following the 
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Standard Singapore Occupation Classifications 2005 as described in 
Chapter 5. 
 
b. To examine the effects of sun exposure for recreational and occupational 
purposes and related behaviours. In Chapter 6, we investigate the 
tropical sun effect on the risk of lymphoma as compared with previous 
studies conducted in temperate region. 
 
c. To investigate the modifiable lifestyle factors of tobacco use and alcohol 
drinking behaviours in order to examine the link between lymphoma risk 
with these addictive behaviour.  The details of this sub-study are 
described in Chapter 7. 
 
 
Finally, in Chapter 8, we summarise the current knowledge about 
lymphoma, discuss the findings from our studies, highlight the strength and 
limitations of the studies, as well as provide an overall conclusion and suggest 
scope for future work.  
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Chapter 2 
Overview of study designs 
 
The basic purposes of epidemiological studies are to quantify the 
occurrence of disease or health-related issues, and to assess whether an 
exposure is associated with the diseases or outcome of interests in a population.  
It is never possible to design a research study without flaws, however, it is 
important for us to identify the strength and limitations, and select the best 
suitable design to answer our research questions. 
 
 
2.1 Definition of terms 
 
Cases – an individual in a population presented with the disease, or undergo an 
event of interest.  Cases may be identified through disease registries, hospital 
records, pathology reports, or even death certificates.  The cases must comply 
with the standard definition for the study, e.g. first diagnosis of disease, or 
recurrent episodes of non-fatal condition etc.  This numerator includes all cases 
in the study population at risk. 
 
Population at-risk – The denominator refers to the size of population at-risk of 
the event under investigation, and where the cases originates from, e.g. the 
catchment population of a hospital, the total population of a country etc.  
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Time period – Since most of the health-related event does not occur constantly 
over time, any measure of disease incidences shall be fixed at regular time 
period, to measure all cases arise from the population at risk, e.g. the number of 
colorectal, breast and prostate cancers were much lower at the beginning of 




2.2 Time trends of disease 
 
Information on changes in cancer risk over time can generate etiological 
hypothesis or support suspected associations between risk factors and disease 
in a country.  Using secondary data source, i.e. already existing dataset which 
routinely collected from data-collection system, provides a relatively fast and 
economical way of analysing data without the process of facing each disease 
subject.   
 
The population-based cancer registry is an organization for the 
systematic collection and storage of all new cancer cases occurring, e.g. the 
Singapore Cancer Registry.  They describe and report the cancer statistics 
displaying the nature of cancer burden in the population on every 5-yearly, it is 
also a resource for epidemiological studies.  Cancer registry has a clear 
definition of catchment population of all new cases in the community.  
Information on incident cancer cases were collected through compulsory cancer 
notifications from all sections of the medical profession, pathology reports, 
hospital reports and death certificates (Table 2.1).  We understand that 
notification is part of the clinical services, there may be cases missed to inform 
Ch.2 – Overview of designs 
37 
during the process.  The accuracy of cancer registration was increased by active 
reviewing of medical records at the hospitals and clinics and updating regularly. 
Cancer-specific incidence rates can be generated over the total population at-
risk and reported in their statistical reports. International Classification of 
Diseases for Oncology (ICD-O) was used to code the topography and 
morphology of the tumours (Percy et al. 2000) (Appendix 2 and 3).  The 
advantages of population-based cancer registry are the validity of data, but the 
database in cancer registry may have collected limited information on age, 
gender and ethnicity only. 
 
Table 2.1 Sources of cases and types of notifications, 1998-2007 (Source: 
Singapore Cancer Report) (Chia et al. 2000; NRDO 2010; Seow et al. 2004) 
 1993-1997 1998-2002 2003-2007 
 n (%) n (%) n (%) 
Cases notified by medical 
practitioners 
23339 (73.3) 27301 (71.0) 18680 (41.4) 
• Spontaneously 9551 (30.0) 15164 (39.4) 15928 (35.3) 
• On request 13789 (43.3) 12137 (31.6) 2752 (6.1) 
       
Cases registered by staff on the 
basis of 
8490 (26.7) 11146 (29.0) 26460 (58.6) 
• Pathology reports 6574 (20.7) 9075 (23.6) 23324 (51.7) 
• Hospital records 1587 (5.0) 1717 (4.5) 2536 (5.6) 
• Death certificate 329 (1.0) 354 (0.9) 600 (1.3) 
TOTAL 31829  38447  45140  
 
On the other hand, hospital-based cancer registries record information 
on all cancer patients attended to a particular institution.  They have readily 
accessible medical records on the patients with cancer, the treatments received 
and their outcomes.  The purpose is to monitor and plan for patient care and 
resources allocation at hospital level.  The advantage of hospital-based cancer 
registry is more extensive data collected than population registry, e.g. cancer 
Ch.2 – Overview of designs 
38 
topography and morphology, TNM and staging, treatments, and number of 
admissions etc.  However, no definite catchment population was in hospital 
settings, incident rates cannot be determined since the data only represent one 
hospital.  They may also have limited access to the death certificates for the 
outcomes, and no standardized method of collection across all hospitals (dos 
Santos Silva 1999).  Therefore, in order to compare the trends of cancer 




2.3 Types of study designs 
 
There are two basic approaches to assessing whether an exposure is 
associated with a particular outcome: by experimental or observational studies.  
The experimental or intervention approach refers to investigations carried out in 
laboratory environment, or randomized control trials on volunteer healthy 
subjects, with substance or various factors which they can control. For ethnical 
reasons, usually only experimental studies with potential benefits were 
conducted, which will not be focused on in this thesis.  Most of the 
epidemiological studies conducted were observational studies, and will be 
discussed in the following.  
 
Cohort study – Cohort study is a prospective observational study.  It starts with 
a selection of population, i.e. a cohort, from a defined study base, and they are 
free from the disease of interest.  The subjects are similar individuals but 
different with respect to certain exposure factor under study, and usually the 
exposure is few and limited.  The information of exposure status is collected at 
Ch.2 – Overview of designs 
39 
the beginning of cohort, follows over a long period of time for events to occur in 
this large group of people.  Cohort study is used to estimate how this factor 
affects the average risk of certain outcomes or disease state, the incidence of 
the disease in the exposed individuals is compared with the incidence of the 
non-exposed group.  The relative risk of disease is measured as the cohort 
remains at risk and under observation for the entire follow up time.  For 
examples, the British doctor study by Sir Richard Doll is a cohort study from 
1951 to 2001, on the analysis of association between tobacco smoking and risk 
of lung cancer (Doll et al. 2004). 
 
Case-control study – Case-control study is a retrospective observation study.  
It starts with two groups of subjects with the presence or absence of disease 
state or outcome of interest, and determines the past exposure levels and their 
association with current disease status.  This design allows the evaluation of a 
wide range of exposures that could be related to, or interacted with other factors 
and the disease of interest.  A precise definition of cases is required for 
selection of eligible cases into this design, e.g. histological confirmation of 
cancers, and mainly recruited in hospital or clinic settings where patients 
attended.  Controls should be selected from the same source population which 
give rise to the study cases, and they should be selected independently of their 
exposure status.  Case-control study cannot yield estimates of effect as 
measures from cohort study, since the ratio of cases and controls are pre-
determined and recruited by researchers, it estimated the incidence odds ratio.  
For example, the multi-country InterLymph study is a case-control study design, 
to assess multiple aetiology factors on the genesis of lymphoma in the West 
(Kricker et al. 2008; Morton et al. 2005a; Morton et al. 2005b).  
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Nested case-control study (Ernster 1994) – This is a specific group of case-
control analysis conducted within a fixed cohort study.  It begins with a defined 
cohort.  Cases are cohort members who developed with the disease of interest 
after a certain follow-up period, and the controls are a sample of disease-free 
individuals at the time of selection, but not all members of the cohort.  Time 
matching is essential for each case and control combination.  For each case, a 
number of controls are selected based on several variables e.g. age, date of 
entry into cohort, length of time in cohort, or any other variables.  Cohort 
members who serve as controls may later become a case.   
 
 
2.4 Selection of controls 
 
Wacholder et al have published a clear definition of selection of controls 
in case-control studies (Wacholder et al. 1992a; Wacholder et al. 1992b; 
Wacholder et al. 1992c).  Two rules of thumb for selection of controls: 1) 
controls should be selected from same population which gives rise to cases, 2) 
controls should be selected independently of their exposure status of interest.  
Apart from nested case-control study that controls were arise from designated 
cohort population, other case-control studies do not have a clear and well-
defined study base, therefore random selection from general population is not 
possible.   
 
There are several sources of controls for population-based case-control 
studies.  Neighbourhood controls refer to people living in the same 
neighbourhood; they are similar to cases in many aspects e.g. social economic 
status.  It is time-consuming and expensive to draw a control to individually 
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match with cases on, for example, age, gender and ethnicity simultaneously.  If 
the cases were being identified in a hospital which is related to specific 
exposure, then recruiting controls from the neighbourhood may introduce bias, 
since the exposure might not be the same.  Friends or relatives controls are 
another source for individual matching with cases.  Friends and their 
acquaintances may engage in similar activities and diet habit, or colleagues in 
the same occupational environment, which also related to the exposure of 
interest as cases, hence these may lead to overmatching in terms of exposures 
and other characteristics.  Random-digit dialling, a method which is more 
commonly used in Western countries, offers researcher a cheap and efficient 
approach to the general population by a simple telephone call, especially if the 
area covered is huge.  But this method is not suitable in Singapore since we do 
not have area code to identify the specific area we would like to make calls.  
There are also other limitations on this method that people may have more than 
one contactable telephone number, e.g. residential home phone, mobile phone, 
office phone lines etc.  Residential phone line is not a must for every household, 
or it may be shared by several members of different age groups.  
 
Hospital-based controls refer to a group of people who would be 
treated in a given hospital if they developed disease in question.  If these 
‘hospital users’ were came from the similar catchment area as the cases, and 
they were under the same referral patterns from primary physicians, they may 
be the same pool of patients that give rises to cases.  Comparatively these 
hospital controls are easy to be identified, they also experienced illness and 
hospitalization, they may resemble the cases with respect to similar area of 
residence, tendency to answer questions, and have less biased estimates to 
recall differently from cases.  The major problem for hospital controls is their 
illness may share risk factors with cases, and the possibility of over or under 
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represent the exposure distribution in the source population.  Limiting the 
admission diagnosis for controls in conditions associated with cases, and select 
controls with various different conditions may cancel out the bias introduced by 
specific diseases.  
 
 
2.5 Bias and confounding factors 
 
Bias is defined as systemic errors in the design or conduct of a study, 
the observed study results will tend to be different from the true results.  On the 
other hand, confounding factors are risk factors correlated with the exposure 
under study, and it must be also an independent risk factor for the disease, but 
not an intermediate factor in the casual pathway between exposure and the 
disease.  The presence of confounding factors will obscure the real effects 
between the exposure and the outcome of interest (Szklo & Nieto 2004).  
 
Selection bias occurs when there is a difference between the 
characteristics of the people selected in the study, and those who did not 
participate, due to improper procedure of acquiring persons from the target 
population into the study.  It results in a distortion in a measure of association.  
For example, when the exposure of interest are related to the conditions for 
controls to be hospitalized, and at the same time with the disease of study, thus 
the association will biased towards null.  This is known as the Berkson’s bias in 
hospital-based case-control study infamously.  Self-selection is also a bias, 
when people who volunteer to participate in a study tend to be different from the 
non-responders, in terms of demographic and lifestyle factors (e.g. more health 
conscious or with better education), which could be the risk factors for outcome 
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of interest.  Healthy worker effects are another bias in occupational exposure 
studies.  When cases are workers, controls should also be workers in order to 
compare occupational-related exposures, since working individuals are 
generally healthier than people who are not (fit for) working.  In a nutshell, 
differential recruitment criteria for cases and controls, or individual hospitalized 
for disease related to exposure under investigation should be excluded to 
eliminate selection bias (dos Santos Silva 1999).   
 
Measurement (information) bias occurs when there are errors in 
measurement, e.g. interviewer bias, the interviewer probe the respondents 
differently due to their disease status.  A standard operating procedure should 
be administrated, and with trainings provide for interviewers to maintain the 
quality since the disease states of cases and controls cannot be blinded in a 
hospital-based case-control setting.  The questionnaire should also be 
standardized and administrated to all participants, the quality assurance should 
follow through from the beginning to the end of study, e.g. using of voice 
recording device to maintain the standard.  Recall or reporting bias is another 
kind of information bias, where the cases and controls recall differently on the 
exposure of interest.  When cases and controls are both hospitalized patients, 
they experienced the similar referral pattern, thus will reduce the discrepancy 
between cases and controls on recalling past exposures.  
 
In order to control for confounding factors, it is best to do this in the 
design phase, rather than in the analysis phase.  Randomization is the gold 
standard method in experimental studies, i.e. randomized control trials.  
Restriction on inclusion criteria is a convenient but efficient way to control for 
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strong confounding factors, however the restricted variables cannot be 
assessed for confounding in the subsequent analysis.  Matching is another 
method to constraint the distribution of confounding variables within cases and 
controls are similar, e.g. age, gender, race, social economic status. The 





In conclusion, there are several factors need to be considered in 
designing a study for investigations on a rare disease such as lymphoma: 
 
(1) In order to investigate the trends of lymphoma in Singapore, the population-
based cancer registry provided a highly valid data source, which came from 
a defined population at-risk in the country.  Age-standardized rates can be 
calculated across the periods and compared with other countries; 
 
(2) The advantage of nested case-control study is that both cases and controls 
arise from a defined cohort population, where in case-control study that is 
not easily defined.  Smaller number of study subjects are needed for 
analysis than cohort study, thus it is less expensive and less time 
consuming.  This is particularly important for expensive laboratory analysis 
with limited amount of samples collected.  Data are likely collected prior to 
diagnosis of disease than conventional case-control study, hence recall bias 
is not an issue.  Nested case-control study consists of both the robustness 
of cohort study, and the ability to assess multiple exposures as case-control 
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study.  It would be a perfect choice to investigate aetiology factors of rare 
disease as lymphoma, if such a cohort is existed.  In the Singapore context, 
we would be able to ascertain cases from the Singapore Cancer Registry, 
however we still need to recruit controls from the general population.  
 
(3) Regarding the aetiology factors investigation, a hospital-based case-control 
study design would be appropriated, based on the biology of disease, long 
duration of exposure and long period of time for lymphoma to accumulate.  
It requires smaller sample size in case-control design than cohort studies 
and thus more cost-effective.   
 
(4) The referral pattern from primary physicians to generalized hospitals for 
further investigations and treatments are the same in Singapore, regardless 
the admission is related to cancer or any other clinical diseases, and they 
are usually come from the catchment area of the nearest hospital.  Thus the 
Berkson’s bias would be reduced. 
 
(5) There were no known risk factors to explain for lymphoma, no vaccines 
available at the market to prevent lymphoma, no health programmes offered 
on how to prevent lymphoma, nor screening programme offered by any 
clinic or hospitals at the time being.  Most of the general population have no 
idea about the cause of lymphoma in Singapore; differential reporting in 
information bias may not be a concern.  
 
(6) Quality assurance procedures should be implemented to reduce bias and 
confounding factors in the study design.  Standard operating procedures for 
recruitment should be adhered to by trained-interviewers, including 
inclusion and exclusion criteria for cases and controls.  The interviewer shall 
follow the standardized questionnaire throughout the study.  
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(7) Since the population is dynamic and it is difficult to define the population at-
risk, hospital controls should be time-matched with cases by recruitment of 
controls that are still at-risk at each time a case is diagnosed.  Matching on 
strong confounding factors such as age and gender would increase 
precision and lower the cost by recruiting a relatively lower sample size. 
 
(8) In the analysis phase, adjustment for known confounding factors would 
remove the effect from confounding factors, and may remove the related 
unknown risk factors.  
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Chapter 3 
Trends of lymphoma in Singapore from 1968-2007 
 
 
The age-period-cohort (APC) modelling is often used to examine the 
temporal variations in disease incidence and typically of chronic diseases 
(Clayton & Schifflers 1987), e.g. primary bone cancer incident rate in the United 
States (Anfinsen et al. 2011), gastric cancer mortality in Europe (Malvezzi et al. 
2010).  The time trend of disease rates is attributed by the effects of a) 
chronological age at diagnosis, b) period or year of diagnosis, c) cohort or the 
year in which an individual is born (Holford 1991).  The chronological age effect 
suggests the different risks associated with time since birth.  The predominance 
of period effect suggests a change in a particular calendar year of diagnosis 
which affects all age groups, e.g. change in method of diagnosis or disease 
classification system.  Lastly, the birth cohort effect suggests differences 
between distinct generations (birth cohorts) of individuals in the population, i.e. a 
change in lifestyle or prevalence of an infectious disease over a lifetime.  
 
 
3.1 Source of data  
 
This is a retrospective population-based study, using aggregated 
unidentified data requested from the Singapore Cancer Registry, in January 
2008 for the period 1968-2002.  Further updates on the data for the duration 
2003-2007 was obtained in September 2010.  The Singapore Cancer Registry is 
a well-documented registry since 1968.  It receives cancer notification mainly 
from the medical profession, as well as review from pathology reports, hospital 
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records and occasionally death certificates.  The data is managed by the 
National Registry of Diseases Office, Singapore.  The completeness of cancer 
reporting was close to 100% since 1990 (NRDO 2010).  The histological grading 
of lymphoma was classified by ICD-9 for the period of 1968-1992, ICD-O-2 for 
1993-2002, and ICD-O-3 for 2003-2007.  The lymphoma data was presented in 
5-yearly age intervals (0-4, 5-9 to 75-79, and 80+ years) and for the periods 
(1968-1972, 1973-1977, 1978-1982, 1983-1987, 1998-2002, and 2003-2007). 
  
Statistics of the Singapore population (i.e. denominators) for the period 
1968 to 2007 were obtained from the Department of Statistics.  These were 
derived by interpolation using the 1970, 1980, 1990, and 2000 census data, and 
extrapolation for 1968 to 1970 and 2001 to 2007.  The denominator was 
presented in 5-yearly intervals (0-4 to 80+ years) using the same calendar 
period (1968-1972 to 2003-2007).  
 
 
3.2 Statistical analysis 
 
a) Age-standardized rates of lymphoid neoplasms 
 
The LN incidence was grouped in 5-yearly intervals for both age at 
diagnosis (0-4 to 80+ years) and calendar year of diagnosis (period) (1968-1972 
to 2003-2007), and stratified by gender.  The age-standardized rate were 
calculated by direct standardization according to the World Standard Population 
(Segi 1960) and was expressed per 100,000 person-years.  The age-
standardized incidence rate across periods was plotted separately by gender.   
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b) Age-specific rates of lymphoid neoplasms 
 
The 5-yearly age-specific rates of lymphoid neoplasms were calculated 
using the incident cases of LN as numerator, and the Singapore population at 
the respective age range as denominator.  The age-specific rates were 
presented per 100,000 person-years.  The age-specific temporal trends were 
plotted for both year of diagnosis (period) and of birth cohort according to 




c) APC modelling by maximum likelihood approach 
 
Due to the complexity and changes in lymphoma classifications in the 
past few decades, the subtypes of lymphoma included in each analysis varies 
across publications.  We generated 3 different models to compare age, period 
and cohort effects, to take into account the changes in classification system.  
Considering that the paediatric cases may behave differently from the rest of 
adult lymphoma cases, and the open-ended oldest group (i.e. aged 80 years 
and above) may have limited cases and hence resulted in unstable estimates, 
both these groups were excluded from APC analysis.  Thus these APC models 
included only subjects aged 15 to 79 years, for the period 1968 to 2007:  
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• Model 1 – NHL: This is based on the classification of Non-Hodgkin 
lymphoma as in most of the previous publications.  Traditional NHL included 
diffuse and follicular lymphoma, marginal zone B-cell lymphoma and T/NK-
cell lymphomas only (ICD-9 codes 200, 202). 
 
• Model 2 – B-/T-cell NHL : This NHL model is based on the WHO 
classification of B-cell neoplasms and T/NK-cell neoplasms (Jaffe et al. 2001).  
This model includes Model 1 of traditional NHL, plasma cell tumours and 
immunoproliferative neoplasm (ICD-9 203 / ICD-O 9731-9734 and 9760-
9768), and precursor lymphoid leukaemia and chronic lymphoid leukaemia 
(ICD-9 204 / ICD-O M9727-9729, 9820-9837). 
 
• Model 3 – WHO LN : This model is based on the WHO classification of 
lymphoid neoplasms.  This includes NHL from Model 2 with Hodgkin 
lymphomas cases (ICD-9 201 / ICD-0 9650-9667). 
 
 
Figure 3.1 Schematic diagrams of Models 1 to 3. 
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To obtain the effects of age, period and cohort, a log-linear model was 
fitted to the data using Poisson regression with a log link function, and adjusted 
for gender in all models.  
 
The general form of the age-period-cohort model is 
log(lijk) = µ + αi + βj + γk + εijk 
where lijk= the incidence rate in the ith age group, jth period and kth cohort, µ = the  
intercept, αi = the effect of the ith age group (i=1,2…I), βj = the effect of the jth 
period (j=1,2…J), γk = the effect of the kth birth cohort (k=I-i+j), and εijk = random 
error term.  The model fitting was based on 13 age groups (15 to 79 years), 8 
periods (1968-2007) and 20 birth cohorts (1891-1895 to 1986-1990).  The first 
calendar period in 1968-1972, the middle age group of 40-44 years as well as 
birth cohort 1941-1945 were used as reference groups. 
 
We used the model building approach suggested by Holford (1991).  For 
each classification, the following models were generated: a one-factor age 
model, two-factor age-drift, age-period and age-cohort models and full 3-
factor age-period-cohort model.  The first model with only age assumes no 
temporal variation, and that chronic disease incidence takes time to accumulate 
as people age.  The two-factor age-drift model refers to regular drift which 
cannot be attributed to period or cohort influences.  
 
Likelihood ratio tests were carried out on nested models to assess the 
significance of added effects.  The effects of these risk factors were quantified 
using estimates obtained from the best fitting log-linear model.  We compare the 
one-factor model with the two-factor models.  The age-drift model was then 
compared specifically with age-period and age-cohort model separately.  
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Subsequently the comparisons of each two-factor model were made with the full 
3-factor model.  Since the 3 components are interrelated, there is an exact linear 
dependency between the age, period and cohort.  To overcome this 
identifiability problem, we constrained the first two calendar-year periods as 
identical i.e. replacing the period of 1973-1977 with 1968-1972, assuming the 
incidence rates of the first 2 periods were the same (Holford 1991). 
 
The deviance statistics was used to determine the goodness-of-fit of the 
models and significance of the effects (Clayton & Schifflers 1987).  A low 
deviance and a non-significant p-value in the test indicate a good fit of the 
model to the data.  In addition, we further estimated the residual deviate from 
linear regression of the full APC model as these estimates were identifiable and 
invariant.  The non-linear deviates for each factor in the full APC model were 
known as the curvature and plotted by age, period and cohort factor separately.  
All statistical analysis was performed using R 2.8.1 statistical software package, 
assuming a two-sided test at the 0.05 level of significance. 
 
 
3.3 Lymphoma incidence from 1968 - 2007 
 
From 1968 to 2007, a total of 8,903 (5,261 males, 3,642 females) 
lymphoid neoplasms were recorded in the Singapore Cancer Registry for cases 
aged 0 to 80+ years (Table 3.1).  There were 262 cases in males and 157 
cases in females for the period 1968-1972, then it increased to 1,309 and 974 
cases in males and females respectively between 2003 and 2007.  The number 
of lymphoid neoplasms cases was presented according to 4 major subtypes, 
including Precursor, Plasma cell myeloma, HL, and the rest of NHL in Figure 
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3.2.  The major group of NHL subtypes increased dramatically, while HL, 
plasma cell and precursor subtypes rose gradually over the 40–year period.  
 
As presented in Figure 3.3 the age-standardized incidence rates (ASR) 
of lymphoid neoplasm increased from 5.08 per 100,000 per year (6.37 in males, 
3.82 in females) in 1968-1972, to 11.89 per 100,000 per year (14.06 in males, 
9.92 in females) in 2003-2007.  HL rates were relatively stable across the four 
decades, while NHL rates rose steadily.  In terms of gender difference, the ASR 
in males across all periods was consistently higher than females, and ranged 
from 1.39 to 1.69:1 (Table 3.1).  
 
Age-specific incidence rate of LN among age 15 to 79 years 
 
The log-scaled age-specific incidence per 100,000 person-years of LN 
was plotted by calendar period and birth cohort in Figure 3.4.  For clarity of 
presentation, only data for every other 5-year age group are shown for age 
between 15 to 79 years.   
 
Within each age group, the incidence rate of LN increased with each 
successive calendar period.  Within the same calendar period, the incidence 
rates increased with age, particularly in those over 40 years old.  The pattern 
was consistent across all calendar periods, with the highest rates being 
observed in the oldest age group.  Likewise, the parallel age-specific curve 
showed increasing incidence with each successive birth cohorts.  This same 
pattern was observed for both genders, as shown separately for calendar period 
in Figure 3.5 and birth cohort in Figure 3.6.  The incidence rates in males were 
consistently higher than females.  
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Table 3.1 Lymphoid neoplasms according to subtypes and gender, 1968-2007. (Source: Singapore Cancer Registry) 
 Histological subtype (ICD coding) Period   68-72 73-77 78-82 83-87 88-92 93-97 98-02 03-07 TOTAL 






 • Lymphosarcoma and reticulosarcoma (200) 
• Hodgkin’s disease (201) 
• Other malignant neoplasm of lymphoid and histiocytic tissue (202) 
• Multiple myeloma and immunoproliferative neoplasm (203) 































• Malignant lymphoma, NOS (9590/3) 
• Non-Hodgkin lymphoma, NOS (9591/3, 9593/3, 9595/3, 9672/3) 
• Hodgkin lymphoma (9650/3-9667/3) 
• B-cell lymphoma (9670/3-9698/3, 9760/3-9761/3, 9823/3,9826/3, 9940/3) 
• T- and NK-cell lymphoma (9700/3-9717/3, 9827/3) 
• Plasma cell myeloma (9731/3, 9732/3, 9830/3) 
• Precursor lymphoid leukaemia (9727/3-9729/3, 9820/3-9821/3) 























TOTAL incidence  262 288 382 527 620 822 1051 1309  5261 
Age Standardized Rate per 100,000  6.37 6.80 8.42 10.24 10.29 11.71 13.05 14.06   






 • Lymphosarcoma and reticulosarcoma (200) 
• Hodgkin’s disease (201) 
• Other malignant neoplasm of lymphoid and histiocytic tissue (202) 
• Multiple myeloma and immunoproliferative neoplasm (203) 































• Malignant lymphoma, NOS (9590/3) 
• Non-Hodgkin lymphoma, NOS (9591/3, 9593/3, 9595/3, 9672/3) 
• Hodgkin lymphoma (9650/3-9667/3) 
• B-cell lymphoma (9670/3-9698/3, 9760/3-9761/3, 9823/3,9826/3, 9940/3) 
• T- and NK-cell lymphoma (9700/3-9717/3, 9827/3) 
• Plasma cell myeloma (9731/3, 9732/3, 9830/3) 
• Precursor lymphoid leukaemia (9727/3-9729/3, 9820/3-9821/3) 























TOTAL incidence  157 192 234 353 462 549 721 974  3642 
Age Standardized Rate per 100,000  3.82 4.54 4.98 6.53 7.39 7.20 8.20 9.92   
TOTAL NUMBER OF INCIDENCE 419 480 616 880 1082 1371 1772 2283  8903 
Male-to-female ratio on ASR 1.67 1.50 1.69 1.57 1.39 1.63 1.59 1.42   
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*NHL includes including diffuse large B-cell lymphoma (incl. Burkitt); follicular lymphoma; B-cell SLL; marginal zone lymphoma; Hairy cell leukaemia; B-cell lymphoma, NOS;  













1968-1972 1973-1977 1978-1982 1983-1987 1988-1992 1993-1997 1998-2002 2003-2007



























Rates adjusted to World Standard Population for subjects aged 0 to 80+ years. 
HL – Hodgkin lymphomas only; B-/T-cell NHL – classification as defined in Model 2, including B-cell Precursor (include. ALL),diffuse large B-cell lymphoma (incl. Burkitt); 
follicular lymphoma; B-cell chronic lymphatic leukaemia (incl. SLL); marginal zone lymphoma; Hairy cell leukaemia; multiple myeloma/plasmacytoma; and B-cell lymphoma, 
NOS; T-cell ALL (incl. ALL + adult T-cell leukaemia); mycosis fungoides/Sézary syndrome; peripheral T-cell lymphoma; cutaneous T-cell lymphoma; T-cell lymphoma, NOS;  
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3.4 APC modelling 
 
Model 1: APC modelling of NHL using traditional classification  
 
Using NHL definition of previous publications (ICD-9 200, 202), 
restricting age of subjects to between 15 to 79 years for the APC modelling, 
there were 5,058 cases (3,014 males and 2,044 females) in this analysis.  The 
models with Age-Period (AP), Age-Cohort (AC) and full Age-Period-Cohort 
(APC), all adjusted for gender, showed good fit with p>0.05  (Table 3.2).  
However, the full APC model showed the smallest deviance of 182.1 with 169 
degree of freedom (p=0.232), with all variables (age, period, birth cohort and 
gender) achieving statistical significance, and no residual over-dispersion found. 
 
Using the likelihood ratio test for model comparisons, both period and 
cohort effects showed significant improvement in the fit of model, in addition to 
age effect alone.  Comparing models AP and APC, we concluded that the cohort 
effect was statistically significant (∆deviance=33.38 on 18 degrees of freedom, 
p=0.015) after adjusting for age, gender and period effect.  Likewise, comparing 
models AC and APC, we found that the effect of calendar period is significant 
(∆deviance=13.31 on 6 degrees of freedom, p=0.038) after adjusting for age, 
gender and cohort effects.  The results indicated both period and cohort played 
a significant role in the development of NHL for both men and women over the 
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Model 2: APC modelling of B/T-NHL   
 
With the addition of plasma myeloma and CLL subtypes in the definition 
of NHL based on the updated WHO classification system, there were 6,635 NHL 
cases (3,917 males and 2,718 females) included in this model.  The results of 
APC modelling for Model 2 were very similar to Model 1 (Table 3.2).  Models 
with AP, AC and full APC showed good fit (p>0.05).  All the variables (age, 
period, birth cohort and gender) were statistically significant, and no residual 
over-dispersion was found.  The full APC model resulted in the smallest 
deviance of 177.5 with 169 degree of freedom (p=0.312).   
 
Using the likelihood ratio test for model comparisons, including both 
period and cohort effects, in addition to age effect, significantly improved the fit 
of model.  By comparing models AP with APC, the cohort effect after adjusting 
for age, gender and period was statistically significant (∆deviance=33.78 on 18 
degrees of freedom, p=0.013).  Likewise, comparing models AC with APC, we 
found that, after adjusting for age, gender and cohort effects, the effect of 
calendar period is significant (∆deviance=14.76 on 6 degrees of freedom, 
p=0.022).  The results indicated both period and cohort played a significant role 
in the NHL for both men and women over the years.  A similar result was found 
when comparing models AD with AP and AC respectively. 
 
The effect estimates from the full log-linear APC regression model were 
plotted in Figure 3.7.  The reference points used were the mid-point of age 
groups at 40-44 years and birth cohort at 1941-1945, and the starting of 
calendar period 1968-1972.  The age, period and cohort effects were all 
increasing steadily, with age effects presented with the steepest slope.    
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Figure 3.8 showed the curvature effects of age, period and cohort from 
the full APC model under this classification.  Large curvature for the age effect 
suggested departure from linear age trend.  With age 40-44 years as the lowest 
point, positive deviation was observed below age 20 years, and age 55 years 
and above.  Curvature was minimal for period effect, indicating slight deviations 
of period estimates from a linear periodic trend.  The departure of cohort from 
linear cohort trends suggested a strong cohort curvature effect among people 
who were born between 1906 and 1951.   
 
We have also tested for interactions between gender and age, period or 
cohort effects (i.e. age-gender, period-gender and cohort-gender interactions).  
None of the interaction terms were significant indicating the APC models do not 
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Model 3: APC modelling of LN  
 
In Model 3, we included the HL cases with NHL, since they were broadly 
classified as lymphoid neoplasms according to WHO classification.  There were 
7,217 cases in Model 3 (4,284 males and 2,933 females) aged between 15 and 
79 years (Table 3.2).  
 
All the variables (age, period, birth cohort and gender) were statistically 
significant, and no residual over-dispersion was found.  By comparing models 
AP with APC, we observed that, after adjusting for age, gender and period effect, 
cohort effect was statistically significant (∆deviance=48.92 on 18 degrees of 
freedom, p<0.0001).  However, the period effect did not improve the fit of the 
model (∆deviance=9.34 on 6 degrees of freedom, p=0.156) after adjusting for 
age, gender and cohort effect.  After HL was added into the model, the period 
effect disappeared. 
 
We have also tested for interactions between gender and age, period, or 
cohort effects (i.e. age-gender, period-gender and cohort-gender interactions).  
None of the interaction terms were significant indicating the APC models do not 




Ch. 3 – APC modelling on lymphoma trends 
64 
Table 3.2 Summary of goodness-of-fit and likelihood-ratio test statistics of APC analyses. 
 Model 1: NHL  Model 2: B-/T-cell NHL  Model 3: LN 
 Female Male Total  Female Male Total  Female Male Total 
Number of cases (age 15-79 years) 2,044 3,014 5,058  2,718 3,917 6,635  2,933 4,284 7,217 
            
Terms in model** Deviance* df p-value§  Deviance* df p-value§  Deviance* df p-value§ 
Age (A) 645.4 194 <0.001  615.2 194 <0.001  652.5 194 <0.001 
Age + Linear Drift‡  (AD) 234.7 193 0.022  231.1 193 0.032  244.0 193 0.008 
Age + Period (AP) 215.5 187 0.075  211.3 187 0.108  233.5 187 0.012 
Age + Cohort (AC) 195.4 175 0.139  192.2 175 0.177  193.9 175 0.156 
Age + Period + Cohort (APC) 182.1 169 0.232  177.5 169 0.312  184.5 169 0.196 
            
Model comparison** ∆Deviance ∆df p-value†  ∆Deviance ∆df p-value†  ∆Deviance ∆df p-value† 
Drift effect : A nested in AD 410.7 1 <0.001  384.1 1 <0.001  408.5 1 <0.001 
Period effect : A nested in AP 430.0 7 <0.001  403.9 7 <0.001  419.0 7 <0.001 
Cohort effect : A nested in AC 450.0 19 <0.001  423.0 19 <0.001  458.6 19 <0.001 
Period effect : AD nested in AP 19.3 6 0.004  19.8 6 0.003  10.6 6 0.103 
Cohort effect : AD nested in AC 39.3 18 0.003  38.8 18 0.003  50.2 18 <0.001 
Period effect : AC nested in APC 13.3 6 0.038  14.8 6 0.022  9.3 6 0.156 
Cohort effect : AP nested in APC 33.4 18 0.015  33.8 18 0.013  48.9 18 <0.001 
Abbreviations : df, degree of freedom;  
*Deviance from Poisson model; §p-value from Goodness-of-fit test; †p-value from likelihood ratio test. 
**Reference groups are: age group 40-44, period 1968-1972 and cohort 1941-1945.  All models adjusted for gender. 
‡ The “drift” parameter represents a log-linear change in rate not exclusively identifiable as a period or cohort effect. 







































































































































































































































































































Our data showed the overall age-adjusted incidence rate of lymphoid 
neoplasms has increased markedly since 1968.  Although many reasons have 
been suggested over the years, for example, changes in the classification of 
lymphoma, aetiology factors relating to virus/bacterial infections and 
environmental lifestyle changes, none of these has been able to explain the rise 
in rates satisfactorily.  Our APC analysis on the incidence of NHL showed that 
all age, period and cohort effects may have contributed a significant impact in 
the development of NHL in the population for ages 15 to 79 years. 
 
Trends of NHL and HL 
 
As mentioned in Chapter 1, many countries investigated their lymphoma 
trends across time.  Higher incidence rates of NHL was observed in North 
America, Australia and Europe than Asia (Ferlay et al. 2010). Most countries 
reported increasing trends of NHL in the past few decades, but in a few 
countries it started to level off in the 1990s (Sandin et al. 2006), while others 
(Bhurgri et al. 2005; Cartwright et al. 1999) including Singapore were still on the 
rise.  HL is not as common as NHL, but the increasing trends were noted 
particularly among the adolescence.  Hjalgrim et al (2008) reported the trends of 
HL in Singapore from 1968 to 2004, the incidence peak emerged among 
adolescents and young adults between the age 15 to 24 years, with a much 
faster rate observed in young females than males.  
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As explained in Chapter 1, diagnosis of lymphoma consisted of a series 
of investigations, including biopsy at site of presentation, full body imaging to 
confirm the degree of involvement in the whole body, plus bone marrow biopsy 
etc., and not just clinical presentation.  As compared with other cancers, the 
chance of misdiagnosing as lymphoma is relatively low.  There was no 
screening offer for lymphoma.  Most of the lymphoma diagnosed in Singapore 
were aggressive subtypes, the disease presentation such as organ failure or 
palpable mass were fast, and it could be within weeks.  The proportion of 
patients, who were rather well but incidental finding of slow growing lymphoma 
by body check-up, was not high.  Lymphoma is a very heterogeneous group of 
cancer in the immune system, which consists of many entities with different 
levels of aggressiveness, targeting different age groups and may be caused by 
various risk factors.  Cancer development is a multi-stage process.  It started 
from initiation, promotion and progression stage.  Different risk factors may 
affect different lymphoma subtypes at different stage of cancer development.  It 
is almost impossible to identify a single risk factor, unless it is a common risk 
factor which affects the initiation of all subtypes of lymphoma.    
 
Our results showed that the number of LN cases has increased 5 to 6 
times in the last 40 years.  The ASR of LN in 2003-2007 has doubled as 
compared in 1968.  The increase is consistently observed in both males and 
females.  The increasing trend, although at different pace across time, were 
consistent among the 4 major subtypes, namely HL, plasma cell neoplasms, 
lymphoid leukaemia and NHL.  Since the beginning of cancer registry at 1968, 
several classifications have been proposed and implemented in the world: 
Rappaport, Kiel, Working Formulation, REAL, and WHO.  We may not know the 
exact timing when pathologists in Singapore switched from one classification 
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system to another.  The change in classification did not result in changing 
downward trend in specific subtypes corresponding to increase in trend in other 
subtypes.  Thus the results suggested the increase in incidence rates of NHL 
observed was not a result of regrouping lymphoma within subtypes, but a 
genuine increase in the incidence in all lymphoma.  As presented in Appendix 1, 
Hodgkin lymphoma, Non-Hodgkin lymphoma and Multiple Myeloma were 
traditionally considered as separate diseases, and Lymphoid Leukaemia were in 
the grey zone, bouncing between lymphoma and leukaemia depends on 





In the last 20 years, several studies have attempted to examine the 
effects of time trends on the development of NHL using APC modelling.  Holford 
et al (1992) using the Connecticut registry data from 1935-1989 showed 
increasing trends of NHL were attributed to both the period and cohort effects.  
Pollan et al (1998) reported that the rise in NHL in Spain between 1972 to 1997 
was not only related to the period of diagnosis but also to the birth cohort.  Liu et 
al (2003) studied 60,617 incident cases of NHL in Canada from 1970 to 1996, 
and suggested period effect played a major role, while birth cohort effect might 
be different according to gender.  The tri-national assessment of 84,049 NHL 
incident cases from Sweden, Denmark and Finland between 1960 to 2003 
concluded the predominance of calendar period over birth cohort effects 
(Sandin et al. 2006).  The mixture of period and cohort effects were also 
supported in a study of nine population cancer registries by Bray et al (2001).  
However, the study by Viel et al (2010) on NHL incidence in the Doubs region in 
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France (1980-2005) supported a strong period effect only, starting from 1983 
and stabilizing in 1992.  
 
In our analysis, in order to overcome the identifiability problem, we 
assumed the first two periods are the same.  This assumption was supported by 
our data that the age-standardized incidence rates were closest in the 1968-72 
and 1973-77 (Figure 3.2).  The classification of NHL subtypes as defined in 
Model 1 was based on the standard definition used in previous publications 
(Bray et al. 2001; Holford et al. 1992; Liu et al. 2003; Pollan et al. 1998; Sandin 
et al. 2006; Viel et al. 2010).  Our results in the Model 1 supported both period 
and cohort effects as above mentioned studies.   
 
Based on the updated WHO lymphoid neoplasm classifications, we re-
defined NHL in Model 2 by including plasma cell myeloma cases, precursor 
lymphoma or indolent chronic lymphocytic leukaemia subtypes.  The similarities 
between Models 1 and 2 in our results suggested that, the addition of other NHL 
subtypes did not alter the trends of the rest of NHL in Singapore, it decreased 
the p-value as the sample size increased by 1,577 cases (31% increase).  It is 
possible these subtypes previously not considered as NHL as in Model 1, which 
also originated from B- or T-lymphocytes at different stage of differentiation, are 
behaving similarly as the rest of NHL subtypes and is considered in Model 2.  In 
fact, small lymphocytic lymphoma (SLL) and chronic lymphocytic leukaemia 
(CLL) are considered as the same disease by WHO - “one disease at different 
stages, not two separate entities”.  The surface markers in both are CD5+, 
CD19+, CD23+, weak CD79b and FMC7- by immunostaining.  Traditionally SLL 
is considered as NHL, it usually presented in lymph nodes and referred to 
oncologist, while CLL is usually presented in blood stream and bone marrow, 
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and under the treatment of haematologist.  The treatment regimen for CLL is 




As the age-specific rate of lymphoma was higher in older than younger 
adults, all studies agreed advancing age played a significant role in the 
development of lymphoma.  Advancing age may be related to the duration of 
accumulation of certain exposures since birth, or the DNA repairing 
mechanisms are not as effective as younger age (Hoeijmakers 2009). The 
results of these two models confirmed that both period and cohort effects have 
contributed to the increasing trend of lymphoma in Singapore, on top of the age 





As mentioned above, most of the lymphoma studies supported the effect 
of calendar period as one of the major contributing factor for the rise of 
lymphoma.  The predominance of period effect suggests a change in a 
particular calendar year of diagnosis which affects all age groups.  The changes 
in disease classification systems were frequently suggested as part of the 
reason for the rising trend.  However, from the analysis of curvature effect 
based on the full APC in model 2, our result suggested minimal deviation from 
linear trends.  We did not observe any sudden surge in the time when new 
classification proposed, or the few years after that; for example, the Kiel 
classification in 1974, the Working Formulation in 1982, the REAL classification 
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in 1994, the WHO classification in 2001.  A change in method of diagnosis by 
using advancing imaging techniques, e.g. CT/MRI scan, full body PET scan, 
were also mentioned.  Period effect may also be explained as a slow exposure 
to certain risk factors in the environment which affects all age groups 





The birth cohort effect suggests differences between distinct generations 
(birth cohorts) of individuals in the population.  A change in lifestyle, a rapid 
exposure to an unknown risk factor which only affects certain age groups, or 
prevalence of an infectious disease over a lifetime could be the reasons.  From 
the analysis of curvature effect in model 2, our result showed a sudden increase 
in deviation from linear trend among those who were born between 1941 and 
1946, which coincide with the period of World War II in Singapore.  It is 
reasonable to speculate their childhood during war period was affected by the 
environment and hence compromised the immune system in later development.  
The deviation from linear trend subsided from 1946 onwards.  This might be due 
to improvement in the environment and public health after the war. 
 
We have increasing evidence to show the importance of cohort effect in 
explaining the rising trend of lymphoma.  In our case, 40 years is too short to 
have genetic mutations across generations, therefore environmental exposure 
would be the only possible reason.  This may be reflected by the different causal 
environment factors that each successive birth cohort was exposed to as well as 
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societal change over time, which may have contributed to the increasing trend 
of lymphoma in Singapore.   
 
There were many epidemiological studies in search for risk factors which 
may be associated with the development of lymphoma.  Immunodeficiency is 
the strongest known risk factor, including primary immune deficiency, 
acquired/iatrogenic immune deficiency etc. For example, immunosuppression 
treatment received in solid organ transplant recipients, human deficiency virus 
(HIV) patients with depleted CD4+ T-lymphocytes leading to acquired immune 
deficiency syndrome (AIDS).  NHL was considered as AIDS-defining cancers in 
1987 by the Centre for Disease Control and Prevention (CDC) (CDC 1987).  
These subjects have higher risk of developing lymphoma, but they constitute 
few new cases in the general population. The theory was supported by studies 
in transplant and HIV cohorts (Grulich et al. 2007b; McGinnis et al. 2006; Shiels 
et al. 2009).  From the Singapore HIV Observational Cohort Study (SHOCS), 
among the 1,504 patients infected with HIV who attended the Communicable 
Diseases Centre in 1985-2001, 834 patients developed one or more AIDS-
defining conditions, with 8 new cases of Burkitt’s lymphoma, 20 primary cerebral 
lymphoma and 25 extra cerebral NHL (Bellamy et al. 2004).  
HIV/Immunosuppression alone cannot explain for all the lymphoma incident 
cases that occurred in Singapore.   
 
 
Model 3 LN 
 
In our subsequent analysis on Model 3, when both NHL and HL was 
included, only age and cohort effect was detected, the period effect disappeared.   
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In all the previous studies, HL was considered as a separate entity, and 
were never analysed together with NHL trends.  As mentioned in Chapter 1, the 
target age groups are slightly different in each subtype of lymphoma.  Generally 
speaking, the NHL affects mainly adults and elderly, while HL affects early 
adolescents and older adults (i.e. 2 peaks in trends).  As summarized in Table 
1.8, the clinical presentation of HL and NHL are very different, e.g. nodal 
involvement and spreading, involvement of bone marrow and liver, and 
response to chemotherapy.  However, the WHO classification system since 
2001 grouped HL and NHL together under a new title, Lymphoid Neoplasms, 
and the concept of “Non-Hodgkin lymphoma” is no longer valid (Jaffe et al. 
2001).  Both the subtypes of HL and NHL are basically derived from 
lymphocytes, but only differ from various stage of cell maturation.  
 
The new WHO classification system was the work and experience of 
more than hundred pathologists in the world, the classification system increases 
in complexity as the technology progress.   For example, “the B-cell neoplasm, 
cannot differentiate between DLBCL and classical Hodgkin lymphoma” is one of 
the new entity in the updated WHO 2008 version (Jaffe 2009).  Reed-Sternberg 
cells were once the gold standard for confirming Hodgkin lymphoma.  The new 
entity tells us the possibility of misclassification between subtypes, especially 
between NHL and HL, in the past few decades. Therefore in the analysis of 
lymphoma trends in a country, it is unwise to consider HL and NHL separately.  
 
When only NHL subtypes were considered in the APC model, the 
observed period effect might not be simply due to a change in classification, but 
a systematic error of misclassification between NHL and HL. The changes in 
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classification only increase the “branch” within subtypes, i.e. the increase in 
entities under an existing entity, rather than combine and pushing an existing 
subtype to another.  On the other hand, if period effect was due to a slow 
exposure of environmental factors, it is possible the diverse group of lymphoid 
neoplasms cancelled out the individual effect.  
 
The main purpose of this study is to clarify the lymphoma trends over the 
past few decades in Singapore, and in the attempt to figure out the possible 
answers.  The important public health message from this APC analysis is, when 
the overall lymphoma trend was considered, we should use lymphoid 
neoplasms, including both HL and NHL subtypes, which will not be affected by 
internal misclassifications.  As summarised in Chapter 1, the target age groups, 
clinical presentation, response to treatments, and potential risk factors are very 
different between HL and NHL.  When it is aetiology-driven analysis, the HL and 
NHL subtypes should be considered separately. NHL should be further divided 
by aggressive and indolent natures if sample size is large enough to give 
enough power.  There is a genuine increase in lymphoma incident over the 
years, and an increasing disease burden in the population especially in the 
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3.6 Strengths and limitations of the APC analysis  
 
Our data came from a very well-documented national cancer registry with 
a high coverage starting from the period 1968-1972, and maintaining coverage 
of close to 100% at all other periods.  The incident cases were obtained not only 
from passive notification by medical practitioners, but actively acquired from 
hospital records, pathology reports and death certificates. The increase in 
cancer incidence observed is not due to artifactual reporting.  Besides, a period 
of forty years (with 8 study periods) is long enough to detect any changes in 
trend.   
 
This is the first study to use the WHO classification to compare the trend 
of lymphoid neoplasm, with traditional classifications used in previous published 
papers.  This is particularly important since the WHO classification is now 
adopted universally, and in the latest 2008 version, the concept of “Non-Hodgkin 
lymphoma” is replaced by “B-cell neoplasms, T-/NK-cell neoplasms”.  In the 
dataset from National Cancer Registry, although several disease classification 
systems were implemented over the years, there were centralised all cases 
using only 2 coding systems, i.e. ICD-9 for the period of 1968 to 1992, and ICD-
O for 1993 to 2007.  Thus it reduces the chance of losing important information 
during the change in systems.  
 
As compared with other cancers, lymphoma has been put through 
several complex classification systems and with numerous subtypes.  We 
acknowledge that at the time of requesting data from Cancer Registry, we may 
have missed some very rare subtypes which were recently categorized as 
“Lymphoid Neoplasms” under the 2008 classification.  These rare subtypes 
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usually have very few incidences, and thus should not have a significant impact 
on our total sample size and the subsequent APC analysis.  The other limitation 
of our study is, even after including 40 years of data, the sample size of 
lymphoma cases is still small and hence lack the statistical power to further 
analyse by subtypes. It is important to understand the pattern of incidence rates 
which varies between the indolent and aggressive subtypes, in order to further 
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Chapter 4  
The Singapore Lymphoma Study 
 
 
The Singapore Lymphoma Study (SLS) is a multi-ethnic case-control 
study of lymphoid neoplasms in Singapore.  To our knowledge, this is the first 
epidemiologic study of malignant lymphomas conducted in a multi-ethnic Asian 
population in a tropical location.  This study started in 2004, in an attempt to look 
at the potential risk factors of lymphoma which may be unique to a tropical 
country.  The rest of epidemiological studies were conducted in the West where 





The SLS is a hospital-based case-control study carried out in 3 major 
public hospitals (National University Hospital, Singapore General Hospital, Tan 
Tock Seng Hospital); and 2 national referral centres for skin diseases (National 
Skin Centre) and cancer (National Cancer Centre).  The study was approved by 
the research ethics committees or Institutional Review Board (IRB) at each 
participating hospital or institution.  The participants were recruited between 
April and October 2004 for the pilot phase, and between February 2005 and 
December 2008 for the main study.  The commencement of recruitment in each 
institution depends on the IRB approval accordingly. 
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Written informed consent was obtained from all participants.  This study 
comprised a standard questionnaire (see Appendix II) based interview by 
trained research nurses, the collection of 20ml peripheral blood or 2ml of saliva 
for genetic analysis, and pathology data from medical records.  A face-to-face 
interview with both cases and controls was done by intensively-trained research 
staff in the respective hospital.  Interviews were conducted in the language 
(English, Malay or Chinese dialect) which the participant was most familiar with, 




The study base included Singapore citizens and permanent residents of 
Chinese, Malays and Indians origin aged 18 years and above.   
 
Definition of cases: Eligible patients were newly diagnosed with malignant 
lymphoma within 6 months at the participating institutions, or the recently 
diagnosed subjects who received treatments for lymphoma at the 
participating hospitals.  Histological diagnosis was confirmed by their 
panel of pathologists and haematologists.  The classification was made 
according to the 2001 WHO classification system, including mature B- and 
T-cell neoplasms and Hodgkin lymphoma (ICD-O M9590-9596, M9650-
9667, M9670-9699, M9700-9729, M9731-9734, M9823-9831 and M9940-
9948).  Relapsed cases after remission of first lymphoma diagnosis were 
not included.  Lymphoma patients diagnosed with HIV infection or AIDS 
were not recruited since our university laboratory was not equipped with 
facilities to handle HIV virus samples.   
 
Ch. 4 - SLS 
80 
Definition of controls: Controls were patients who were admitted to the 
departments of orthopaedic, internal medicine or general surgery in the 
same hospitals as the lymphoma patients.  Only patients admitted for 
acute diagnosis during the same period were considered eligible.  The 
current admission was not for any of the following diagnosis: asthma, 
atopic eczema or allergy, immune-related disorders, peptic ulcer disease, 
viral hepatitis or tuberculosis or suspicion of malignancy.  Participants 
diagnosed with HIV infection or AIDS were not recruited.  Controls were 
frequency-matched for age within 5 years age intervals, gender, study 
centres and month of diagnosis.   
 
 
4.2 Data collection  
 
The questionnaire used in the SLS was developed with reference, in part, 
to the questionnaire originally developed and used by the EpiLymph Group 
(Besson et al. 2006b), a project in European countries under the IARC in 2001-
2003, and modified for local use.  An in-person interview on the basis of the 
standardized questionnaire lasts about 50 minutes. 
 
Basic demographics  
 
Detailed information on personal demographics and other potential 
confounders were collected.  SLS questionnaire included self-reported ethnicity 
and was categorized into Chinese, Malay and Indian for the analysis.  Calendar 
age at recruitment (in years), gender (male, female), marital status (currently 
married, separated / divorce / widow, never married), country of birth (Singapore, 
Malaysia, China, Hong Kong, Taiwan, India, Others), education levels (in years), 
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current housing types (public housing ≤3 rooms, public housing >3 rooms, 
private housing including condominium or landed property, others), and family 
history of cancers (yes, no) were collected.   
The body weight (in kg) and height (in cm) in usual adulthood were 
collected, and used to calculate the body mass index (BMI, in kg/m2).  The 
height was separated by gender, using the quartile cut-offs in each control 
group, and further grouped into quartiles in males (<164cm, 164-168.9cm, 169-
172.9cm, ≥173cm) and females (<154cm, 154-157.9cm, 158-162.9cm, ≥163cm).  
Similar, the weight was grouped separately for males (<61kg, 61-68kg, 68.1-
78kg, >78kg) and females (<54kg, 54-60kg, 60.1-70kg, >70kg). 
 
General physical activity in the past one year in terms of hours spent on 
activities of (1) vigorous intensity (i.e. strenuous sports of tennis/swimming laps, 
loading or unloading trucks, shovelling or equivalent manual work), (2) moderate 
intensity (i.e. heavy housework, light sports including brisk walking/tai 
chi/bowling), (3) light intensity/sitting and (4) sleeping on weekdays and 
weekends were also recorded.  Physical activity of different intensities were 
converted to metabolic equivalent levels (MET), defined as the ratio of work 
metabolic rate to standard resting metabolic rate (Ainsworth et al. 2000), in 
order to compute the total energy expenditure per week.   
 
Dietary consumption was collected using a 64-item food frequency 
questionnaire (including 28 items on vegetables, 16 items on fruits, 14 items on 
meat with details in Appendix II), which was validated by the Singapore Chinese 
Health Study group (Hankin et al. 2001).  Self-reported medical history such as 
Diabetes Mellitus (DM) and cataract were also collected as potential 
confounders. 
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4.3 Statistical analysis 
 
Variables collected by the questionnaire were analysed by their status 
(cases or controls) using Chi-square test for categorical variables, or Student’s t-
test for continuous variables.  
 
An unconditional logistic regression model was used to quantify the 
effect of individual variables on the risk of malignant lymphoma via the odds 
ratio (OR) estimate and its 95% confidence interval (CI).  Crude OR and 95% CI 
were reported for the background variables excluding the matching variables 
that defined the controls and lymphoma cases. 
 
Individuals with missing data for any variables were excluded for that 
analysis.  All statistical tests were evaluated assuming a two-sided test at the 
0.05 level of significance.  Analyses were performed with STATA/SE 10.1 
software. (StataCorp, Texas 77845 USA, 1984-2009) 
 
 
4.4 Response rate of the study 
 
Of the 634 lymphoma cases ascertained during the 2004-2008 
recruitment period, 31 subjects agreed to participate but passed away before 
the interview could be carried out.  Furthermore, 59 eligible cases (9.8%) 
refused to participate or participation was declined by family members on his/her 
behalf, 3 cases (0.5%) refused to be interviewed and subsequently dropped out 
of the study.  Thus this left us with 541 cases (315 males and 226 females) with 
a response rate of 89.7%.  Among the 1330 controls ascertained and initially 
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confirmed as eligible, 500 hospital patients (37.6%) refused to participate. There 
were thus 830 controls (response rate 62.4%) in this analysis (Figure 4.1). 
 
Figure 4.1 Flowchart of SLS recruitment 
 
























4.5 Subtypes of lymphoma cases and hospital controls recruited  
 
Table 4.1 shows the histological subtypes of lymphoid malignancy cases 
recruited in the SLS.  There were 74 Hodgkin lymphoma (HL) (13.7%), 465 non-
Hodgkin lymphoma (NHL) (86.0%) and 2 composite lymphomas (0.4%).  NHL 
1,330 Eligible controls in hospitals 
830 Controls in final analysis (response rate 62.4%) 
500 subjects refuse to participate 
634 lymphoma cases ascertained in hospitals 
541 lymphoma cases in final analysis (response rate 89.7%) 
31 subjects passed away before interview 
3 refuse to be interviewed & drop out of study 
59 subjects refuse to participate by subject/proxy 
603 eligible lymphoma incident cases  
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consisted of 404 cases of B-cell and 61 cases of T-cell lymphoid neoplasms.  
Among the B-cell NHL, the aggressive diffuse large B-cell lymphoma (DLBCL) is 
the most common subtype (n=243), followed by the indolent follicular lymphoma 
(n=64) and marginal zone B-cell lymphoma (n=52). 
 
Among the 541 lymphoma cases recruited, there were consistently more 
males than females in every lymphoma subtypes we recruited in this study.  The 
male-to-female ratios ranged from 1.2:1 for DLBCL subtype, to 2.2:1 for T-/NK-
cell neoplasms.  The higher male to female ratios were concordant with previous 
Singapore Cancer Registry reports (NRDO 2010), and consistently observed 
across the world, as mentioned in Chapter 1. 
 
In terms of ethnicity, 77.1% were Chinese, 16.5% and 6.5% from Malays 
and Indians respectively.  The ethnic distributions were similar to the Singapore 
population (Statistics 2000), with higher proportions of Malays (16.5% vs. 13.9% 
in census) and less Indians (6.5% vs. 7.9% in census) recruited in our study. 
DLBCL subtype was the most prevalent subtype across 3 ethnic groups.  
Follicular lymphoma, NK/T-cell lymphomas and marginal zone B-cell lymphoma 
were more common in Chinese than the other ethnic groups.  Hodgkin 
lymphoma was more frequent in Malays and Indians than Chinese.  The 2 cases 
of composite lymphoma were recruited in Malays.  
 
The hospital controls were mainly came from three departments, i.e. 
orthopaedic surgery, general medicine, and surgery, and the eligible controls 
were recruited from a wide range of admission diagnosis (Table 4.2), with none 
of the diagnosis comprise of more than 10% in total. 
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Table 4.1 Histological subtypes of lymphoid malignancies in the Singapore Lymphoma Study, 2004-2008.  
Lymphoma subtype 
All  Gender  Ethnicity 
No (%) 
 Male Female M:F 
ratio* 
 Chinese Malay Indian 
 No (%) No (%)  No (%) No (%) No (%) 
Hodgkin lymphoma (HL) 74 (13.7)  46 (14.6) 28 (12.4) 1.6:1  42 (10.1) 20 (22.5) 12 (34.3) 
                
Non-Hodgkin lymphoma (NHL) 465 (86.0)  267 (84.8) 198 (87.6) 1.3:1  375 (89.9) 67 (75.3) 23 (65.7) 
B-cell neoplasms 404 (74.7)  225 (71.4) 179 (79.2) 1.3:1  320 (76.7) 64 (71.9) 20 (57.1) 
• Diffuse large B-cell lymphoma  243 (44.9)  132 (41.9) 111 (49.1) 1.2:1  176 (42.2) 53 (59.6) 14 (40.0) 
• Follicular lymphoma  64 (11.8)  39 (12.4) 25 (11.1) 1.6:1  58 (13.9) 3 (3.4) 3 (8.6) 
• Marginal zone B-cell lymphoma  52 (9.6)  28 (8.9) 24 (10.6) 1.2:1  51 (12.2) 1 (1.1) 0 (0) 
• Multiple myeloma  13 (2.4)  7 (2.2) 6 (2.7) 1.2:1  7 (1.7) 3 (3.4) 3 (8.6) 
• Other B-cell types 32 (5.9)  19 (6.0) 13 (5.8) 1.5:1  28 (6.7) 4 (4.5) 0 (0) 
T- cell and NK-cell neoplasms 61 (11.3)  42 (13.3) 19 (8.4) 2.2:1  55 (13.2) 3 (3.4) 3 (8.6) 
                
Composite lymphoma (HL+NHL) 2 (0.4)  2 (0.6) 0 (0)   0 (0) 2 (2.3) 0 (0) 
TOTAL  541 (100)  315 (58.2) 226 (41.8) 1.4:1  417 (77.1) 89 (16.5) 35 (6.5) 
* Male-to-female ratio
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Table 4.2 A list of admission diagnosis in hospital controls 
 
Admission diagnosis n %  Admission diagnosis n % 
Abscess  
Accident - general 

















Orthopaedic - general  
Orthopaedic - limb 
Orthopaedic - spine  
Pain - general 
Pain - abdominal  

















DM and related problem 













 Pain - chest  
Pain - limb  
Pancreatitis  
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4.6 Background characteristics of participants  
 
The descriptive characteristics of the study population are presented in 
Table 4.3.  The average age of cases and controls were 54.2 years (SD 16.0) 
and 50.3 years (SD 16.0) respectively, with 60% male participants.  The ethnic 
difference among the cases was similar to the Singapore ethnic composition 
based on Census in year 2000 (Statistics 2000). However, we oversampled 
Malays (19.4%) and Indians (14.2%) in our control group.   
 
In terms of birth place, we used the Singapore/Malaysia as one 
reference group, since Singapore and Malaysia were one country until 
Singapore’s independence in 1965.  A total of 74.1% of our subjects were born 
before the transition to independence.  10.1% of cases were born in other Asian 
countries as compared with 5.3% in controls (crude OR 2.01, 95%CI 1.33-3.03).  
Most of our participants immigrated to Singapore since childhood, and only 14 
cases (2.6%) and 9 controls (1.1%) came after age of 20 years.   
 
As compared with controls, a higher proportion of cases had either never 
received any formal education (11% in cases versus 9.3% in controls) or had 
≥10 years of educations (32.8% versus 27.7%).  63% of the subjects were living 
in public housing with more than 3 bedrooms, and more cases were living in 
private condominium or landed property (12.9% vs. 4.9%; crude OR 3.91, 
95%CI 2.51-6.09).  The overall housing composition in this study population 
were similar to the types of dwelling in the Singapore household in the Census 
2010 report (Statistics 2010). 
 
While majority of subjects were currently married, 16.3% of cases and 24% 
of controls were never married (crude OR 0.59, 95%CI 0.45-0.79).  A higher 
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percentage of cases than controls (48.2% versus 41.1%) reported being 
previously employed and could have resigned from current job due to diagnosis 
and treatment of lymphoma.  Employment status will be further discussed in 
Chapter 4. 
 
In terms of medical-related conditions, 34.4% of cases and 21.7% of 
controls presented with a family history of cancer in the first-degree relatives, 
and the crude risk of lymphoma was close to 2-fold.  On the contrary, 24.8% of 
controls and 14.0% of cases presented with Diabetes Mellitus (crude OR 0.49, 
95%CI 0.37-0.66).  Both cases and controls consumed similar amount of fruits 
and vegetables by weight (p=0.649), which was calculated from our food 
frequency questionnaire.  Only a subset of subjects (290 controls and 246 cases) 
was asked the additional question on medical history since Sept 2007, 25.5% 
controls and 16.3% cases were reported to have diagnosed with a history of 
cataract.  
 
As analysed separately by gender, female hospital controls were on 
average taller (157.6cm, SD6.2) and heavier (63.3kg, SD14.1) than cases 
(155.7cm, SD7.1; 55.7kg, SD10.6); while the male controls were heavier (70kg, 
SD15.3 versus 67.7 kg, SD 13.0) but of about the same height (168cm, SD 8) 
as the cases.  24% of controls were in the highest weight quartile as compared 
with only 14.0% of cases (crude OR 0.46, 95%CI 0.32-0.65).  In terms of BMI, 
16.8% of controls and 7.0% of cases were considered obese (>30 kg/m2).  The 
mean usual adult BMI in the cases (23.6 kg/m2, SD 4.1) was lower than the 
hospital controls (25.0 kg/m2, SD 5.3) (crude OR 0.94, 95%CI 0.92-0.97).  Both 
groups spent a similar amount of time on physical activities the year before, with 
an average of 20 minutes/day on vigorous intensity activities, <2 hours/day on 
moderate intensity activities, and less than 7 hours/day sleeping.   
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Table 4.3 Background characteristics of cases and controls in the Singapore 
Lymphoma Study, 2004-2008 
Categories 
Controls 
(n = 830) 
Cases 
(n = 541) p-
value Crude OR (95%CI) 
No (%) No (%) 
Age (years) 
      
Range 









































Country of birth       
Singapore/Malaysia 









0.001 1.00 (ref) 
2.01 (1.33-3.03)*** 
Education        
No formal education 























Current housing type       
Public housing (≤3 rooms) 
Public housing (>3 rooms) 
Condominium/Landed Property  





































0.001 1.00 (ref) 
0.83 (0.60-1.13) 
0.59 (0.45-0.79)*** 
















0.023 1.00 (ref) 
1.37 (1.09-1.72)** 
1.22 (0.81-1.84) 
Abbreviations: SD – standard deviation; * P-value<0.05, ** P-value<0.01, *** P-value<0.001. 
† Other Asian countries including China/Hong Kong/Taiwan/Indonesia/Philippines/India/Pakistan etc. 
Numbers did not add up to 830 controls and 541 cases due to missing data. 
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Table 4.3 (cont.) 
Categories 
Controls 
(n = 830) 
Cases 
(n = 541) p-
value Crude OR (95%CI) 
No (%) No (%) 




















































Adult weight (kg)†      
Lightest quartile, gender-specific 
2nd quartile, gender-specific 
3rd quartile, gender-specific 






















Mean weight, male (SD) 













Adult height (m)†      
Shortest quartile, gender-specific 
2nd quartile, gender-specific 
3rd quartile, gender-specific 






















Mean height, male (SD) 







































Mean physical activities in last year (hours/day)     
Vigorous activity (SD) 
Moderate activity (SD) 


























Mean MET/week‡ (SD) 264.6 (51.7) 260.9 (52.7) 0.205 1.00 (1.00-1.00) 
Abbreviations: SD – standard deviation; * P-value<0.05, ** P-value<0.01, *** P-value<0.001. 
†  Adult height and weight were summarised by gender, and grouped into quartiles based on control 
distributions. 
‡  Physical activity expressed in metabolic equivalent intensity level, MET/week. 
Numbers did not add up to 830 controls and 541 cases due to missing data. 
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4.7 Strengths and limitations of hospital based case-control 
study  
 
This is the first multi-ethnic hospital-based case-control study in Asia.  In 
order to understand the high lymphoma rate in Singapore as compared with the 
rest of the Asian countries, an effort has made to find out the aetiology 
background.   
 
Although lymphoma is the top 10 common cancers in Singapore, the 
number of cases occurring each year is scanty.  Based on the Singapore 
Cancer Registry report, there were about 450 incidences each year, including 
non-residence in Singapore, between 2003 and 2007(NRDO 2010).  In order to 
investigate rare cancer such as lymphoma, due to the long waiting time for 
cases to accumulate, the retrospective design of case-control study would be 
able to investigate the various aetiology factors of this rare disease, with 
relatively shorter time and less resource than a cohort study.     
 
Strengths of study  
 
The Singapore Lymphoma Study was first launched in 2004 as a pilot 
study, to access logistics and gather information for the subsequent large-scale 
main study in 2005 to 2008.  We have tested on the possibility of recruiting 
controls from both hospitals and general population. However, due to the 
stringent matching criteria, we were forced to abandon the population control 
due to poor response rate, i.e. one successful neighbourhood control in 42 
households approached.  This small scale preliminary study conducted in order 
to validate the study in the hospital setting, check the feasibility of recruitment in 
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clinics and hospital wards, and finalize the standard operating procedures for 
the main study. 
 
The multi-centre design, including 2 national referral centres for cancer 
and skin diseases, covered the majority of public facilities in Singapore.  The 
high coverage of study centres provided an access to a representative sample 
of eligible incident cases in this country.   
 
The data were collected using standardized techniques.  In order to 
maintain comparability with previous studies conducted in other populations, the 
questionnaire used in the Singapore Lymphoma Study was already validated by 
the EpiLymph group (Besson et al. 2006b), a project in European countries 
under the IARC in 2001-2003. The questionnaire also provides a wide coverage 
on lifestyle factors, medical history and occupational backgrounds.  The Asian 
diet questionnaire is uniquely designed for the Singapore context by a cohort 
study group, the Singapore Chinese Health Study.  The diet questionnaire has 
already been validated in 2001 and published in many international peer-
reviewed journals. 
 
Limitations of study 
 
At the same time, we are mindful of the limitations that are inherent in 
the retrospective nature of this study.  We aware that the controls recruited from 
the hospital-based study design might have Berkson’s bias, where the 
exposure of interest increases the chance of hospital admission, thus leading to 
a higher exposure rate among hospital controls than normal population in the 
study base.    
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We have several measures to eliminate the selection bias by: (1) 
hospital controls were recruited based on admission diagnosis, instead of their 
exposure of interest.  (2) Inclusion and exclusion criteria were set up in advance 
to screen out patients whose admission diagnosis might have higher exposures 
than normal populations, but not excluded people with a history of such 
diagnosis.  Patients admitted for asthma, atopic eczema/allergy, immune-related 
disorders which have been suggested as potential risk factors for the 
development of lymphoma in the literature would not be recruited (Alexander et 
al. 2007).   
 
Besides, these hospitals are generalized hospitals with multidisciplinary 
divisions.  No matter what disease they developed, these patients would go 
through the same referral pattern from primary physicians to the hospitals, and 
likely they came from the nearby geographic location of their residence.  
Therefore, recruiting controls from the same hospital where lymphoma patients 
were recruited, it ensured that the controls were from the same catchment 
population where the cases were generated.  The hospital controls were also 
time-matched with cases whenever there was a new case recruited into the 
study, thus to ensure the controls were came from a similar but dynamic study 
base which give rise to the case. 
 
The relatively low participation rate (62.4%) in our hospital controls might 
also introduce a selection bias.  We did not have the information of the non-
responders, so we could not compare the difference between non-responders 
and participants in our study, in terms of education or lifestyle backgrounds.   
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Only hospital controls with acute diagnosis at admission were recruited 
so as to avoid the recruitment of patient with long term medical problems with 
long stay in hospital, whose exposure might be different from the general 
populations.  We have also made an effort to ensure that none of the diagnosis 
exceeded 10% of the total controls recruited, in order to avoid recruiting hospital 
patients with exposure to certain risk factors that we have no knowledge at the 
time of recruitment.  We did not recruit hospital controls based on the potential 
risk factors in their medical history in order to avoid high prevalence of these 
conditions which may shift the OR towards the null.  We hope through these 
procedures we would minimize the confounding factors which we may not be 
able to control for. 
 
Both cases and controls were recruited and interviewed by research staff, 
therefore we could not blind the research staff with regards to the disease state 
and this might introduce interviewer bias.  We had trained our staff intensively 
on interview techniques using standardized questionnaires, following the 
standard operating procedures to conduct interviews. All interviewers were 
required to interview both cases and controls, and the questionnaire was 
administrated the same way to all participants regardless of their status.  The 
interviews were voice-recorded for quality control purpose throughout the 
recruitment period; the recordings were constantly monitored to make sure the 
interviews were consistent over time.   
 
We chose hospitalized patients as controls instead of fully healthy 
subjects with no medical history.  When both cases and controls had gone 
through similar experience in hospital, both were pre-occupied by their sickness 
under the same environment, we believe they will recall previous exposures 
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similarly.  Since most of the general population did not understand lymphoma 
and the reasons behind the development of lymphoma, any difference reported 
between cases and controls might be non-differential. 
 
Our criteria for matching of controls with cases rely on a combinations of 
strong confounding factors, e.g. age ± 5 years, gender, hospital, and month of 
recruitment. When the project first started, controls were individually matched 
with cases, and matched on ethnicity as well.  However during the early phase 
of study, we noticed we had a hard time of getting suitable candidates in 
hospital since the combination limits the size of the available pool. As a trade-off 
for response rate and recruitment duration, we therefore used frequency 
matching on existing criteria, and adjusted for ethnicity in the analysis phase, in 
attempt to control for any other confounding factors related to ethnicity that we 
did not manage to control for during recruitment.  
 
As compared to a national registry, the number of lymphoma cases in 
this study was much smaller, thus limiting our analysis of aetiology factors by 
rare subtypes.  We acknowledged that we did not manage to interview some of 
the lymphoma patients before they passed away.  This could reflect a loss of 
information in the severely aggressive cases of lymphoma, whose lifestyle 
factors and occupational exposure might be different from the rest of indolent or 
less aggressive subtypes.   
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Chapter 5 
Association between occupational history and  
the risk of lymphoma 
 
 
Although the risk factors for lymphoma include inherited and acquired 
immunodeficiency conditions, infectious, physical and chemical agents have 
also been reported (Alexander et al. 2007).  At present, no conclusive evidence 
of causal relation between occupation and increased lymphoma risk exists.  
Most of the literature reported inconsistent results which may be due to a lack of 
specific individual-level exposure information.  In a recent review on occupation 
and risk of NHL, Boffetta and de Vocht (2007) reported a significant increase in 
the risk of lymphoma among workers in the printing industry, wood workers, 
farmers (especially in animal husbandry) and teachers.  Among all occupations, 
the most notable finding reported from previous studies is the observed 









Numerous studies have examined the relation between the teaching 
profession and the risk of NHL, and these are summarized in Table 5.1.  
Findings from a meta-analysis of 19 studies showed an elevated risk of NHL 
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among teachers (RR 1.47, 95%CI 1.34-1.61) (Boffetta & de Vocht 2007).  
However, it has been suggested that the positive association between the 
teaching profession and NHL could be due to publication bias (Baker et al. 
1999).  Difference in gender effect have been reported in Italian case control 
studies where female teachers (OR 1.7, 95%CI 1.0-2.7) appeared to have a 
higher risk of developing NHL than male teachers (OR 0.7, 95%CI 0.3-1.3) 
(Costantini et al. 2001; Miligi et al. 1999).  No evidence of difference was 
observed in any specific teaching profession in a Swedish cohort study, that is, 
whether the subjects were primary or secondary school teachers, arts or 
theoretical subjects teachers, principals or headmasters (Cano & Pollan 2001).  
There has been no report on the association between teaching profession and 
HL in the past twenty years, this could be due to the small sample size of HL in 
most studies. 
 
Reports on the association between NHL and occupation including 
teaching profession are mostly from the Western populations.  Could the 
increase in NHL in Singapore be contributed by the changes in the working 
pattern from a trading port in the 50’s and 60’s to rapid industrialization in the 
70’s and beyond?  The aim of this study is to examine the possible association 
between occupations in Singapore based on the Singapore Standard 
Occupation Classification and the risk of lymphoma based on information 




The diverse of occupational exposure and in respective industry formed 
a diverse matrix of exposure.  Very few people worked in a single environment 
throughout the entire occupational history. Without any a priori knowledge on 
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the latency period from exposure to the initiation of lymphoma, thus it increase 
the difficulty in analysing the association between occupational exposure and 
risk of lymphoma, unless the specific agent exposed to is discrete and easy to 
measure.   
 
Pesticide exposure is one of the most studied risk factor in lymphoma.  
Alexander et al., (2007) published a very detail review on the association of 
occupational and residential exposure to pesticides and risk of NHL in cohort 
and case-control studies. Pesticides comprise a long list of chemicals, e.g. 
insecticide, herbicide, DDT, phenoxy acids, organophosphates, triazines, and 
carbamates etc.  These include studies on those with frequent contract with 
pesticides including farmers, pesticide manufacturers, pesticide applicators, 
chemical production workers, and even military veterans who served in Vietnam.  
However, these studies have reported inconsistent results.   
 
Apart from pesticides, farmers in animal husbandry may also exposed to 
oncogenic viruses carried by farm animals.  Workers in slaughter house and 
meat inspectors have been found elevated risk of NHL than other occupations 
(Pearce & McLean 2005). Exposure to chemicals showed inconsistent results, 
partly due to the difficulty in measuring correct exposure levels, and the problem 
of multiple exposure to different chemicals etc (Lamm et al. 2005). Studies 
Organic solvents showed in suggested to be involved in the development of 
NHL (Rego 1998), but review studies suggested asbestos (Seidler et al. 2010; 
Weisenburger & Chiu 2002) , gasoline (Kane & Newton 2010b), benzene 
(Bezabeh et al. 1996; Kane & Newton 2010a) does not increase risk of NHL.  
  
Alexander et al. (2007) summarised evaluation of epidemiological 
studies of occupations yielded no specific exposure that is consistently 
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associated with NHL.  Studies on non-ionizing UV radiation from sunlight may 
played reduce the risk of developing in NHL, while studies on other ionization 
radiation found no significant associations.  Cano and Pollan (2001) reported a 
cohort study of close to 3 million Swedish men and women, and 7610 NHL 
cases ascertained at the end of 19 years of follow up.  Many occupations 
reported with relative risk more than 1.20, including accountants and auditors, 
secretaries and typists, auctionists, non-specific rail and road transport workers, 
telecommunications traffic officers, telegraph and radio operators, photographic-
laboratory workers and other production and related work in men and metal 
platers and coaters, truck and conveyor operators and store and warehouse 
workers in women.  No specific agents were identified in most of the 
occupations.   
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Table 5.1 Studies on NHL risk among teachers since 1999 
Reference Country (study) Period Study design Occupation Subtype Risk estimates (95% CI) 
Baker et al. (1999) - 1950-1990 Meta-analysis of 
13 studies 
Teacher  NHL 1.36 (1.13-1.62) 
Miligi et al. (1999) Italy (12 areas) 1991-1993 Case-control Teacher (women only) NHL 1.70 (1.00-2.70) 




 Teacher, theoretical subjects  1.21 (0.91-1.62) 
 Teacher, arts  1.44 (0.95-2.19) 
Constantini et al. (2001) Italy (12 areas) 1991-1993 Case-control Teacher (men only) NHL 0.70 (0.30-1.30) 
Zheng et al. (2002)  USA (Kansas, 
Nebraska) 
1979-1986 Case-control Teacher (men only) NHL 2.50 (1.00-6.50) 
Svec et al. (2005)  USA (24 states) 1984-1998 Case-control Teacher   NHL 1.15 (1.10-1.20) 
 HL 1.41 (1.20-1.66) 
 MM 1.21 (1.13-1.29) 




1958-2002 Ecological  
(Cancer registry) 
Teacher (men only) NHL 1.10 (1.00-1.20) 
Boffetta & de Vocht 
(2007) 
- 1950-1998 Meta-analysis of 
19 studies 
Teacher  NHL 1.47 (1.34-1.61) 
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5.2 Occupation history in the Singapore Lymphoma Study 
 
A detailed description of the Singapore Lymphoma study has been 
provided in Chapter 4.  In brief, the Singapore Lymphoma Study is a hospital-
based case-control study conducted in Singapore from 2004 to 2008.  
Lymphoma patients and hospital participants were interviewed using structured 
standardized questionnaire by trained research staff.  Apart from basic 
demographics and potential confounders, we elicited a complete occupational 
history which included all jobs lasting over one year since graduation from 
school.  For every job, information collected included the year in which 
employment began and ended, occupational title and industry, a description of 
job duty and ever use of chemicals or operation of machinery.   
 
The Singapore Standard Occupational Classification (SSOC) (2006) was 
used for coding the occupation for all subjects; with selected entities of 
occupations presented in Table 5.2.  The SSOC adopts the basic framework 
and principles of the International Standard Classification of Occupations 1988 
(ISCO-88).  It is reviewed and updated periodically to reflect changes in the 
employment structure and the emergence of new occupations in Singapore.  
The SSOC comprises 5-digit codes with each digit giving increasing specificity 
regarding the individual occupation: The 1-digit code represents a very broad 
field of work, and the subsequent digits codes provide a more specific 
description. For example:   
 
• 2 - Professional  
• 23 - Teaching Professionals 
• 231 – University, Polytechnic and Other Higher Education Teachers 
• 2310 – University, polytechnic and other higher education teachers 
• 23101 – University lecturer  
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Table 5.2 Selected 1- and 2-digit codes from the Singapore Standard 
Occupational Classification 2005 (Statistics 2006) 
Coding Occupation  Coding Occupation 
1 Legislators, Senior Officials and 
Managers 
 6 Agricultural and Fishery Workers 
61 Agricultural workers 
11 Legislators and senior officials  62 Fishery workers 
12 Corporate managers    
13 Working proprietors    
   7 Production Craftsmen and Related 
Workers 2 Professionals   
21 Physical, mathematical and 
engineering science professionals 
 71 Building trades workers 
  72 Metal, machinery and related trades 
workers 22 Life science and health professionals   
23 Teaching professionals  73 Precision, handicraft, printing and 
related trades workers 24 Business professionals   
25 Legal professionals  74 Food processing, woodworking, textile, 
leather and related trades workers 29 Professionals not elsewhere classified   
  79 Production craftsmen and related 
workers not elsewhere classified 3 Associate Professionals and 
Technicians 
  
    
31 Physical and engineering science 
associate professionals 
 8 Plant and Machine Operators and 
Assemblers    
32 Life science and health associate 
professionals 
 81 Stationary plant and related operators 
  82 Machine operators and assemblers 
33 Teaching associate professionals  83 Drivers and mobile machinery 
operators 
34 Finance, sales and related business 
associate professionals 
   
   
39 Associate professionals not 
elsewhere classified 
 9 Cleaners, Labourers and Related 
Workers    
   91 Cleaners and related workers 
4 Clerical Workers  92 Porters, attendants and related workers 
41 Office clerks  93 Labourers and related workers 
42 Customer service clerks    
49 Clerical workers not elsewhere 
classified 
 X Workers Not Classifiable By 
Occupation 
     
5 Service Workers and Shop and 
Market Sales Workers 
   
   
51 Service workers    
52 Shop and market sales workers    
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For this study, since there is no prior knowledge on the association of 
duration of exposure in occupation to the onset of disease, we analysed the 
association of occupation history with lymphoma using the following 3 methods:  
 
1. The first occupation : it was the first job that the subject took up after leaving 
school, or his/her first employed job if he or she had not attended school 
which lasted more than one year.   
 
2. The longest occupation : this was determined for each subject using the 
longest duration of any occupation reported.   
o If the subject took up the same job on more than one occasion, the total 
duration in years would be added up together; 
o If two or more occupations lasted for equal period of time, it would be 
removed from the analysis of longest occupation since we cannot 
determine which was the longest. 
 
3. Ever in occupational history : they were counted in as long as the subject has 
ever been employed in that particular occupation for at least a year.  
o We have collected up to 7 different occupations, which mean the 
subjects could be enlisted in a maximum of 7 different occupations, 
which were not mutually exclusive. 
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5.3 Statistical analysis 
 
The distribution of occupations using 1-digit SSOC code among the 
lymphoma cases and controls were compared by simple chi-square test, with 
the occupation of interest verses the rest of occupations in the first and the 
longest occupation.  We further analysed the 2-digit SSOC codes of selected 
occupations which the subjects had ever been employed in the entire 
occupational history by chi-square test. 
 
As mentioned in Chapter 4, an unconditional logistic model was used to 
quantify the association between occupations of interest and the risk of 
lymphoma.  All analyses were adjusted for potential confounders including age 
(as a continuous variable), gender (male/female), ethnic group 
(Chinese/Malay/Indian), education level (no formal education / ≤6 years / 7-10 
years / >10 years), current housing type (public housing ≤3 rooms / public 
housing >3 rooms / private housing / others) as a surrogate for socio-economic 
status, and history of any cancer in a first degree relative (yes/no).  In addition, 
other potential confounders (e.g. BMI, country of birth) which did not change the 
risk estimates of the exposure of interest by over 10% were not considered for 
inclusion in the final models.  
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5.4 Results  
 
Among the 1,371 participants (830 controls and 541 lymphoid 
neoplasms cases), 99.5% of participants (n=1,364) provided information on their 
current employment status. 653 (47.9%) were currently under employment, 599 
(43.9%) retired from occupation, and 112 (8.2%) had never worked (e.g. 
homemaker or students etc).  1,236 participants disclosed detailed occupations 
which lasted for at least 1 year; whereas another 23 participants (14 controls 
and 9 LN cases) who did not disclose any occupation history were treated as 
missing data.  The current analysis was focused on 749 controls (456 males and 
293 females) and 487 LN cases (295 males and 192 females) who provided 
detailed occupational history. For each subject, a maximum of 7 different job 
descriptions in the entire working history was provided.  
 
In Table 5.3, using the 1-digit code of the SSOC to screen both the first 
and longest held occupation, there was a significantly higher percentage of 
“Professionals” (group 2) who were LN cases (first occupation: 9.7%; longest 
occupation: 8.6%) as compared to the controls (4.4%; 5.1%), respectively.  This 
was consistently observed in NHL and HL subtypes in both the first and longest 
occupation.  On the other hand, lower percentages of LN cases were observed 
in “Plant and machine operators and assemblers” (group 8) for first occupation 
(cases=14.4%; controls=19.0%); and “Cleaners, labourers and related workers” 
(group 9) for the longest held occupation (11.9%; 15.9%). We did not observe 
any association in other occupations such as clerical workers or craftsman. 
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Table 5.3 Distribution of the first and longest held occupation among the lymphoid neoplasms cases and controls in the Singapore Lymphoma 
Study. 
Singapore Standard Occupational Classification Controls Lymphoid neoplasms Non-Hodgkin lymphoma Hodgkin lymphoma 
No  (%) No  (%) p-value‡ No  (%) p-value‡ No  (%) p-value‡ 
Group First Occupation            
1 Legislators, Senior Officials and Managers  27  (3.6) 24 (4.9) 0.253 20 (4.7) 0.368 4 (6.9) 0.209 
2 Professionals 33  (4.4) 47 (9.7) <0.001 40 (9.4) 0.001 7 (12.1) 0.010 
3 Associate Professionals and Technicians 61  (8.1) 47 (9.7) 0.359 39 (9.1) 0.567 8 (13.8) 0.138 
4 Clerical workers 86  (11.5) 64 (13.1) 0.383 57 (13.3) 0.354 7 (12.1) 0.893 
5 Service Workers and shop and market sales 132  (17.6) 72 (44.8) 0.189 64 (15.0) 0.237 8 (13.8) 0.458 
6 Agricultural and Fisher Workers 21  (2.8) 17 (3.5) 0.494 17 (4.0) 0.275 0 (0) 0.196 
7 Production craftsmen and related workers 96  (12.8) 61 (12.5) 0.880 53 (12.4) 0.829 8 (13.8) 0.831 
8 Plant and Machine Operators and Assemblers 142  (19.0) 70 (14.4) 0.037 62 (14.5) 0.051 8 (13.8) 0.330 
9 Cleaners, Labourers and Related Workers 137  (18.3) 74 (15.2) 0.157 69 (16.1) 0.346 4 (6.9) 0.028 
X Workers Not Classifiable By Occupation 14  (1.9) 11 (2.3) 0.635 7 (1.6) 0.771 4 (6.9) 0.012 
 Total number of first occupations 749  487   428   58   
Group Longest Occupation            
1 Legislators, Senior Officials and Managers  45  (6.0) 39 (8.0) 0.176 33 (7.7) 0.264 6 (10.3) 0.193 
2 Professionals 38  (5.1) 42 (8.6) 0.014 35 (8.2) 0.035 7 (12.1) 0.026 
3 Associate Professionals and Technicians 85  (11.4) 61 (12.5) 0.542 52 (12.2) 0.692 9 (15.5) 0.344 
4 Clerical workers 90  (12.1) 57 (11.7) 0.855 52 (12.2) 0.959 5 (8.6) 0.436 
5 Service Workers and shop and market sales 139  (18.6) 72 (14.8) 0.081 62 (14.5) 0.071 10 (17.2) 0.796 
6 Agricultural and Fisher Workers 10  (1.3) 7 (1.4) 0.884 7 (1.6) 0.682 0 (0) 0.375 
7 Production craftsmen and related workers 80  (10.7) 54 (11.1) 0.834 50 (11.7) 0.609 4 (6.9) 0.360 
8 Plant and Machine Operators and Assemblers 129  (17.3) 87 (17.9) 0.788 77 (18.0) 0.754 9 (15.5) 0.733 
9 Cleaners, Labourers and Related Workers 119  (15.9) 58 (11.9) 0.049 55 (12.9) 0.153 3 (5.2) 0.028 
X Workers Not Classifiable By Occupation 12  (1.6) 10 (2.1) 0.562 5 (1.2) 0.545 5 (8.6) <0.001 
 Total number of longest occupations† 747  487   428   58   
† 2 subjects with equal duration of occupations were excluded in the longest occupation. 
‡ p-value from chi-square test of significance between group of interest versus others.  
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Following the results of the first and longest held occupations based on 
1-digit SSOC codes, we analysed selected occupational groups for the 
association with lymphoid neoplasms using 2-digit SSOC codes.  These 
included those who had ever worked as a “Professional”, “Plant and Machine 
Operators and Assemblers”, and “Cleaners, Labourers and Related Workers”. 
However “Workers Not Classifiable by Occupation” including those working odd 
jobs which could not be identified and grouped according to job title or nature, 
were not  further analysed since we did not have enough information about it.  
The “Professional” (group 2) and “Associate Professional” (group 3) are 
occupations similar in terms of exposures, but different in ranking of job title, as 
such we included the latter group into consideration for the subsequent analysis.  
As shown in Table 5.4, a higher proportion of LN cases were employed as 
Teaching professionals (code 23) and Business professionals (code 24) as 
compared with controls. A significantly lower proportion of LN cases were 
employed as machine operators and assemblers (code 82) (p=0.046), and 
labourers and related workers (code 93) (p=0.009). 
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Table 5.4 Selected occupations of those who had ever been employed as in the 










2  PROFESSIONALS    
 21 Physical, Mathematical and Engineering Science 
Professionals 
29 (3.9) 24 (4.9) 0.370 
 22 Life Science and Health Professionals 0 (0) 2 (0.4) 0.079 
 23 Teaching Professionals 12 (1.6) 23 (4.7) 0.001 
 24 Business Professionals 7 (0.9) 17 (3.5) 0.001 
 25 Legal Professionals 1 (0.1) 1 (0.2) 0.759 
 29 Professionals Not Elsewhere Classified 6 (0.8) 10 (2.1) 0.057 
3  ASSOCIATE PROFESSIONALS AND TECHNICIANS 
 31 Physical and Engineering Science Associate 
Professionals 
55 (7.3) 29 (6.0) 0.343 
 32 Life Science and Health Associate Professionals 15 (2.0) 14 (2.9) 0.322 
 33 Teaching Associate Professionals 14 (1.9) 12 (2.5) 0.476 
 34 Finance, Sales and related Business Associate 
Professionals 
36 (4.8) 26 (5.3) 0.675 
 39 Associate Professionals Not Elsewhere Classified 0 (0) 0 (0)  
 23,33† Teaching (Professions + Associate Professions) 25 (3.3) 34 (7.0) 0.003 
 24,34† Business (Professions + Associate Professions) 41 (5.5) 38 (7.8) 0.102 
      
8  PLANT AND MACHINE OPERATORS AND ASSEMBLERS 
 81 Stationary Plant and Related Operators 12 (1.6) 9 (1.9) 0.744 
 82 Machine Operators and Assemblers 154 (20.6) 78 (16.0) 0.046 
 83 Drivers and Mobile Machinery Operators 101 (13.5) 69 (14.2) 0.733 
      
9  CLEANERS, LABOURERS AND RELATED WORKERS 
 91 Cleaners and Related Workers 128 (17.1) 78 (16.0) 0.621 
 92 Porters, Attendants and Related Workers 44 (5.9) 23 (4.7) 0.382 
 93 Labourers and Related Workers 101 (13.5) 42 (8.6) 0.009 
* Participants could be presented in more than one occupation. 
† including subjects who were employed in both groups of occupation. 
‡ p-value from chi-square test of significant between group of interest versus all other 
occupations.  
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When teaching and associate teaching professions were considered 
together (i.e. code 23 and 33), there were 34 LN cases (7.0%) and 25 controls 
(3.3%) who reported being in ‘teaching profession’ in the entire occupational 
history (p=0.003). These included 10 primary school teachers (code 23300), 13 
teachers in secondary school and above (code 23102 & 23201), 13 private 
tutors (code 33910) and 23 other different types of teaching professions (Table 
5.5). However, when the two-digit codes in the business profession (code 24 
and 34) were combined in consideration, the proportions observed in cases 
(7.8%) and controls (5.5%) were similar (p=0.102). 
 
 
Table 5.5 Teaching professions in the entire occupation history  
SSOC 
code Occupation 
Control LN cases TOTAL 
n (%) n (%) n (%) 
23102 Polytechnic lecturer 0  (0.0) 1 (2.9) 1 (1.7) 
23201 Pre-university/ secondary school teacher 5  (20.0) 7 (20.6) 12 (20.3) 
23300 Primary school teacher 5  (20.0) 5 (14.7) 10 (17.0) 
23409 Other special education teacher 0  (0.0) 1 (2.9) 1 (1.7) 
23990 Other teaching professional nec 1  (4.0) 8 (23.5) 9 (15.3) 
33110 Pre-primary education teachers 3  (12.0) 4 (11.8) 7 (11.9) 
33202 Arts and crafts school teachers 1 (4.0) 0 (0.0) 1 (1.7) 
33203 Computer school teachers 1 (4.0) 0 (0.0) 1 (1.7) 
33209 Other extra-curriculum teachers 1 (4.0) 1 (2.9) 2 (3.4) 
33910 Private tutors 8 (32.0) 5 (14.7) 13 (22.0) 
33991 Relief teachers 0 (0.0) 2 (5.9) 2 (3.4) 
 TOTAL (%) 25 (42.4) 34 (57.6) 59 (100.0) 
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On average, among the 59 teachers, 23 male teachers had taught 15.7 
years (SD 16.2) which was slightly longer than the 36 female teachers (13.5 
years, SD 13.6).  Table 5.6 shows the OR for those who had ever been in these 
selected occupations versus other occupations for NHL and HL separately.  
Among the 31 teachers with NHL, 22.6% taught in upper secondary schools, 
with equal proportion teaching in and primary, pre-primary schools and private 
tutors (12.9%), and the rest engaged in other forms of teaching (38.7%). As 
compared to non-teachers, teachers had a significantly higher risk of NHL 
(adjusted OR 2.04, 95%CI 1.12-3.71).  Teachers who had taught for 1-10 years 
had significantly higher risk of NHL (adjusted OR 2.43; 95%CI 1.11-5.33), but 
we did not observe an elevated risk for those who reported a teaching duration 
of more than 10 years.    
 
There was no difference in association between those who had ever 
been machine operators as compared with those who had never been machine 
operators.  Those who had ever worked as labourers and related workers had a 
38% decreased in risk in NHL (95%CI 0.41-0.94). We did not detect any 
association between any of these occupations and HL. 
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Table 5.6 Adjusted odds ratios and 95% CIs for the association between the 3 selected occupations with the risk of lymphoma. 
SSOC 
code Occupation 
Controls  Non-Hodgkin lymphoma  Hodgkin lymphoma 
n  (%)  n (%) OR  (95% CI)‡ p-value   n (%) OR  (95% CI)
‡ p-value 
23,33 Never worked as teachers 724 (96.7)  397 (92.8) 1.00  (referent)   55 (94.8) 1.00  (referent)  
 Teachers 25 (3.3)  31 (7.2) 2.04  (1.12-3.71) 0.020  3 (5.2) 1.38  (0.38-4.98) 0.620 
 Teaching duration                
 1-10 years 15 (2.0)  17 (4.0) 2.43  (1.11-5.33) 0.026  3 (5.2) 2.25  (0.58-8.71) 0.241 
 >10 years 10 (1.3)  14 (3.3) 1.61  (0.66-3.92) 0.298  0 (0)    
                
82 Never worked as machine operators 595 (79.4)  355 (82.9) 1.00  (referent)   53 (91.4) 1.00  (referent)  
 Machine operators 154 (20.6)  73 (17.1) 0.82 (0.58-1.15) 0.251  5 (8.6) 0.41 (0.16-1.07) 0.069 
                
93 Never worked as labourers 648 (86.5)  390 (91.1) 1.00  (referent)   55 (94.8) 1.00  (referent)  
 Labourers 101 (13.5)  38 (8.9) 0.62 (0.41-0.94) 0.024  3 (5.2) 0.44 (0.13-1.46) 0.183 
n, number of subjects; CI : confidence intervals; P, p-value from logistic regression. 
Code 23, 33 includes university, polytechnic, upper secondary, secondary and primary education teachers, special education teachers, school principals or 
not elsewhere classified. 
Code 82 includes machine operator supervisors and general foremen, machine operators of metal products, mineral products, chemical products, rubber 
products, plastics or wood products, printing, binding and paper products, textile products, food products, assemblers and quality checkers, or machine 
operators not elsewhere classified. 
Code 92 includes agricultural and fishery labourers, manufacturing labourers, construction labourers, transport labourers or related workers not elsewhere 
classified. 
‡ OR, odds ratio adjusted for age (continuous), gender (male/female); ethnicity (Chinese/Malay/Indian), housing type (Public housing ≤3rooms/ Public 
housing >3rooms/Private housing/Others) and family history of cancer in the first degree relatives (yes/no) in multiple logistic regression model.   
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5.5 Discussions  
 
Among all epidemiological studies on occupations, none of a specific 
agent has been suggested in the causal linkage with lymphoma.  Most of the 
problems occurred in these studies, including the difficulty in correct measure of 
exposure to the agent, or multiple exposures to these agents which may result 
in synergistic effects.  Therefore we screened all occupations reported in the 
Singapore Lymphoma Study using separate criteria, and identified 3 
occupations in Singapore which may have higher chance of developing NHL as 
compared with the rest of occupations.  We have found that teachers appear to 
have a two-fold elevated risk of NHL as compared with non-teachers.   
 
As early as 1983, there have been reports of an increased standardized 
cumulative incidence ratio (SIR) for NHL among teachers (Dubrow & Wegman 
1983).  In a large registry-based analysis in Sweden, researchers used the 
Swedish Cancer-Environmental Registry to link cancer incidence during 1961 to 
1979 with occupational information from the 1960 census; this study reported an 
SIR among school teachers  of 2.1 (p<0.05).  When they included specific 
occupations within this industry they found that “school teacher in other 
education” had an SIR of 3.8 (p<0.05) (Linet et al. 1993).  It was not mentioned 
in the manuscript what ‘other education’ involved.  This study, being registry 
based, had no additional information on exposures and duration of employment 
for one to examine the possible etiological cause for the association.  The 
authors commented that “whether carcinogenic exposures occur among these 
workers is not clear, although socioeconomic and dietary factors may also be 
important” (Linet et al. 1993).  Boffetta and de Vocht (2007) conducted a meta-
analysis based on 19 reported studies to provide an update on occupation and 
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the risk of non-Hodgkin lymphoma.  They reported an increased risk for the 
teaching profession (RR 1.47, 95% CI 1.34-1.61) among other occupations. 
 
Our study would support the hypothesis of a viral aetiology of NHL.  
Teachers are known to come into contact with students frequently in the course 
of their work.  In Singapore, the ratio of teacher to student could be as high as 
1:40; especially in the 1960’s and 1970’s.  Infectious mononucleosis has been 
around in Singapore since the 1950’s and is quite common among the children 
in the community (Wong et al. 1982).  It is thus plausible for the teachers to be 
infected with Epstein-Barr virus (EBV) in their daily contact with children as the 
transmission is generally by infected saliva.  Instead, as compared to non-
teachers, those who had ever been teachers and had taught for between 1-10 
years duration had a two-fold increase in NHL risk in our study.  However, the 
OR for >10 years duration was not significant when compared with non-teachers, 
and a dose response relationship was not found.  This observation is 
understandable given that we are looking at an infectious agent and thus 
cumulative exposure and health effect would not be an important aspect in this 
finding.   
 
Our findings are in agreement with other studies which also reported no 
statistically significant differences between teachers in primary or secondary 
education (Boffetta & de Vocht 2007; Miligi et al. 1999).  We did not observe any 
marked difference in the distribution of teachers with NHL in different levels of 
teaching.  What is interesting though is that among the 31 ever-teachers cases 
diagnosed with NHL, 48.4% were teaching in the secondary, primary and pre-
primary schools.  The students from these groups would be in their adolescent 
and early childhood which placed them in the prevalent group for infectious 
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mononucleosis.  Infectious agents are close to being regarded as established 
agents for NHL with EBV as an important example.  EBV is generally acquired 
in early childhood in developing countries while in developed countries it is more 
prevalent among the adolescents (Engels 2007).  
 
Working in the agricultural and fishery industry were the least common 
occupations reported in our study.  We did not detect any associations between 
NHL and farmers although studies have found strong associations (Boffetta & 
de Vocht 2007; Linet et al. 1993; Schenk et al. 2009).  This is not surprising as 
Singapore is not an agricultural country and has never been given its small land 
area (710 square kilometres).  Likewise, we did not find any association 
between NHL and industrial workers (viz. printers, cleaners), which was also 
reported in other studies (Boffetta & de Vocht 2007; Mester et al. 2006; t 
Mannetje et al. 2008).  It could be possible that the workers in Singapore may 
not be exposed to significant level of the chemicals and/ or agents which were 
strictly monitored and under surveillance by the Workplace Safety and Health 
Act. 
 
We do not have an explanation for the observed NHL risk reduction 
among labourers and related workers.  This is a diverse group of labourers 
requiring physical efforts and use of simple hand-held tools during every day 
work; including odd job workers in transport, manufacturing and construction 
sites, and in agricultural and fishery area.  However, there were only 42 
lymphoma cases and 101 controls in this group, the sample size is too small to 
further investigate more specific groupings.  We also did not detect any 
associations with HL subtypes.  This could be due to small sample size as in 
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other case-control studies, and we could not identify any specific agents or 
exposure that may be unique in the HL.  
In summary, based on the occupational history we collected from the 
Singapore Lymphoma Study, the current analysis provided us an overview of 
the common occupations in Singapore where the study population were worked 
as.  The results of our analysis suggested excess NHL risk in the teaching 
profession, but provided little evidence on the association with machine 
operators and labourers.  Further specific studies on the occupations in relation 
to industry exposures are needed. 
 
 
5.6  Strength and limitations of occupational analysis 
 
Strength of occupational analysis 
The detailed occupational history was collected by standard 
questionnaire for all cases and controls in this study. The questionnaire was 
modified from the EpiLymph questionnaire for local context, and thus it was 
comparable with previous studies in other populations.  We marked down a 
detail description of that full time work, and chemical exposures they faced in 
every job during interview.  This helps us to correctly identify the occupational 
title for analysis, which based on the job description but not only rely on the title 
provided by the company. The occupations were coded using the standardized 
occupational classification in Singapore (2006) for local context.   
 
We did not recruit any hospital controls who were admitted as a result of 
industrial accidents. There were no established association between 
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occupational exposures with lymphoma known in the general population.  We 
collected every single job since they graduate from school, as long as it lasted 
over 1 year. Therefore we have no reasons to believe the participants recall 
their previous occupations differently, and influenced by their current illness.  
We have monitored and eliminated the recall bias in this retrospective study. 
 
Limitations on occupational analysis 
We acknowledged that under the same occupational title, the 
environmental exposure varies across different industry. For example, the 
exposure for cleaner working at industrial chemical plant would be very different 
from those who work in residential estates.  Therefore the wide range of 
environmental exposure may even out the effects and draw the risk estimates 
towards null. 
 
Furthermore, the literature review on occupational analysis was very 
specific with regards to chemicals the study subjects were exposed to and its 
association with a particular subtype of lymphoma.  However, many of the low 
skilled workers did not know much about the chemicals they worked with years 
ago, and they are not willing to provide details about the company they used to 
work in, therefore we were not be able to collect detail information on the 
potential hazards they were exposed to in each occupation.  Due to a lack of a 
priori knowledge on the induction period between exposure to potential hazards 
and diseased state from the literature, we do not have enough sample size to 
make specific analysis based on all these factors suggested.  
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Chapter 6 




As mentioned in Chapter 1, the parallel trends of non-melanoma 
tumours and lymphoma were noticed in the past decade.   Ever since, the solar 
ultraviolet (UV) radiation have been suggested as a common risk factor for both 
skin cancer and lymphoma.   
 
Ultraviolet radiation (wavelengths 100-400nm) is a naturally occurring 
electromagnetic radiation emitted by the sun, which divided into UV-A, UV-B 
and UV-C rays.  High energy, short wave UV-C rays (wavelength 100-280nm) 
are absorbed by dioxygen in Earth’s atmosphere. Most of the solar radiation 
reach the Earth’s surface are long wave UV-A rays (wavelengths 315-400nm) 
and ~10% are UV-B rays (wavelength 280-315nm) (WHO).  
 
UV-A and UV-B are of major importance to human health, and is a two-
way sword to human beings.  Ultraviolet radiation is a known carcinogen by 
IARC.  Over-exposure to ultraviolet radiation may result in acute or chronic 
health problems on the eye, skin or in immune system, e.g. cataract, melanoma 
(El Ghissassi et al. 2009; Halliday et al. 2011; WHO).  Small amount of UV 
exposure on human skin is crucial as it is our major source of vitamin D3 
production, which is critical for development, growth and maintenance of 
calcium homeostasis.   Rickets is a skeletal deformities disease associated with 
vitamin D deficiency, and was epidemic in the 19th century (Holick 2003; Holick 
2006).   
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The amount of ultraviolet radiation we received on Earth is affected by 
several factors.  All UV-C and majority of UV-B are blocked by ozone layer.  
Only a portion of the sunlight is UV, and this portion reduces with sun angles, 
that is, the less UV at geographical locations away from Equator as distance 
travelled increases.  Others factors include high cloud cover, low altitude, at 
early morning or late afternoon hours, or during winter are situations with less 
UV radiation reaches the ground (Kimlin 2008).  The ultraviolet radiation levels 
are monitored by meteorological offices in many countries, and report as the 
Global Solar UV Index (WHO). 
 
 
6.1 Literature review on sun exposure and the risk of lymphoma 
 
Studies on the association between sun exposure and the risk of 
lymphoma are summarized in Table 6.1.  In epidemiology studies using area of 
residence as a measurement for ambient UV exposure, positive associations 
were found between UV radiation at various geographical latitudes and 
incidence and mortality from NHL (Bentham 1996; Bertrand et al. 2011; 
Langford et al. 1998; Uehara et al. 2003).  However, the association was either 
not supported (Hartge et al. 1996; Newton 1997; Waltz & Chodick 2008) or 
inversely reported  (Boscoe & Schymura 2006; Chang et al. 2011; Grant 2002; 
Hu et al. 2004) in other studies.   
 
Studies on individual sun exposure levels have been investigated in 
many case-control studies.  A protective effect of leisure-time sun exposure on 
NHL was generally reported (Boffetta et al. 2008; Grandin et al. 2008; Hughes et 
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al. 2004; Kelly et al. 2010; Kricker et al. 2008; Soni et al. 2007).  These 
exposures included outdoor leisure activities, vacation at sun-exposed locations, 
or use of sunbed or tanning booth etc.  In the pooled analysis of case-control 
studies conducted by the InterLymph consortium, a 23% reduction in risk of NHL 
was found for men and women in the highest quartile of recreational sun 
exposure with intermittent patterns of exposure, but there was no association 
between the risk of NHL and non-recreational sun exposure (Kricker et al. 2008).  
The beneficial effect of sun exposure was suggested as a result of vitamin D 
production after sun exposure.  
 
Several studies have also examined the incidence and mortality of NHL 
with occupational sun exposure.  An increased risk of NHL with outdoor 
occupation was found in 2 independent case-control studies in Sweden (OR 1.1, 
95%CI 1.0-1.2) (Smedby et al. 2005) and US Connecticut women (OR 1.8, 
95%CI 1.0-3.4) (Zhang et al. 2007).  Other studies reported no association with 
NHL overall (Hughes et al. 2004; Kelly et al. 2010; Kricker et al. 2008; Weihkopf 
et al. 2007).  A reduced risk of DLBCL subtype with occupational exposure to 
natural UV radiation was reported in a European study (OR 0.72, 95%CI 0.54-
0.97) (Boffetta et al. 2008).   
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UV exposure and pigmentary factors  
 
Melanin is the primary determinant of human skin colour, it is also found 
in hair and pigmented tissue of the eye.  Upon UV irradiation, melanocytes 
located at the lower level of the skin will produce melanin to the skin’s surface, 
i.e. darker skin colour, to absorb UV and reflects extra UV-B photons by entering 
the dermis as a natural protective mechanism. The tone of human skin is 
determined by gene.  Africans are generally darker than Europeans, and Asians 
are usually somewhere between them.   
 
The associations between pigmentary factors and lymphoma risk were 
inconsistent in the literature.  Compared with those with brown eyes, those with 
light eyes were reported to have increased NHL risk (Hughes et al. 2004; 
Smedby et al. 2005) or decreased NHL risk (Hartge et al. 2006; Veierod et al. 
2010), while others did not support an association (Boffetta et al. 2008; Grandin 
et al. 2008).   
 
 
UV exposure and sunburn history 
 
Sunburn is caused by an intense amount of sunlight exposure to skin, or 
long period of exposure, thus it is another surrogate for sun exposure.  However, 
a person’s natural skin colour has an impact on their reaction to exposure under 
sun, the degree of sunburn varies on the skin sensitivity.  In a Swedish case-
control study, sunburn at 5-10 years before interview was inversely associated 
with NHL risk (p-trend=0.003) (Smedby et al. 2005) but this association was not 
found in any other studies (Grandin et al. 2008; Kelly et al. 2010). 
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Many studies in the West have investigated the association between 
sunlight and the risk of lymphoid neoplasms. However, most of these studies 
conducted in temperate countries where ultraviolet radiation is relatively low and 
varies across the year. The primary aim of this study was to evaluate the 
association between the risk of lymphoid neoplasms and sun exposure in a 
tropical country, with constant and high ultraviolet index throughout the year.  
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Table 6.1 Sun exposure and risk of lymphoma in cohort and case-control studies since 1996 
Reference Country (study) Period Study design Sun exposure measure* Subtype Risk estimates (95% CI) 
Bentham (1996) England & Wales 1968-1985 Ecological  
(Cancer registry) 
• Residential latitude in high UV radiation NHL 1.16 (1.14-1.17) 
Hughes et al. (2004)  Australia 2000-2001 Case-control • Exposed on working days 
• Exposed on nonworking days 
• Lifetime occupational exposure 














Smedby et al. (2005)  Sweden & Denmark 
(SCALE) 
 
1999-2002 Case-control • Sunbathing >4 times/week (5-10yrs ago) 








Hartge et al. (2006)  USA 
(NCI-SEER) 
1998-2000 Case-control • Exposure >28 hrs. in the mid-day sun in 
the last 10 yrs. 

















• Exposure >30 hours/week 













• Vacations at sun-exposed location LN 0.60 (0.40-0.80) 
Zhang et al. (2007)  USA  
(Connecticut) 
1996-2000 Case-control • Having suntan 
• Spending time in strong sunlight during 
summer 














*Measurement comparisons are the highest exposure category vs lowest/no exposure category, unless specified  
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Table 6.1 (cont.) 
Reference Country (study) Period Study design Sun exposure measure* Subtype Risk estimates (95% CI) 
Boffetta et al. 
(2008) 
(EpiLymph) 1998-2003 Meta-analysis of 
5 case-control 
studies 
• Sunlamp use >25 times 
• Free days during childhood 










Kricker et al. 
(2008)  
(InterLymph) 1995-2005 Meta-analysis of 
11 case- 
control studies 
• Composite total sun exposure 







Freeman et al. 
(2010) 
USA (USRT study) 1994-2005 Nested case-
control 
• Personal exposure (>21hrs/week) 
• Summer ambient exposure 
• Winter ambient exposure 














Kelly et al. 
(2010)  
USA (Rochester) 2002-2005 Case-control • Exposure >8 hours/week (5-10yrs ago) 
 














Veierod et al. 
(2010)  
Sweden & Norway (The 
Norwegian-Swedish 
Women’s Lifestyle & 
Health Cohort Study) 
 
1991-2007 Cohort • Sunbathing vacations ≥1week/yr (age 10-39) 
• Use of artificial tanning device ≥once/month in 







Bertrand et al. 
(2011)   
USA (Nurses’ Health 
Study) 
 
1976-2006 Cohort • Residing in high ambient UV radiation NHL 1.21 (1.00-1.47) 
Chang et al. 
(2011)  
USA  (California 
Teachers Study) 
1995-2007 Cohort • Minimum residential UV radiation [≥5100 vs 
<4915 W-h/m2] 
NHL 0.58 (0.42-0.80) 
*Measurement comparisons are the highest exposure category versus lowest/no exposure category, unless specified 
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6.2 Definition of sun exposure-related variables 
 
The detail of the study has been described in Chapter 4. In brief, the 
Singapore Lymphoma Study is a hospital-based case-control study in Singapore 
from 2004 to 2008.  Malignant lymphoma patients and hospital participants were 
interviewed using structured standardized questionnaire by trained research 
staff.  
 
In this section, we described detailed information on sun sensitivity and 
pigmentary related characteristics, as well as outdoor sunlight exposures for 
both recreational and occupational purposes which were collected to evaluate 
the association between sun exposure and the risk of lymphoma. 
 
Sun sensitivity and Pigmentary variables: Participants were asked about skin 
colour (white or light tan, tan, dark brown or black) on the inner side of 
the arm, eye colour (black or dark brown, light brown, other) and natural 
hair colour (black, dark brown, light brown, other).  Other variables 
included history of sunburn (frequency and age at first sunburn), the use 
of sun protection including hat, sun-cream, long sleeves or umbrella; and 
the skin reaction to strong sunlight without any protection (severe 
sunburn with blistering, painful sunburn followed by peeling, mildly burnt 
and some tanning, go brown without sunburn). 
 
Leisure sun exposure variables: The number of hours spent under the sun on 
leisure activities were used as a measure for sun exposure.  Participants 
were asked how many hours they spent outdoors regularly between 9am 
and 5pm, not staying under any shade on activities such as swimming, 
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sailing, jogging, playing tennis etc., on school days or weekends in 
childhood (i.e. <20 years of age), and on working days or rest days in 
adulthood (i.e. 20 years of age and above).   
 
Measures of recreational sun exposure were constructed for the 
statistical analysis as follows: Daily exposure was defined as “regular” if 
at least 30 minutes per day were spent on outdoor recreational activities 
on a regular basis; separately for (1) SCHOOL DAYS and (2) NON-
SCHOOL DAYS in childhood, (3) WORKING DAYS and (4) NON-
WORKING DAYS in adulthood.  The daily exposure was capped at 8 
hours per day.  Weekly exposure was calculated by adding up the daily 
exposure reported over 5 school days and 2 non-school days in 
childhood (i.e. CHILDHOOD PER WEEK), and 5 working days and 2 
non-working days in adulthood (i.e. ADULT PER WEEK).  The weekly 
exposure was capped at 56 hours per week.  The unexposed group 
served as the reference category.   
 
Occupational sun exposure variable: As in Chapter 5, we asked for a 
complete occupational history of jobs held which lasted at least one year 
or more.  Information included the year when employment started and 
ended, and the average daily hours of exposure to the sun for every job.  
Participants were defined as working outdoor if they had spent at least 
30 minutes outside under the sun without any shade (between 9am to 
5pm).  We categorized participants into ‘INDOOR WORK ONLY’ workers, 
and those who spent all or part of their working hours outdoors (i.e. 
‘MIXED INDOOR ± OUTDOOR’).  
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6.3 Statistical analysis 
 
The distribution of sun exposure behaviours between males and females 
were compared by simple chi-square test for categorical variables and Student’s 
t-test for continuous variables. 
  
As in Chapter 5, an unconditional logistic regression model was used to 
quantify the effect of outdoor sun exposure on the risk of malignant lymphoma 
via the OR estimate and its 95%CI.  In addition to potential confounders such as 
age, gender and ethnicity, we further consider the inclusion of BMI and skin 
colour (white or light tan/tan/dark brown or black) in the model.  We further 
assessed the interaction effect of sun exposure and gender in the multivariable 
model.  Further adjustment of hair colour, skin sensitivity, marital status, height, 
weight, and energy expenditure on physical activities did not change the risk 





Sun exposure behaviour between males and females 
 
The sun exposure factors (n=1,357, 799 males and 558 females) and 
pigmentary-related behaviour (n=1,362, 802 males and 560 females) were 
significantly different between genders in our study population (Table 6.2).   
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Mean age at first sunburn (SD) 19.5 (10.3) 17.7 (7.2) 0.039 
Skin reaction to strong sunlight with no protection   
Go brown only 
Mildly burnt and tanned 
Painful burn and peeling 










Mean recreational sun exposure (SD)    
On childhood school days (hrs/day) 2.13 (2.2) 1.16 (1.8) <0.001 
On childhood non-school days (hrs/day) 2.57 (2.7) 1.17 (2.1) <0.001 
Childhood weekly (hrs/week)  15.76 (15.6) 8.14 (12.6) <0.001 
On adult working days (hrs/day) 0.53 (1.2) 0.27 (0.8) <0.001 
On adult weekends (hrs/day) 0.97 (1.8) 0.51 (1.4) <0.001 
Adult weekly (hrs/week)  4.59 (8.2) 2.38 (5.7) <0.001 
Mean occupational sun exposure (SD)    
On adult working day (hrs/day) 2.17 (2.6) 0.44 (1.3) <0.001 
TOTAL 810 561  
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As compared with male subjects, female subjects were lighter in skin 
complexion (59.6% white/light tan versus 34.9% in males), less likely to 
experience sunburn (30.4% versus 47.8%), and had more sensitive skin 
reaction to strong sunlight without protection (15.7% vs. 21.4%).  Male subjects 
spent more time under the sun, for recreational or occupational purposes, during 
both childhood and adulthood.  The weekly exposure in adulthood was 4.59 
hours (SD 8.2) in men and 2.38 (SD 5.7) in women; corresponding figures for 
childhood exposure are 15.76 hours (SD 15.6) for boys, and 8.14 hours (SD 
12.6) for girls.  These variables supported the hypothesis that female spending 
less time under the sun. 
 
 
Pigmentary characteristics and risk of lymphoma 
 
The associations between pigmentary and sun sensitivity characteristics 
and risk of malignant lymphoma were shown in Table 6.3.  Limited variation was 
observed in eye and hair colour since the majority of subjects were reported as 
having black/dark brown eyes (96.3%) and black hair (97.0%).  Although the 
number of persons with natural lighter-coloured hair (brown, as opposed to 
black) was small, this characteristic conferred a two-fold risk of all lymphomas 
combined (OR 1.95, 95%CI 0.98 – 3.89).  Forty per cent of the study 
populations have ever had sunburn in their lifetime; 16.9% of cases and 20.4% 
of controls experienced painful/severe burn after repeated sun exposure.  There 
was no association between skin colour and sun sensitivity (sunburn history, 
age at first sunburn or skin reaction to strong sunlight without protection) and 
risk of either NHL or HL.  
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Table 6.3 Association between pigmentary and sun sensitivity and risk of lymphoid malignancies in the Singapore Lymphoma Study 
Pigmentary and sun 
sensitivity characteristics 
Controls  Lymphoid neoplasms  non-Hodgkin lymphoma  Hodgkin Lymphoma 
No (%)  No (%) ORa (95% CI)  No (%) ORa (95% CI)  No (%) ORa (95% CI) 











































































































































Skin reaction to strong sunlight with no protection              
Go brown only 
Mildly burnt and tanned 
Painful burn and peeling 

























































Abbreviation:  ref, referent; * P-value<0.05, ** P-value<0.01, *** P-value<0.001. 
Numbers did not add up to 829 controls and 533 cases due to missing data. 
a OR, odds ratio adjusted for age (continuous), gender (male/female), ethnicity (Chinese/Malay/Indian), education (never/<6/7-10/>10yrs), current housing 
types (Public housing ≤3rooms/Public housing >3rooms/Private housing/Others), BMI (continuous) and history of any cancer in the first degree relatives 
(yes/no) in multiple logistic regression model. 
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Use of sun protections 
 
The habit of using sun protection during leisure outdoor activities was not 
common in this study population.  Only 5.1% of controls and 2.3% of cases reported 
they ever use any in childhood, and 9.3% of controls and 8.4% of cases in 
adulthood.  Among the adults who had ever used sun protection, this was more 
prevalent in females, although only half of them had engaged in any form of regular 
leisure exercise outdoor.  The prevalence of using sun protection was very low in 
this study population, only 4.0% of participants had ever used sun protection during 
childhood (3.6% used in school days and 3.4% in non-schooldays).  The usage was 




Occupational sun exposure  
 
As in Chapter 5, 749 controls and 487 cases reported detailed occupation 
history.  Of these, 745 controls and 482 cases reported the number of hours spent 
working under the sun in each job for the current analysis.  On average, cases and 
controls spent 1.4 hours/day (SD 2.3) and 1.5 hours/day (SD 2.3) working outdoors 
respectively.  Participants who had ever engaged in outdoor occupations had a 
decreased risk of NHL overall (OR 0.75, 95%CI 0.55 – 1.03) and for B-cell NHL 
subtypes (OR 0.73, 95%CI 0.53 – 1.02) as compared with those who only worked 
indoors (Table 6.4).   
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Table 6.4 Association between outdoor sun exposure for recreational or occupational purposes and risk of lymphoid malignancies in the 
Singapore Lymphoma Study, 2004-2008 
Outdoor sun exposure 
Ctrl  Lymphoid neoplasms  non-Hodgkin lymphoma  Hodgkin lymphoma 
    NHL B-cell NHL T-cell NHL   
No  No ORa (95% CI)  No ORa (95% CI) No ORa (95% CI) No ORa (95% CI)  No ORa (95% CI) 
Occupational                     
Indoor work only 

































                    
Regular recreational                     
Daily                    
Childhood on School days                     
No regular exposure 

































Childhood on Non-school days                    
No regular exposure 

































Adult on Non-working days                    
No regular exposure 

































Weekly b                    
Childhood per week                    
No regular exposure 

































Adult per week                    
No regular exposure 

































Abbreviations : Ctrl, control; n, number; ref, reference group; * P-value<0.05, ** P-value<0.01, *** P-value<0.001. 
Numbers did not add up to 829 controls and 528 cases due to missing data. 
aOR, Odds ratio adjusted for age (continuous), gender (male/female), ethnicity (Chinese/Malay/Indian), skin colour (white-light tan/tan/dark brown-black), education 
(never/<6/7-10/>10yrs), current housing types (Public housing ≤3rooms/Public housing >3rooms/Private housing/Others), BMI (continuous) and history of any cancer in the first 
degree relatives (yes/no) in multiple logistic regression model.  (Further adjustment of hair colour, skin sensitivity, height, weight, MET did not change risk estimates.) 
bWeekly sun exposure = 5 x school days + 2 x non-school days (age <20yrs); or 5 x working days + 2 x non-working days (age ≥20 yrs) 
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Recreational sun exposure 
 
During childhood, cases and controls spent, on average, 11.9 
hours/week (SD 15.4) and 13.1 hours/week (SD 14.6) respectively, on 
recreational activities under the sun.  The amount of time was reduced 
substantially to 3.2 hours/week (SD 6.9) and 4.0 hours/week (SD 7.6), 
respectively, during adulthood.   
 
Compared to those without regular recreational sun exposure, those who 
regularly spent at least 30 minutes/day outdoors on non-school days during 
childhood had a 38% reduction in risk of lymphoma.  A significant association 
was observed for NHL (OR 0.62, 95%CI 0.46 – 0.83), and for B-cell lymphoma 
(OR 0.56, 95%CI 0.41 – 0.77) in particular.  Similarly, the risk of NHL among 
those who reported regular recreational sun exposure in adulthood on non-
working days was also significantly reduced (OR 0.70, 95% CI 0.51 – 0.97).  For 
T-cell lymphoma, the observed reduction (OR 0.19, 95% CI 0.06 – 0.54) was 
based on a small number of cases.  In terms of weekly recreational sun 
exposure, a significant risk reduction was observed consistently for lymphoid 
neoplasms (OR 0.73, 95%CI 0.55 – 0.96), NHL (OR 0.73, 95%CI 0.54 – 0.99) 
and B-cell NHL (OR 0.69, 95%CI 0.51 – 0.95) in childhood, but not in adulthood.   
 
The protective effect of childhood sun exposure was more evident in 
females (Table 6.5).  There was a 50% to 60% risk reduction in NHL observed 
in females; on school days (OR 0.54, 95%CI 0.34 – 0.87), non-school days (OR 
0.38, 95%CI 0.23 – 0.61), and on combined weekly exposure (OR 0.43, 95%CI 
0.27 – 0.68).  
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Table 6.5 Association between childhood sun exposure and non-Hodgkin lymphoma by gender 
Recreational sun exposure in childhood 
Males  Females 
P interaction 
Control Cases ORa (95% CI)  Control Cases ORa (95% CI) 
Daily           
On School days           
No regular exposure 



















On Non-school days            
No regular exposure 



















Weekly b           
No regular exposure 



















Abbreviation : ref, referent; OR, odds ratio; CI, confidence intervals; ** P value<0.01 *** P value<0.001. 
Numbers did not add up to 829 controls and 453 cases due to missing data. 
a OR, odds ratio adjusted for age (continuous), ethnicity (Chinese/Malay/Indian), skin colour (white-light tan/tan/dark brown-black), education (never/<6/7-
10/>10yrs), housing type (Public housing ≤3rooms/Public housing >3rooms/Private housing/Others), BMI (continuous) and history of any cancer in the first 
degree relatives (yes/no) in multiple logistic regression model.  
b Weekly sun exposure = 5 x school days + 2 x non-school days (age <20yrs); 
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6.5 Discussions  
 
Our results suggest that in this study population, regular leisure-time sun 
exposure in both childhood and adulthood are associated with a reduced risk of 
non-Hodgkin lymphoma.  Lower estimated risk was also found in who were 
darker in skin pigmentation than those who were comparatively fair skinned.  
The degree of skin pigmentation among the 3 Asian races in Singapore is 
different from Caucasian populations, according to the Fitzpatrick skin type 
classification (Fitzpatrick 1988). When stratified by gender, the reduction in risk 




Recreational sun exposure 
 
Our findings on the protective association of recreational sun exposure 
are generally consistent with other studies on personal sun exposure in the 
West (Boffetta et al. 2008; Hartge et al. 2006; Kelly et al. 2010; Kricker et al. 
2008; Smedby et al. 2005; Soni et al. 2007; Weihkopf et al. 2007).  A case-
control study by Hughes et al (2004) in Australia was the first to report an 
inverse association between personal ultraviolet radiation exposure and the risk 
of NHL.  There were reduced risk with exposure on non-working days in 
adulthood, suggesting that an intermittent pattern of sun exposure might be 
protective; and the protective effect of year-round sun exposure was greatest 
during childhood.  The InterLymph analysis of 10 case-control studies in the 
West reported a pooled odds ratio of 0.76 (95%CI 0.63 – 0.91) for recreational 
sun exposure (Kricker et al. 2008).  A recent case-control study in Rochester 
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(Kelly et al. 2010) reported a decrease in NHL risk in subjects who had 
sunbathed more than once per week versus never (OR 0.28, 95%CI 0.10 – 0.79) 
over the past 10 years.  A Scandinavian study also demonstrated a reduced risk 
in NHL, especially the B-cell type, with increasing adult personal sun exposure, 
and among subjects who had spent vacations in sunny southern climates 
(Smedby et al. 2005).  In contrast, a population-based case-control study of 
Connecticut women showed an increased risk of NHL among those who 
reported spending time (between 9am and 3pm) in strong sun during summer 
(OR 1.7, 95%CI 1.2 – 2.4) (Zhang et al. 2007). 
 
In the multi-country InterLymph study, the recreational sun exposures 
was measured at different time periods in life (e.g. lifetime, age 10-17, age 18-
40, and 10 years before diagnosis) (Kricker et al. 2008).  However, the level of 
ultraviolet radiation on Earth affects by many factors. These epidemiological 
studies also measure personal sun exposure behaviours include vacations 
overseas at sun-exposed areas (Hughes et al. 2004; Smedby et al. 2005; 
Veierod et al. 2010; Weihkopf et al. 2007; Zhang et al. 2007), this reflects the 
effect of sun exposure at a different geographical location. The use of artificial 
sun-tanning device (Boffetta et al. 2008; Hartge et al. 2006; Veierod et al. 2010) 
which provide a constant source of artificial ultraviolet radiation, but these two 
behaviours are more prevalent in the population at higher social economic class. 
Some studies measured sun exposure behaviour at summer and winter 
separately (Bertrand et al. 2011; Hughes et al. 2004). As in the Singapore study, 
we measured the sun exposure at everyday life behaviour in both childhood and 
adulthood. Since there is no significant seasonal difference in Singapore, the 
study populations are exposed under the constant strong ultraviolet radiation. 
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The reason for the strong association in women is not immediately clear.  
It is possible that the effect is greater because of the lower baseline exposure in 
this group, compared with their male counterparts.  Our results were supported 
by the Australian study reported by Hughes et al. (2004), that the association of 
sun exposure and the NHL risk reduction was apparently stronger in women. In 
our population, the higher exposure hours in childhood than adulthood may be 




Occupational sun exposure 
 
The average occupational sun exposure reported in our study was 
comparable with other studies on pterygia and sun exposure in Singapore 
(Khoo et al. 1998; Saw et al. 2000).  In the study by Khoo et al (1998), the 
control group of 125 subjects spent on average 1.6 hours per day (SD 1.6) at 
the time of study and 1.9 hours per day (SD 1.8) 5 years before.  We detected a 
marginal protective effect of occupational exposure in adults, although this was 
not evident in the pooled analysis based on the InterLymph data (Kricker et al. 
2008).  However, EpiLymph reported a similar result, which was only limited to 
the Diffuse large B-cell lymphoma subtype (OR 0.72, 95%CI 0.54 – 0.97) 
(Boffetta et al. 2008).  Most of the studies in the West did not detect any 
association between occupational sun exposure and NHL risk. 
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Possible mechanisms of protection 
 
As mentioned earlier, ultraviolet radiation has duel function. It can 
function as a carcinogen and has immunosuppression functions (Norval 2001), 
that skin aging and sunburn are mainly caused by DNA-damaging UVA (95% of 
UV radiation).  On the other hand, sun exposure may reduce the risk of 
lymphoid neoplasms by means of vitamin D-related pathways (Giovannucci 
2005).   
 
The main source of vitamin D (cholecalciferol) production in humans is 
the skin, where it is synthesized from 7-dehydrocholesterol following exposure 
to UV-B radiation in sunlight (Holick 1994).  7-dehydrocholesterol in skin is 
converted to previtamin D2 by UV-B photos, and later metabolized in the liver to 
25-hyrdoxyvitamin D [25(OH)D], which is used to determine the serum vitamin D 
level. 25(OH)D is then metabolized in the kidney to active form 1,25-
dihydroxyvitamin D [1,25(OH)D], and is tightly regulated by parathyroid hormone 
and calcium levels.  Vitamin D levels can be directly measured from serum 
(Holick 2007).  Experimental studies have demonstrated that the active form of 
vitamin D has anti-proliferative and pro-differentiation effects on tumour cells 
(Studzinski & Moore 1995) and lymphoma cell lines (Hickish et al. 1993); and its 
deficiency might be related to rheumatoid arthritis, Type 1 Diabetes, 
autoimmune diseases or even cancers (Cutolo et al. 2009; Holick 2004; Zella & 
DeLuca 2003).   
 
Vitamin D production decreases with increasing age (Holick et al. 1989; 
MacLaughlin & Holick 1985), increasing skin colour pigmentation (Clemens et al. 
1982), or under protective shielding including long sleeve clothing or face veil, 
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umbrella or sunscreen use (Holick 1994).  The duration spent under the sun is 
directly proportional to vitamin D produced, until the maximum capacity in the 
skin is reached.  Given the same amount of exposure time, those with darker 
skin would produce much less vitamin D as compared with those with fairer skin, 
the amount of UV enter the skin is reduced by melanin. However, experiments 
on pigmentation on sun exposure in the 1980s showed that Indians (with darker 
skin colour) had the same vitamin D capacity as Caucasians (with fairer skin 
colour), and they needed longer time of exposure under sun to produce the 
same quantities (Holick et al. 1981; Lo et al. 1986).   
 
Since the skin cancer has increased in Singapore in the past few 
decades, many public health education programmes emphasize on the 
avoidance of excessive sun exposure (Sng et al. 2009).  In our study population, 
only a small proportion of subjects used any sun protection devices during their 
time spending outdoor.  Sun avoidance is common in the fairer skinned and in 
female participants.  Subjects with darker skin were the one spending more time 
under the sun.  As reported by a UK study,  the Caucasian females showed low 
level of 25(OH)D in fair skin types compared to darker skin types due to sun 
avoidance, although their fairer skin has better efficiency in producing vitamin D 
under the same amount of exposure time (Glass et al. 2009).   
 
Vitamin D insufficiency is common in the world, and it is not limited to 
only dark skin colour population such as Blacks or Indians.  Surveys in Malaysia 
and India revealed more than 70% of healthy postmenopausal Malay and Indian 
women had insufficient vitamin D level (25-50nmol/l), which may be related to 
their darker skin colour (Arya et al. 2004; Harinarayan 2005; Rahman et al. 
2004).  Lips (2007) reviewed the serum vitamin D levels in Europe and Asia, 
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and found more than 80% of Lebanon and Saudi Arabia women were vitamin D 
deficient (<25nmol/l) due to completely veiled clothing.   
 
The main source of vitamin D comes from skin upon sun exposure, and 
minority come from diet or dietary supplements sources.  To date, epidemiologic 
studies that have examined the association between self-reported dietary 
vitamin D intake from food-frequency questionnaires and NHL have yielded null 
associations (Chang et al. 2011; Freedman et al. 2007; Hartge et al. 2006; Kelly 
et al. 2010; Purdue et al. 2010; Soni et al. 2007).  Hartge’s analysis of SEER 
data supported the significance of residential UV level on the reduction of NHL 
risk (RR 0.76 per 50 RB-units increase).  They did not find an association 
between vitamin D intake from food or supplements and NHL risk (Hartge et al. 
2006).  This study was later supported by the California Teachers Study (Chang 
et al. 2011).  Residential UV radiation levels were associated with reduced risk 
of overall NHL, but not associated with dietary vitamin D in this cohort study.  
Both studies suggested that higher routine exposure to UV radiation in the 
vicinity of residence may reduce the lymphoma risk.  Since dietary intake is the 
minority source of vitamin D, and the lack of an association with risk of 
lymphoma suggest the effect may not be replaced by diet or vitamin 
supplements, or possibly an alternate sun exposure-related but vitamin D-
independent pathway between ultraviolet radiation and lymphomagenesis.  On 
the other hand, in a nested case-control study, Lim et al (2009) reported an 
inverse association only in cases diagnosed in less than 7 years from the 
baseline, (highest versus lowest tertile of serum 25(OH)D: OR 0.43, 95%CI 0.23 
– 0.83, p-trend=0.01), but not in later diagnosis (OR 1.52, 95%CI 0.82 – 2.80).  
It suggested the potentially protective effect of vitamin D may only have a short 
term effect on risk reduction of NHL.   
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The primary aim of this study was to evaluate whether the previously 
described effects of sun exposure on the risk of lymphoid neoplasms can be 
replicated in an Asian population living in the topics.  Our study supported the 
intermittent pattern of recreational sun exposure in both childhood and 
adulthood, in this Tropical country with constantly high ultraviolet radiation 
throughout the year. Our study concurred with previous studies on the 
importance of outdoor solar exposure on lymphoma risk reduction.  The 
possible underlying protection mechanism may be due to the vitamin D 
produced upon sun exposure, but further studies are needed to understand the 
mechanisms behind.  
 
 
6.6 Strength and limitations of sun exposure analysis  
 
The strengths are that the data were collected using standardized 
techniques, with effort made to maintain comparability with previous 
questionnaires used in other populations.  The multi-centre design provided 
access to a representative sample of eligible incident cases in this country.  
 
At the same time, we are mindful of the limitations that are inherent in 
the retrospective nature of this study, and the limited sample size.  Specifically, 
we were unable to make inferences about the effect of sun exposure on 
Hodgkin lymphoma, and on the T-cell NHL subtypes, although the risk 
estimates suggested interesting differences.  The relatively low participation rate 
(62.4%) in our hospital controls may introduce a selection bias, but it is unlikely 
that this is related to sun exposure in a way that would account for the 
associations observed.  And, we acknowledge that reporting and recall bias 
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could occur in this study, but as the hypothesis regarding sun exposure and 
lymphoma risk is not widely known in the general population, the differential 
reporting in sun exposure is unlikely to be related to the respective disease 
status, and as such we would expect a misclassification to be non-differential.    
 
As sun exposure (and not vitamin D) was the primary exposure studied, 
we did not include dietary sources of vitamin D.  This was due to the relatively 
low intake of vitamin D-rich food sources in this population, and difficulties in 
obtaining accurate data on supplement intake, and we recognize that this limits 
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Chapter 7 
Association between smoking and drinking and  
the risk of lymphoma 
 
 
It is well known that lifestyle factors, such as tobacco smoking and 
alcohol drinking, have contributed to the development of cancers, particularly 
along the gastrointestinal tract (Anand et al. 2008).  The role of tobacco smoking 
and alcohol drinking in lymphoma remains unclear, partly due to small sample 
size in most of the epidemiological studies reported.  
 
 
7.1 Literature review on tobacco smoking and lymphoma 
 
Tobacco smoking is practised worldwide for a long time in history, and it 
becomes popular since cigarettes are manufactured massively in factories.  
Commonly cigarettes are made from fine-cut tobaccos, wrapped in a paper with 
or without filters. Nicotine, tar, and numerous hazardous additives are identified 
in cigarettes. Active smoking produces carbon monoxide, benzene and volatile 
organic compounds in the exhaled air (IARC 2004). Tobacco smoking and 
tobacco smoke (main stream or side stream smoke) are classified as 
“Carcinogenic to human” (Group 1) by the IARC  (2012).  There is sufficient 
evidence in human showing smoking are attributed to increased risk of at least 
14 types of cancer, e.g. oesophagus, lung, stomach, liver, kidney (Anand et al. 
2008; IARC 2004). However, the study results reported for lymphoma were 
conflicting.   
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Epidemiological studies on cigarette smoking and the risk of lymphoma 
are summarised in Table 7.1.  Conflicting results were reported over the years, 
with some showing elevated NHL risk (Freedman et al. 1998; Linet et al. 1992; 
Morton et al. 2005a; Talamini et al. 2005), while others showing no association 
(Besson et al. 2006b; De Stefani et al. 1998; Fernberg et al. 2006; Herrinton & 
Friedman 1998; Monnereau et al. 2008; Nieters et al. 2008; Willett et al. 2004; 
Zahm et al. 1997) .  The InterLymph consortium of pooled case-control studies, 
involving 6,594 cases and 8,892 controls,  found a slightly elevated NHL risk 
with ever smokers (OR 1.07, 95%CI 1.00-1.15) and current smokers (OR 1.10 
95%CI 1.00-1.20) (Morton et al. 2005a).  Compared with non-smokers, heavy 
smokers who consumed ≥20 cigarette/day (Talamini et al. 2005) or ≥50 
pack/year (Freedman et al. 1998), or long-term smokers who smoked ≥36 years 
(Morton et al. 2005a) also reported with increasing NHL risk.  Among NHL 
subtypes, smoking appeared to be associated with follicular lymphoma in some 
studies (Besson et al. 2003; Herrinton & Friedman 1998; Morton et al. 2003a; 
Stagnaro et al. 2004).   
 
 
Studies on cigarette smoking consistently showed increased risk of HL 
(Besson et al. 2006a; Briggs et al. 2002a; Glaser et al. 2004; Hjalgrim et al. 
2007; Nieters et al. 2006; Nieters et al. 2008; Willett et al. 2007).  A meta-
analysis of 17 studies reported an elevated risk of HL in current smokers (OR 
1.35, 95%CI 1.17-1.56, p<0.001), but not former smokers (Castillo et al. 2011).  
In the European multi-centre study, doubled-fold risk of HL was observed in 
current smokers ≥35 years (OR 2.35, 95%CI 1.52-3.61) only (Besson et al. 
2006a).  HL risk increased linearly with years of smoking and packs smoked per 
days in the Selected Cancer Study in US (p-trend <0.0001) (Briggs et al. 2002a), 
but no such association was found in the Danish-Swedish case-control study 
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(Hjalgrim et al. 2007).  Apart from active smoking, exposure to environmental 
tobacco smoke in childhood was associated with the risk of lymphoma in young 
adult females (OR 1.6, 95%CI 1.03-2.4)  in a case-control study in US women 





Ch.7 – Smoking & Drinking 
145 
Table 7.1 Summary of epidemiological studies on tobacco smoking and the risk of lymphoma from 1992 
Reference Country (study) Period Study design Tobacco smoking measure* Subtype Risk estimates  (95% CI) 
Linet et al. (1992) US (Minnesota) 1967-1986 Cohort • Ever smokers 







Zahm et al. (1997) US (Nebraska, Iowa/  
Minnesota, Kansas) 
1979-1983 Case-control • Ever smokers NHL 1.00 (0.80-1.10) 
De Stefani et al. (1998) Uruguay 1988-1995 Case-control • Ever smokers NHL 2.40 (0.90-6.40) 
Freedman et al. (1998) US (Selected 
Cancers Study) 
1984-1988 Case-control, men 
only 
• Ever smokers 







Herrinton & Friedman 
(1998) 
US (SEER) 1964-1991 Cohort • Former smokers 







Briggs et al. (2002a) US (The Selected 
Cancer Study) 
1984-1988 Case-control, men 
only 
• Ever smokers 







Besson et al. (2003) France (Rhone-
Alpes) 
1999-2001 Case-control • Current smokers, men only 
• Current smokers, women only 










Morton et al. (2003a) US (Connecticut) 1995-2001 Case-control, women 
only 
• Ever smokers 







Glaser et al. (2004) US (California Great  
Bay Area) 
1988-1994 Case-control, women 
only 
• Current smokers HL 2.90 (1.03-8.00) 
Stagnaro et al. (2004) Italy (11 areas) 1990-1993 Case-control • Ever smokers using Blond NHL 1.40 (1.10-1.70) 
Willett et al. (2004) England 1998-2001 Case-control • Ever smokers 
o start smoking >18 years 
• Smoked ≥40 years 













Morton et al. 2005 US + Europe 
(InterLymph) 
1990-2004 Meta-analysis of 9 
case-control studies 
• Ever smoker (pooled) 







* Never smokers served as reference   
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Table 7.1 (cont.) 
Reference Country (study) Period Study design Tobacco smoking measure* Subtype Risk estimates  (95% CI) 
Talamini et al. (2005) Italy (Pordenone & 
Naples) 
1999-2002 Case-control • Current, ≥20 cig/day 







Besson et al. (2006a) Europe (EpiLymph) 1998-2004 Meta-analysis of 6 
case-controls studies 
• Ever smokers  
o Age ≥35 years 










Besson et al. (2006b) Europe (EpiLymph) 1998-2004 Meta-analysis of 6 
case-controls studies 
• Ever smokers NHL 1.06 (0.92-1.21) 
Fernberg et al. (2006) Sweden 1969-1992 Cohort • Ever smokers NHL 1.00 (0.87-1.15) 
Lim et al. (2007) US (NIH-AARP) 1995-2000 Cohort • Current smokers 







Willett et al. (2007) England 1998-2003 Case-control • Ever smokers 











Monnereau et al. (2008) France 2000-2004 Case-control • Ever smokers NHL 0.90 (0.70-1.20) 
Nieters et al. (2008) Europe (EPIC) 1992-2005 Cohort • Ever smoker  
• Current smoker  













Kanda et al. (2009) Japan (Aichi) 1988-2005 Case-control • Current smokers 













Castillo et al. (2011) - 1971-2005 Meta-analysis of 17 
studies 
• Current smokers 







* Never smokers served as reference  
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7.2 Literature review on alcohol drinking and lymphoma 
 
The IARC working group reviewed  published studies on the association 
between consumption of alcoholic beverages and risk for 27 human cancer sites 
(IARC 2010a).  Consumption of large quantities of alcoholic beverages 
increases the risk of cardiovascular diseases and cancers along the 
gastrointestinal tract (Parry et al. 2011; Willett & Trichopoulos 1996).  
 
However, the association on alcohol consumption and the risk of 
lymphoma is inconsistent in previous reports (Table 7.2).  While most 
epidemiological studies of NHL have reported a lower risk of lymphoma in 
drinkers as compared with non-drinkers (Kanda et al. 2009; Klatsky et al. 2009; 
Lim et al. 2007; Monnereau et al. 2008), this observation was not supported in 
other studies (Benedetti et al. 2009; Besson et al. 2006b; Chang et al. 2010b; 
Chang et al. 2004; De Stefani et al. 1998; Deandrea et al. 2007; Polesel et al. 
2007; Tavani et al. 2001; Troy et al. 2010; Willett et al. 2007; Willett et al. 2004).   
 
Moderate inverse relation between ever alcohol drinkers and NHL risk 
(OR 0.83, 95%CI 0.76-0.89) was reported in the InterLymph study (Morton et al. 
2005b).  A UK cohort study reported an association between increasing levels of 
alcohol consumption and decreased risk of NHL.  As compared with non-
drinkers, women drinkers who drank ≥15 standard drinks/week had a 23% 
reduction in risk of NHL (OR 0.77, 95% 0.62-0.94, p-trend 0.001) (Allen et al. 
2009).  The type of alcoholic drink did not change the risk estimates in some 
studies (Morton et al. 2005b; Nieters et al. 2006), but other studies reported a 
lower risk of NHL in wine drinkers only (Briggs et al. 2002b; Morton et al. 2003b).   
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In an European case-control study on HL, a similar protective effect of 
alcohol was reported in both younger subjects (age<35 years) (OR 0.58, 95%CI 
0.38-0.89) and older subjects (age ≥35 years) (OR 0.50, 95%CI 0.34-0.74) 
(Besson et al. 2006a).  Gorini et al (2007) found a protective effect of alcohol 
consumption was observed only in non-smokers. 
 
In this chapter, we intend to further understand the above-mentioned 
modifiable lifestyle-related factors and their association with lymphoid 
neoplasms.  The environmental carcinogens may play an important role in the 
development of lymphoma in an Asian setting which could be different from the 
Western society. 
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Table 7.2 Summary of epidemiological studies on alcohol drinking and the risk of lymphoma from 2001 
Reference Country (study) Period Study design Alcohol drinking measure* Subtype Risk estimates  (95% CI) 
Tavani et al. (2001) Northern Italy 1981-1994 Case-control • >7 drinks/week 
• Wine intake (≥7 drinks/day) 
• Beer intake (≥3 drinks/day) 

















• Drinker w/ >1 wine/day 
o Start wine drinking <16 yrs 
• Beer drinker ≥3 drinks/day 



























Morton et al. (2003b) US (Connecticut) 1995-2001 Case-control, 
women only 
• Drinker >12 drinks/year 
o Wine drinker  
 Drink >40 years 
o Any beer drinker 
















Willett et al. (2004) England 1998-2001 Case-control • Drink of the days/wk 







Chang et al. (2004) Sweden (SCALE) 1999-2002 Case-control • Ever drinker 













• Ever drinker (pooled) 
• Current drinker (pooled) 
• Former drinker (pooled) 













Besson et al. (2006b) Europe  
(EpiLymph) 
1998-2004 Case-control • Drinkers in men only NHL 0.76 (0.62-0.93) 






* Never drinkers served as reference
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Table 7.2 (cont.) 
Reference Country (study) Period Study design Alcohol drinking measure* Subtype Risk estimates (95% CI) 
Lim et al. (2007) US (NIH-AARP) 1995-2000 Cohort • Drinkers with >28 drinks/week NHL 0.77 (0.59-1.00) 
Polesel et al. (2007) Italy 1999-2002 Case-control • Former drinkers 







Gorini et al. (2007) Italy (11 areas) 1990-1993 Case-control • Non-smoking drinkers 
o > 20 servings/wk 










Willett et al. (2007) England 1998-2003 Case-control • Drinking frequency HL 0.80 (0.50-1.30) 
Monnereau et al. (2008) France 2000-2004 Case-control • Ever drinker 
 

















• Women drinking ≥15 drinks/wk 













Kanda et al.(2009)  Japan (Aichi) 1988-2000 
2001-2005 






Klatsky et al. (2009) UK (San 
Francisco) 
1978-1985 Cohort • Ex-drinker 
 













Chang et al. (2010b) US (California 
Teachers Study 
Cohort) 
1995-2007 Cohort • Former drinker 
• Current drinker ≥20 g/day 










Troy et al. (2010) US (PLCO) 1993-2001 Cohort • Ever drinker ≥14 drinks/week 
• Beer ≥3 drinks/wk 
• Wine ≥3 drinks/wk 













* Never drinkers served as reference 
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7.3 Characteristics of smoking and drinking behaviours 
 
The details of the Singapore Lymphoma study have been described in 
Chapter 4.  In brief, the Singapore Lymphoma Study is a hospital-based case-
control study conducted in Singapore from 2004 to 2008.  Lymphoma patients 
and hospital participants were interviewed using structured standardized 
questionnaire by trained research staff.  Apart from basic demographics and 
potential confounders, extensive information about smoking and alcohol drinking 
was collected to evaluate its association with the risk of lymphoma in this study. 
 
Definition of smoking status: Smoking status was determined by the following 
question: “Have you ever smoked more than 100 cigarettes in your 
lifetime?”  Those who answered “yes” were considered as ‘exposed group’ 
and classified as “Ever smokers”.  Smoking information such as the age 
when the subject started smoking regularly, frequency of smoking 
(number of cigarettes smoked in a day, number of smoking days in a 
week), and the age when the subject quitted smoking were collected.  “Ex-
smoker” was defined as those who stopped smoking at least 1 year prior 
to the date of diagnosis or interview.  The reference (i.e. unexposed group) 
called “Never smokers”, included subjects who did not smoke at all, or 
who smoked less than 100 cigarettes in their lifetime.   
 
The quantitative smoking variables were categorized into 2 groups 
based on the distribution of ever smokers among the controls.  Among 
ever smokers, we assessed the age when the subject started smoking 
(>17, ≤17 years), smoking intensity (1-10, >10 cig/day), smoking duration 
(≤17, 17-30, >30 years), and cumulative exposure in terms of pack-years 
(≤20, >20 pack-years).  The smoking intensity in the current smokers was 
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further analysed separately.  The years of quitting (>10, ≤10 years) was 
assessed in ex-smokers.   
To assess the exposure to environmental tobacco smoke (ETS) 
(i.e. passive smoking), we also recorded information on whether 
household members smoked cigarettes daily at home or colleagues at 
work place, for at least 1 year or longer.   
 
 
Definition of drinking status: Information on alcohol drinking is elicited from 
the following question: “Have you ever drunk alcohol more than once a 
month on average?”  Those who answered “yes” were defined as “Ever 
drinker”, and proceeded to answer additional questions.  Data collected 
included age when the subject started drinking (years), frequency (number 
of drinking days per week) and portion size at each occasion (in terms of 
glass, cans, small bottle, or large bottle whichever applicable) for beer, 
wine and hard liquor separately.  Alcoholic drinking was expressed in 
terms of standardized portion size: one standard drink equals to a 330ml 
can of beer, 150ml glass of wine, or a 30ml shot of liquor.  One large 
bottle of hard liquor equals to 17 standard drinks (NIH 2010).  “Never 
drinkers” were those who did not consume or who consumed any 
alcoholic drink irregularly, and was used as the reference group. 
 
Weekly alcohol consumption was determined by the total amount 
of alcohol consumed per week (i.e. the number of drinks on each drinking 
day multiplied by number of days per week), and expressed in terms of 
standard drinks for beer, wine and hard liquor separately.  Based on the 
distribution of drinkers in the hospital controls, the continuous variables of 
alcohol consumption were categorized into 2 groups or tertiles as follow: 
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the age when the subject started drinking (>19, ≤19 years), the 
consumption of beer (<3, 3-14.9, ≥15 drinks/week), wine (<0.5, ≥0.5 
drinks/week), and hard liquor (≤3, >3drinks/week).  The total alcoholic 
consumption equals to the combined consumption of all 3 alcoholic types 
per week (<4, 4-39.9, >40 drinks/week).  Preference of alcoholic beverage 
type was further divided into 7 categories (only beer, only wine, only hard 




7.4 Statistical analysis  
 
The distribution of smoking and drinking behaviours between males and 
females were compared by simple chi-square test for proportions, and Mann 
Whitney test if the data were skewed.  
 
As mentioned in Chapter 4, an unconditional logistic regression model 
was used to quantify the effect of smoking or drinking on the risk of malignant 
lymphoma via the OR estimate and its 95%CI.  In addition to potential 
cofounders such as age, gender, and ethnicity, we further considered adult BMI 
(continuous), Diabetes Mellitus status (yes/no), and vegetables and fruits 
consumption (in 4 categories) in the current analysis.  The additional potential 
confounder of smoking status (Never / quitter / current smoker) was included in 
the alcohol consumption model; likewise drinking status (yes/no) was added in 
the smoking model.  For other potential confounders such as marital status and 
country of birth, they did not change the risk estimates by over 10% and hence 
were not included in the respective final models.   
  




Smoking and drinking characteristics by gender 
 
Table 7.3 summarized the characteristics of smoking and drinking 
behaviours by gender.  In this study population, 829 controls and 532 cases 
answered questions on smoking behaviours.  There were 62.6% and 12.9% of 
ever smokers in males and females respectively, and close to half of them had 
quitted smoking for at least a year.  On average both gender started smoking at 
about 17 years old.  As compared with female subjects, the median duration of 
smoking were doubled in males (12.5 years in females and 27 years in males).  
The smoking intensity was tripled (5 cigarette/day in females and 16 
cigarette/day in males).  57.1% of females were exposed to environmental 
tobacco smoke at home or workplace, as compared to 43.3% in males.  
 
In terms of drinking habit, 45% of men and 12.5% of women were 
regular drinkers, and both gender started drinking at 20 years old.  Beer was the 
most commonly consumed beverages (8.0 drinks/week in males and 1.0 
drink/week in females), and wine was the least common beverage with an 
average consumption of 0.5-0.6 drinks/week in this study population.  In terms 
of total alcohol consumption per week, the male subjects were consuming close 
to 7 times as much as females (14.0 drinks/week in males and 1.8 drinks/week 
in females). 
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Table 7.3 Characteristics of smoking and drinking variables by gender. 
 Males  Females  p-value 
CIGARETTE SMOKING      
Never smokers, n (%) 300 (37.4%) 487 (87.1%)  
Ever smokers, n (%) 502 (62.6%) 72 (12.9%) <0.001 
Ex-smokers, n (%) 219 (27.3%) 38 (6.8%) <0.001 
Current smokers, n (%) 283 (35.3%) 34 (6.1%) <0.001 
      
Ever smokers      
Current age (years)* 53 (42 – 66) 44.5 (28.5 – 66) 0.006 
Age start smoking (years)* 17 (15 – 20) 17.5 (15 – 25) 0.043 
Years of smoking up to 1 year ago (years)* 27 (16 – 37) 12.5 (5 – 27.5) <0.001 
Intensity (cigarette/day)* 16 (8 – 20) 5.0 (1.7 – 10) <0.001 
Cumulative dose (pack-years)* 18 (6.3 – 38.4) 2.5 (0.3 – 10.9) <0.001 
      
Ex-smokers      
Current age (years)* 61 (51 – 70) 49 (40 – 70) 0.023 
Years of smoking up to 1 year ago (years)* 25 (13 – 35) 9.5 (6 – 29) 0.001 
Years of quitting up to 1 year ago (years)* 0 (0 – 9) 0 (0 –12.5) 0.428 
      
Environmental tobacco smoke (ETS)      
No exposure to ETS, n (%) 455 (56.7%) 270 (48.3%) 0.002 
Exposure to ETS, n (%) 347 (43.3%) 289 (51.7%)  
      
ALCOHOL DRINKING      
Never drinker, n (%) 415 (55.0%) 472 (87.6%)  
Ever drinker, n (%) 340 (45.0%) 67 (12.5%) <0.001 
Current age (years)* 50 (39 – 60) 41 (27 – 55) <0.001 
Age start drinking (years)* 20 (18 – 25) 20 (18 – 26) 0.339 
Weekly consumption (drinks/week)* 14.0 (3.1 – 64) 1.8 (0.3 – 9.5) <0.001 
Beer (drinks/week)* 8.0 (2.5 – 24) 1.0 (0.2 – 3.0) <0.001 
Wine (drinks/week)* 0.5 (0.1 – 2.9) 0.6 (0.1 – 2.5) 0.892 
Hard liquor (drinks/week)* 3.1 (0.3 – 44.5) 1.0 (0.2 – 7.7) 0.055 
TOTAL 810  561   
* Median (interquartile range) 
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Cigarette smoking behaviour in cases and controls 
 
In this study, 211 (39.7%) lymphoma cases (59.7% males, 12.1% 
females) and 363 (43.8%) hospital controls (64.4% males, 13.4% females) were 
ever smokers.  On average, there was no difference in smoking intensity 
between cases and controls, with the median intensity of 15 cigarettes per day.  
Both started smoking at around 17 years old, but cases smoked longer than 
controls (29.0 years vs 24.4 years, p<0.001).  More cases than controls quitted 
smoking, but this was less likely to be influenced by their illness since the time 
of quitting was at least 1 year prior to the date of interview. 
 
The associations between lymphoid neoplasm and cigarette smoking are 
presented in Table 7.4.  We did not observe any association between cigarette 
smoking behaviour with overall risk of lymphoma, regardless of the smoking 
status: ever smokers (OR 0.91, 95%CI 0.66-1.26), current smokers (OR 0.80, 
95%CI 0.53-1.19) or ex-smokers (OR 1.01, 95%CI 0.70-1.47).  Compared with 
never smokers, age when as subject started smoking regularly, smoking 
intensity and duration did not suggest any association with the risk of NHL or 
any subtypes.  There was also no association between environmental tobacco 
smoke exposure and the risk of any lymphoid neoplasms.  A reduced risk of HL 
was observed among ever smokers who smoked ≤25 years, had low intensity 
smoking (less than 10 cigarettes/day), and who had smoked less than 20 pack-
years.   
 
Since the smoking habit differed greatly by gender, we further assessed 
the interaction effect between smoking status and gender. However, no 
difference was observed between the males and females in the risk of any 
lymphoma subtypes.  
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Table 7.4 Estimates of OR and 95% CI for association between cigarette smoking and lymphoma  
Smoking variables Ctrl  Lymphoid neoplasms  Non-Hodgkin lymphoma  Hodgkin lymphoma 
No (%)  No  (%) ORa (95% CI)  No (%) ORa (95% CI)  No (%) ORa (95% CI) 
Never smoker 466 (56.2)  321 (60.3) 1.00 (ref)  273 (59.7) 1.00 (ref)  48 (65.8) 1.00 (ref) 
Ever smoker 363 (43.8)  211 (39.7) 0.91 (0.66-1.26)  184 (40.3) 1.00 (0.71-1.41)  25 (34.3) 0.52 (0.25-1.07) 
Duration                  



























































































































Current smokers only 215 (25.9)  102 (19.2) 0.80 (0.53-1.19)  85 (18.6) 0.85 (0.55-1.32)  17 (23.3) 0.54 (0.23-1.24) 































Abbreviation:  * P-value<0.05, ** P-value<0.01, *** P-value<0.001. 
Numbers did not add up to 829 controls and 532 LN cases due to missing data. 
a OR, odds ratio adjusted for age (continuous), gender (male / female), ethnicity (Chinese/Malay/Indian), education (never/<6/7-10/>10yrs), current housing types (Public 
housing ≤3rooms/Public housing >3rooms/Private housing/Others), BMI (continuous) and history of any cancer in the first degree relatives (yes/no), vegetable & fruits 
consumption (4 categories), drinking status (yes/no) and Diabetes Mellitus (yes/no) in multiple logistic regression model.   
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Table 7.4 (cont.) 
Smoking variables 
Ctrl  Lymphoid neoplasms   Non-Hodgkin lymphoma   Hodgkin lymphoma 
No (%)  No (%) ORa (95% CI)  No (%) ORa (95% CI)  No (%) ORa (95% CI) 
Never smoker 466 (56.2)  321 (60.3) 1.00 (ref)  273 (59.7) 1.00 (ref)  48 (65.8) 1.00 (ref) 
Ex-smokers only 148 (17.9)  109 (20.5) 1.01 (0.70-1.47) 99 (21.7) 1.11 (0.75-1.65)  8 (11.0) 0.49 (0.19-1.30) 
Years of quitting                  
Quit >10 years 





























                  
Environmental Tobacco Smoke (ETS)                
No ETS exposure 307 (37.0)  214 (40.3) 1.00 (ref)  182 (39.9) 1.00 (ref)  32 (43.8) 1.00 (ref) 
Exposed to ETS 522 (63.0)  317 (59.7) 0.84 (0.65-1.10) 274 (60.1) 0.91 (0.69-1.22)  41 (56.2) 0.61 (0.35-1.07) 
                  
Abbreviation:  * P-value<0.05, ** P-value<0.01, *** P-value<0.001. 
Numbers did not add up to 830 controls and 541 LN cases due to missing data. 
a OR, odds ratio adjusted for age (continuous), gender (male / female), ethnic (Chinese/Malay/Indian), education (never/<6/7-10/>10yrs), current housing types 
(Public housing ≤3rooms/Public housing >3rooms/Private housing/Others), BMI (continuous) and history of any cancer in the first degree relatives (yes/no), 
vegetable & fruits consumption (4 categories), drinking status (yes/no) and Diabetes Mellitus (yes/no) in multiple logistic regression model.  
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Alcoholic drinking behaviour in cases and controls 
 
Table 7.5 shows the association of alcohol consumption and the risk of 
lymphoma.  The alcohol-related questions were included in the SLS 
questionnaire in February 2005, therefore only 801 controls and 492 cases 
answered questions on alcohol consumption.  35.7% of hospital controls (n=286) 
and 24.6% of lymphoma patients (n=121) reported drinking alcohol regularly at 
least once a month.  Among ever drinkers in Singapore, beer was the most 
common alcoholic beverage and was consumed by ~90% of participants (88.5% 
controls, 90.1% cases).  Hard liquor was consumed by 69.6% of controls (n=199) 
and 60.3% cases (n=73).  Wine was the least common beverage consumed by 
40% of participants only (109 controls and 53 cases).  
 
Compared with never drinkers, ever drinkers reported a reduced risk of 
lymphoid neoplasms (OR 0.71, 95%CI 0.51-0.98) and NHL (OR 0.68, 95%CI 
0.48-0.96).  Among those who started drinking above 19 years of age, the NHL 
risk was halved (OR 0.47, 95%CI 0.28-0.78).  Participants who reported over 40 
standard drinks per week experienced ~50% decrease in risk of NHL (95%CI 
0.27-0.93).  However, we did not detect any association between alcoholic 
beverages and HL. 
 
In terms of alcoholic beverage types, we detected a reduced NHL risk in 
subjects who consumed all 3 types of beverages, i.e. beer, hard liquor and wine 
(OR 0.48, 95%CI 0.27-0.85) (Table 7.5).  We further investigated the individual 
effect of alcoholic beverage, with additional adjustment for consumption of other 
alcoholic drinks; no association with any alcoholic drink was detected with the 
risk of lymphoma (Table 7.6).   
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Table 7.5 Estimates of OR and 95% CI for association between alcohol drinking and lymphoma 
Drinking variables 
Control  Lymphoid neoplasms  Non-Hodgkin lymphoma  Hodgkin lymphoma 
No (%)  No (%) ORa (95% CI)  No (%) ORa (95% CI)  No (%) ORa (95% CI) 
Never drinker 515 (64.3)  371 (75.4) 1.00 (ref)  325  (76.5) 1.00 (ref)  45  (68.2) 1.00 (ref) 
Drinker 286 (35.7)  121 (24.6) 0.71 (0.51-0.98)*  100  (23.5) 0.68 (0.48-0.97)*  21  (31.8) 0.98 (0.49-1.93) 
Age start drinking                   
> 19 years 





























Weekly consumption                   
<4 drink/week 
4 – 39.9 drink/week  











































Alcoholic types    
 
             
All 3 types  
Beer + hard liquor 
Only beer 
Only hard liquor 
Beer + wine 




































































































Abbreviation:  OR: odds ratio; CI: confidence intervals; * P-value<0.05, ** P-value<0.01, *** P-value<0.001.  
Numbers did not add up to 801 controls and 492 LN cases due to missing data. 
a OR adjusted for age (continuous), gender (male / female), ethnicity (Chinese/Malay/Indian), education (never/<6/7-10/>10yrs), current housing types (Public 
housing ≤3rooms/Public housing >3rooms/Private housing/Others), BMI (continuous) and history of any cancer in the first degree relatives (yes/no), 
vegetable and fruits consumption (4 categories), smoker status (never/quitter/smoker), and Diabetes Mellitus (yes/no) in multiple logistic regression model.  
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Table 7.6 Estimates of OR and 95%CI for association between alcoholic beverage types and lymphoma 
Beverage types 
Control  Lymphoid neoplasms  non-Hodgkin lymphoma  Hodgkin lymphoma 
No (%)  No (%) ORa (95% CI)  No (%) ORa (95% CI)  No (%) ORa (95% CI) 
Never drinker 515 (64.3)  371 (75.4) 1.00 (ref)  325 (76.5) 1.00   45 (68.2) 1.00  
Drinker 286 (35.7)  121 (24.6) 0.71 (0.51-0.98)*  100 (23.5) 0.68 (0.48-0.97)*  21 (31.8) 0.98 (0.49-1.93) 
Beer drinker 1 253 (31.6)  109 (22.2) 0.85 (0.51-1.41)  90 (21.2) 0.80 (0.46-1.38)  19 (28.8) 1.29 (0.45-3.66) 
< 3 drink/week 
3 – 14.9 drink/week 











































Hard Liquor drinker 2 199 (24.8)  73 (14.8) 0.93 (0.38-2.28)  58 (13.6) 0.92 (0.33-2.56)  15 (22.7) 1.02 (0.19-5.35) 
≤ 3 drink/week 





























Wine drinker 3 109 (13.6)  53 (10.8) 1.65 (0.57-4.80)  45 (10.6) 1.78 (0.58-5.43)  8 (12.1) 0.94 (0.09-9.26) 
< 0.5 drink/week 





























Abbreviation:  OR: odds ratio; CI: confidence intervals; * P-value<0.05, ** P-value<0.01, *** P-value<0.001. 
Numbers did not add up to 801 controls and 492 LN cases due to missing data. 
a OR adjusted for age (continuous), gender (male/female), ethnicity (Chinese/Malay/Indian), education (never/<6/7-10/>10yrs), current housing types (Public 
housing ≤3rooms/Public housing >3rooms/Private housing/Others), BMI (continuous) and history of any cancer in the first degree relatives (yes/no), 
vegetable & fruits consumption (4 categories), smoker status (never/quitter/smoker) and Diabetes Mellitus (yes/no) in multiple logistic regression model.  
1 Model with additional adjustment for consumption of wine (never / ever) and hard liquor (never / ever) 
2 Model with additional adjustment for consumption of beer (never / ever) and wine (never / ever) 
3 Model with additional adjustment for consumption of beer (never / ever) and hard liquor (never / ever) 
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7.6 Discussions  
 
In this hospital-based case-control study, we found no association 
between cigarette smoking and NHL subtypes, but a decreased HL risk among 
those who smoked ≤20 pack-years, however this could be due to small sample 
size resulting in chance difference.  On the other hand, a protective effect of 
alcohol on the risk of lymphoma was suggested. Both results showed no 
interactions between gender and alcohol or cigarette smoking. 
 
 
Association between cigarette smoking and the risk of lymphoma 
 
Our results did not support the association between cigarette smoking 
and the overall risk of lymphoid neoplasms, in terms of smoking status (ever 
smokers, ex-smokers or current smokers), pattern of smoking (active smoking, 
second hand smoking in environmental tobacco smoke), intensity, frequency or 
dose (pack-years).  This is consistent with previous studies such as the 
European case-control (Besson et al. 2006b) and cohort (Nieters et al. 2008) 
studies, Connecticut case-control study (Morton et al. 2003a), and Swedish 
cohort studies on construction workers (Fernberg et al. 2006).  However several 
case-control and cohort studies reported an increased NHL risk.  The large-
scaled InterLymph study reported a 7% increase in NHL risk among ever 
smokers (OR 1.07, 95% CI 1.00-1.15) (Morton et al. 2005a).  Other studies only 
detected elevated risk in the follicular lymphoma subtype (Besson et al. 2003; 
Freedman et al. 1998; Herrinton & Friedman 1998; Morton et al. 2005a; Morton 
et al. 2003a). 
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Follicular lymphoma is a common indolent subtype in West, but not very 
common in Singapore. Chromosomal translocation t(14;18) is a characteristic of 
follicular lymphoma. But this may also be found in some other non-Hodgkin 
lymphomas, or detected in a small amount of peripheral blood lymphocytes in 
normal healthy people (Rabkin et al. 2008; Schuler et al. 2003). The prevalence 
of t(14;18) in Asians healthy individuals are lower than in Caucasians, and the  
frequency increased with age and smoking intensity as in pack-years (Schuler 
et al. 2003). As mentioned earlier, nicotine, tar, carcinogens and numerous 
hazardous additives are components in cigarettes. Exposure to dioxin or 
pesticides may cause t(14;18) clonal expansion, and these can also be found in 
cigarettes (Baccarelli et al. 2006; Muto & Takizawa 1989).  Most of the cases we 
recruited in the Singapore Lymphoma Study are the aggressive subtypes, 
particularly Diffuse Large B-cell Lymphoma.  Chang et al (2010a) reported a 
study using fluorescence in situ hybridization (FISH) to identify common 
translocations in NHL, t(14;18) was identified in 84% of follicular lymphoma but 
only 39% of DLBCL. Thus it may explain why we lack the statistical power to 
detect smoking-related associations in our study, possibly due to the small 
sample size of follicular lymphoma in our sample population.   
 
The different associations observed across study populations may be 
due to various smoking intensities.  From the literature, positive associations 
with NHL were observed in those with long duration or high intensity of smoking 
habits, and had increased pack-years of smoking (Freedman et al. 1998; Morton 
et al. 2005a).  Comparing smoking intensities among ever smokers, only 7.4% 
controls and 5.5% cases in US Selected Cancer Studies smoked less than 0.5 
packs per day (i.e. 10 cigarettes/day), and they reported a 45% increased NHL 
risk among those who smoked more than 2.5 packs per day (i.e. 50 
cigarettes/day) (Freedman et al. 1998).  In the pooled InterLymph study, 34.6% 
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controls and 32.2% NHL cases smoked with less than 10 cigarettes per day, 
and there was a 19% increase in risk of NHL amongst those who smoked 21-30 
cigarettes/day.  However in our study, 45.2% controls and 47.4% lymphoma 
cases smoked 10 or less cigarettes/day, or a median of 15 cigarettes per day.  
When comparing with other study populations, close to half of our study 
populations were “light smokers”.  It is possible that we did not have enough 
sample size for those who smoked “heavy” enough, in terms of daily intensity or 
pack-years, to show the association with NHL. 
 
 
Association between alcohol drinking and the risk of lymphoma 
 
In terms of alcohol drinking, 50.2% of males and 14.7% females of 
hospital controls reported being ever drinkers in our study.  The National Health 
Surveillance Survey conducted on general population in 2007 showed 36.4% 
males and 14.2% females reported being ever drinkers (MOH 2009).  We 
acknowledged that the use of hospital-based controls may have recruited 
patients admitted to hospital with drinking-related disease, thus may 
overestimating the level of drinking in the control group.  Excessive alcohol 
drinking is associated with an increased risk of type 2 diabetes via development 
of insulin resistance, and obesity with truncal adiposity, which in turn is also a 
strong factor for Diabetes Mellitus (Howard et al. 2004).  We have tested by 
removing patients admitted for Diabetes Mellitus and related chronic diseases 
(n=66) and repeated the analysis, but the results remained largely the same as 
we have presented in this chapter earlier.  
 
In our study, compared with subjects who did not drink, results of 
decreased NHL risk among drinkers were consistent with the InterLymph 
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consortium (OR 0.83, 95%CI 0.76-0.89) (Morton et al. 2005b), US cohort study 
of >120,000 adults (≥3 drinks/day: OR 0.6, 95%CI 0.4-0.9, p-trend=0.004) 
(Klatsky et al. 2009), and UK Million Women Study (≥15 drinks/week: RR0.77, 
95%CI 0.62-0.94, p-trend=0.001) (Allen et al. 2009).  Other studies did not 
support any association with alcohol drinking (Benedetti et al. 2009; Deandrea 
et al. 2007; Kanda et al. 2009; Nieters et al. 2006; Polesel et al. 2007; Tavani et 
al. 2001; Troy et al. 2010; Willett et al. 2004).  Several studies reported 
decreased NHL risk related only to wine consumption, but not with beer, spirits 
or hard liquor (Briggs et al. 2002b; Morton et al. 2003b).  However, our results 
did not find any difference between beverage types, which is consistent with 
most of the other studies (Gorini et al. 2007; Morton et al. 2005b; Nieters et al. 
2006; Tavani et al. 2001; Troy et al. 2010), suggesting exposure to alcohol may 
be reason for the decrease in risk estimates. 
 
Alcohol has also been classified by IARC as Group 1 carcinogenic to 
human (IARC), and it has been positively related to many cancers, including 
liver cancer and other cancers along the gastrointestinal tract (Parry et al. 2011).  
The possible reasons to explain for the protective effects of alcoholic drinking 
against lymphoma may be related to the improved immunocompetence by low 
to moderate alcohol intake (Diaz et al. 2002), or due to the presence of 
antioxidants which protects against cell damage, and increased insulin 
sensitivity (Kato et al. 2003).  Polyphenolic compounds presented in wine were 
suggested as the additional protective reasons.  Among the polyphenols, the 
presence of resveratrol from red wine, has anti-inflammatory and antioxidant 
effects, inhibits metabolic activation of carcinogens, and induce apoptosis 
(Bianchini & Vainio 2003).  However, we did not detect any risk reduction in 
minority local wine drinkers. 
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In conclusion, up to now, our data do not support a casual association 
with cigarette smoking in this Asian population. This could be explained by the 
light-smoking pattern in the Singapore population, as oppose to the elevated 
risk reported in the heavy-smoking populations. It is also possible that we may 
not have enough Follicular lymphoma accumulated in our Singapore Lymphoma 
Study database, we might observe a different conclusion if more cases are 
ascertained in this study.  On the other hand, our results have suggested an 
inverse association between alcoholic consumption and risk of non-Hodgkin 
lymphoma, but not in Hodgkin lymphoma.  The association did not vary with the 
choice of alcoholic beverages, indicating the possible effects by the alcohol in 
the immune system.  We are mindful the drinking behaviour reflects for the 
period of life when “they drink regularly”, our results did not suggest these are 
lifelong continuous drinking patterns.  Further studies are needed to clarify the 
potential links between alcohol drinking and the lymphomagenesis.  
 
 
7.7 Strength and limitations of smoking and drinking analysis  
 
The strength of our current analysis is that the assessment of smoking 
characteristics in questionnaire is well established and validated in many studies.  
No a priori knowledge on the association between smoking and drinking with 
lymphoma was publicly known in the general population.  Most people may 
understand their association with lung/gastrointestinal tract-related cancers, but 
not with lymphoma.  The observed difference in risk estimates in this study 
population was unlikely due to differential reporting in smoking and drinking 
behaviour.   
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Secondly, we consider 1 year prior to the diagnosis of lymphoma or date 
of interview in hospitals as the cut-off point for defining smoking status, either as 
current smoker or ex-smoker.  Since the hospital controls were admitted for 
acute medical problems only, it is unlikely for participants to report a biased 
smoking status due to the current illness or treatments received.  We 
acknowledged that it is possible for lymphoma patients to quit smoking due to 
the disease symptoms.  However, we have a mixed of aggressive (>50%) and 
indolent types of lymphoma in our study population, and the progression of 
aggressive lymphoma is usually fast, within weeks or months only.  As for the 
slow-growing nature of indolent lymphoma, they may be undetectable for a long 
period of time. It is possible the cases quit smoking at their own will, long before 
the symptoms appear as a result of the progression of lymphoma.  
 
We are mindful that other limitations exist in our study.  Smoking and 
drinking are considered as addictive behaviours but it may change over time.  
The assumption made in this study is that the behaviour was consistent 
throughout the assessment period, unless the duration is specified specifically.   
 
Comparing our results with the National Health Surveillance Survey 
(NHHS) at 2007, which involving >7000 respondents aged 18 to 69 years from 
the general population, smoking behaviour was much prevalent in hospital 
controls than general population, i.e. 64.4% hospital controls vs. 23.7% daily 
smoker in general population in males, and 13.4% vs. 3.7% in females. 
However, the reported smoking intensity from our study population was similar 
to NHHS 2007.  The average cigarette smoked per day was 13 cigarettes/day 
and 9 cigarettes/day in males and females respectively (MOH 2009). Similarly, 
more hospital controls than general population in males are at least occasional 
drinkers (i.e. ≥ 3 drinks per month) (50.2% vs. 36.4%), but it is the same in 
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females (14.7% vs. 14.2%). The results suggested our controls recruited in 
hospitals may be associated with smoking- or drinking-related diagnosis. In a 
case-control study design, we assessed the exposure retrospectively.  We are 
aware the possibilities of Berkson’s bias in hospital-based settings, we have 
tried our best to tackle it by spreading out the admission conditions as diverse 
as possible, with none of the diagnosis was more than 10% of total number of 
admission diagnosis.  The hospital controls were recruited based on their 
admission diagnosis but not on exposure levels.  
 
Secondly, most of the hospital-based case-control studies did not find 
any associations with cigarette smoking (Besson et al. 2006b; De Stefani et al. 
1998; Monnereau et al. 2008; Talamini et al. 2005), but the positive associations 
were reported in many population-based case-control studies (Freedman et al. 
1998; Morton et al. 2005a).  Considering the reason above, cigarette smoking 
and alcohol drinking may be associated with a wide variety of medical 
conditions, e.g cardiovascular diseases, and hence increased the chances of 
admission.  Thus it may obscure the true association behind towards null.  
However, the elevated risk of lymphoma with smoking behaviour was detected 
in some cohort studies (Herrinton & Friedman 1998; Linet et al. 1992; Nieters et 
al. 2008) only but not all (Fernberg et al. 2006; Troy et al. 2010).  
 
Due to the complexity of lymphoma subtypes, we did not know the 
potential induction period of aetiology factors on the lymphogenesis.  While we 
could adjust for possible confounders, there will be other factors that we may 
not have information on.  Since Diabetes Mellitus may be a confounder between 
alcohol drinking and lymphoma, we have tested our hypothesis by adjustment of 
DM status, or removing these controls from being included in the study pool. Yet 
both ways showed the same results as we have presented in here. 
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Furthermore, with regards to drinking behaviour, we have only collected 
information on age when the subject started drinking regularly; there was no 
information on the duration of drinking, or when the subject quitted drinking.  
Thus, we could not differentiate the drinking pattern between a continuous 
routine from a habit in the past.  We might also have collected the behaviour at 
the high end of exposure, and assuming this was representative of all periods in 
life, as long as it was more than once a month as in our definition of drinking 
behaviour.   
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Chapter 8  
Thesis summary  
 
 
8.1 Current knowledge of lymphoma 
 
In the past 170 years, there has been a lot of breakthrough in medicine. 
From the discovery of a rare disease by Thomas Hodgkin in 1832, till now we 
have a diverse group of lymphoid neoplasms (LN).  The complexity of 
lymphoma increases by the year, with the help of advanced technology on 
imaging techniques, such as CT/MRI or PET scan; other important techniques 
including immunostaining, FISH and molecular testing to help establishing the 
correct diagnosis of the disease.  Lymphoid neoplasms comprise many different 
subtypes, and all developed from a single lymphocyte.  At each stage along the 
maturation of lymphocyte, it was triggered by different risk factors and 
manifested into different subtype of LN, each presented with different 
aggressiveness and at different target organ.  The correct classification and 
characterization of lymphoma is so important for the suitable regimen to be 
given during treatment, and result in enhancing the survival rate of patients.  
 
Many countries established national cancer registry to keep record of all 
cancer incidence, since then many papers have been published on the 
lymphoma trends changes across these years.  The “Cancer Incidence in Five 
Continents” (IARC 2010b) was first published in 1966 by the International 
Agency for Research on Cancer (IARC) as a reference to the international 
cancer incidence. Many reports from the West suggested at least 3% increase 
per year of non-Hodgkin lymphoma (NHL) incident rates, until it started to level 
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off in early 1990s in Europe (Mitterlechner et al. 2006; Sandin et al. 2006).  
Similarly the Hodgkin lymphoma (HL) trends was increased until 1970s and then 
started to decline (Adamson et al. 2007).   
 
Over the years, many epidemiology studies have been conducted to 
explore the aetiology of lymphoma and its relation to the rise over time.  
However, we still have not yet understood thoroughly about this complex 
disease.  Except for a minority of lymphoma cases which can be explained, 
most of the study on risk factors generated inconsistent results.   
 
Immunodeficiency is a more established risk factor which accounted for 
only a minority of cases.  Studies showed a strong link between 
immunodeficiency and lymphomagenesis, either as primary congenital disease 
(Filipovich et al. 1992), immunocompetence resulted from organ transplant 
procedures (Opelz & Dohler 2004), or due to acquired immune deficiency 
syndrome (McGinnis et al. 2006).  Excess risk in the second lymphoid 
malignancies in cancer survivors can be elevated up to 18-fold after the initial 
lymphoma (Royle et al. 2011).  Besides, factors suggested to be associated with 
increased lymphoma risk including a history of cancer in the first degree family, 
especially a history of haematopoietic cancer; and autoimmune diseases such 
as SLE or Sjogren’s syndrome (Smedby et al. 2006; Soderberg et al. 2006).  
Other risk factors from the literature yielded inconclusive results over the years, 
including pesticides (Merhi et al. 2007) and radiation exposures (Cano & Pollan 
2001), hair dyes used (Zhang et al. 2008), blood transfusion (Castillo et al. 
2010), atopy (Vajdic et al. 2009), contacts with animal (Tranah et al. 2008), 
exposures to bacteria (Parsonnet et al. 1994), virus (Matsuo et al. 2004; Nath et 
al. 2010) or vaccinations (Bernstein & Ross 1992; Tavani et al. 2000), diet 
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(Chang et al. 2006; Zhang et al. 1999), obesity (Renehan et al. 2008), 
reproductive factors (Adami et al. 1997; Glaser et al. 2003), parental age at birth 
(Lu et al. 2010), sleeping pattern (Lahti et al. 2008) or even concordance in 
spouse who shared lifestyles (Weires et al. 2011). 
 
Almost all studies conducted so far were from the West.  The common 
limitation in most studies is the small sample size, which is the main drawback 
to understand the complex lymphoid neoplasms family.  The Interlymph 
Consortium (NCI/NIH), also called the International Consortium of 
Investigators Working on Non-Hodgkin’s Lymphoma Epidemiologic 
Studies, is the largest consortium from 11 countries from North America and 
Europe.  They published pooled analysis results on lifestyle and environmental 
risk factors and genetics analysis from 13 cases-control studies on lymphoma.  
They served as the index group of all case-control studies due to their large 
sample size.  However, there were not much information contributed from Asian 
populations.   
 
 
8.2 What we found in this thesis 
 
Non-Hodgkin lymphoma, as traditionally called, has increased steadily 
across the past few decades in Singapore (NRDO 2010), while some of the 
Western countries already showed a slowing down or plateauing of incidence.  
There were several lymphoma classification systems available in the past few 
decades, with almost a brand new classification in every decade.  Most studies 
used the traditional classification of NHL so as to increase comparability with 
other publications.  The latest age-period-cohort analysis on NHL was published 
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by a French study group in 2010 (Viel et al. 2010).  Although the LN 
classification was release by WHO in 2001 (Jaffe et al. 2001) and updated in 
2008 (Jaffe 2009), no paper has attempted to look at the trends of lymphoid 
neoplasms by incorporating HL, plasma cell myeloma and lymphoid leukaemia 
into consideration.   
 
The novelty of our study was to generate several models based on 
different classification systems.  Using 40 years of data from the Singapore 
Cancer Registry, our APC modelling analysis provided an understanding on the 
trends of lymphoma incidences in Singapore.  From our results, a solid upward 
trend of NHL was observed across the reporting periods, as well as in 
advancing age groups and successive birth cohorts based on our graphical 
presentations.  The first model used traditional grouping of NHL as in all 
previous publications.  Our results showed that a full APC model provided the 
best fit and all three effects - age, period and cohort - contributed to the rising 
trends of lymphoma in Singapore.  When we re-defined lymphoma based on the 
WHO classification of “B-cell neoplasms” and “T-/NK-cell neoplasms”, in 
addition to plasma cell myeloma and lymphoid leukaemia, similar result was 
observed.  The full APC model showed the smallest deviance with all variables 
achieving statistical significance and no over-dispersion of residual found.  
When the novel model of LN was tested, the period effect did not improve the fit 
of the model after adjusting for age, gender and cohort effect.  Thus our results 
supported that after considering HL into LN, the period effect is lost.   
 
HL has long been considered as a separate entity of lymphoma.  Not 
only in terms of aetiology behind, the target age group of patients, presentation 
of disease, regimen given for treatment, and survival rate were different from 
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NHL.  However, HL and NHL now belongs to the same lymphoid neoplasms 
family under the WHO classification.  The new entity “the B-cell neoplasm, 
cannot differentiate between DLBCL and classical Hodgkin lymphoma” in 
updated version provided clues to the possibility of misclassification between 
NHL and HL in the past.  Previous studies explained that the period effect in 
NHL trends was due to a change in classification, which affects all age groups 
at a particular calendar time.  Thus our results explained the period effect 
observed in the model using solely NHL as in previous studies, and why it 
disappeared in the LN model.   
 
Our results also supported that the age and cohort effect have a strong 
impact on the changes in incidence of lymphoma over time.  It has been 
suggested that a change in lifestyle or environmental exposure was responsible 
for the increasing incidence of lymphoma.  We have then conducted a first 
hospital-based multi-ethnic case-control study in Singapore, which is the first in 
Asian countries, to explore the potential lifestyle factors, including occupations, 
sun exposure, smoking and drinking habits.  
 
The Singapore Lymphoma Study was conducted in the public hospitals 
and national referral centres for skin and cancer between 2004 and 2008.  We 
recruited 830 hospital controls and 541 incident cases who were age 18 years 
and above.  The response rates of cases and controls were 89.7% and 62.4% 
respectively.  The data was collected using standardized questionnaire through 
face-to-face interview by trained research nurses.  
 
The analysis on common occupations in Singapore showed an elevated 
risk of NHL among the teaching professionals with ≤10 years, regardless of the 
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levels of teaching.  It has been suggested in the literature that exposure to virus 
due to person-to-person contact in a large group of students may be the reason 
for the lymphomagenesis (Boffetta & de Vocht 2007).  No association was 
detected in machine operators, business professionals or those working in the 
agricultural industry.  This could be due to a lack of statistical power to detect, in 
a limited small sample size with mixed occupations under broad occupational 
category.  
 
Singapore is a tropical country with efficient UV radiation throughout the 
year (WHO), as a perfect candidate to examine the association between sun 
exposure and the risk of lymphoma.  We found that intermittent recreational sun 
exposure in childhood and adulthood were inversely associated with the risk of 
developing NHL, and it is consistent with the growing evidence across various 
populations.  However, we did not detect any association between NHL and 
occupational sun exposure.  Compare to their childhood, adult subjects spent 
much less time under the sun.  It was also reflected by low sun burn frequency 
and few subjects using sun protection.  The protective effect of sun exposure 
was observed to be more profound in females than males.  The underlying 
beneficial mechanisms suggested from other studies were the role of vitamin D 
generated on the skin upon UV radiation.  This is an important public health 
message addressed to the public.  While most of the public campaign 
addresses the issue of protection against UV to avoid skin cancer in this tropical 
country, sun avoidance may result in low serum vitamin level which may lead to 
other medical problems. 
 
A higher rate of lymphoma has been reported in males than females 
across countries (Ferlay et al. 2010).  Generally speaking, there are behavioural 
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differences between the genders with regards to smoking and drinking habits.  
For this reason we have examined the association between alcohol drinking and 
cigarette smoking and the risk of lymphoma.  Our results showed alcohol drinker, 
regardless of beverages types, reduced the risk of NHL.  Cigarette smoking did 
not support the associations with NHL at all in this study population.  We did not 
detect any other significant differences in risk estimates in smoking and drinking 
behaviours between genders. 
 
 
8.3 The strength and limitations of current studies 
 
In the first study of APC modelling, the lymphoma data source was from a 
very well-documented national cancer registry with high coverage, since the 
beginning of the registry in 1968.  We generated several models based on the 
different international standard classifications used in the past few decades.  
The strength in this study is our reliable data source, regardless of the severity 
of disease or method of diagnosis, and the duration of 40 years is long enough 
to detect any changes in trends.  APC modelling is a standard approach to 
investigate the independent effects of age, period and cohort, and it has been 
tested on many cancers in previous publications.  The novelty of this study is 
the parallel comparison of different classifications of lymphoma which was not 
reported in anywhere before.  We acknowledge that we may have missed some 
very rare subtypes which were classified under LN during the request of data, 
however, these subtypes usually have very few incidences, and thus should not 
have a significant impact on the total sample size and the subsequent APC 
analysis.  Due to the complexity of lymphoma, our 40 years of data is not large 
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enough to have adequate statistical power to detect differences at subtype 
levels.  
 
The Singapore Lymphoma Study is the first multi-ethnic hospital-based 
case-control study in Asia.  The strengths of our study are that the data were 
collected using standardized questionnaires, and with reference to a prestige 
study group in Europe.  The multi-centre design covered the majority of public 
facilities in Singapore, and both cases and controls were referred to hospitals 
under similar referral pattern, hence we have accessed to a representative 
sample of eligible incident cases and controls in this country.  The case-control 
study is an effective design for studying the exposures retrospectively within a 
short period.   
 
At the same time, we are mindful of the limitations.  We attempted to 
remove the interviewer bias (since we cannot blind the interviewers regarding 
the participants’ disease states) by standardizing all interviews according the 
standard operating procedures.  Besides, the interviewers were requested to 
interview both cases and controls.  We may have missed some important 
information from the advanced stage patients since they were too sick to be 
interviewed.  Low participation from hospital controls may introduce selection 
bias. We have made an effort to reduce this by recruiting only patients with 
acute diagnosis, and with wide coverage on admission reasons, so as to 
minimize the risk of biased selection of hospital controls who may have over-
exposed to certain risk factors.  We hope through these procedures we would 
minimize the confounding factors which we may not be able to control for.  The 
retrospective nature of case-control study design may have a recall bias.  No 
established association between any known factors, regardless of occupational 
Ch.8 – Thesis Summary 
178 
exposure, sun exposure, smoking and drinking, and the risk of lymphoma is 
well-known in the general population.  The observed difference in risk estimates 
in this study population was unlikely due to differential reporting in these 
behaviour we evaluated in the thesis.   
 
 
8.4 Proposed future studies 
 
Further studies on lifestyle factors and medical history are needed to 
study their association with the risk of lymphoma in this Asian population.  From 
the literature, we know that altered immune function, or immunosuppression, 
was a known reason for the increased risk of lymphoma.  It is possible that 
lymphoma risk also reflects the subtle change in immune system responses 
which was sharpened by childhood exposure to virus or bacteria (Bufford & 
Gern 2005).  Thus the term “hygiene hypothesis” was first proposed by Dr David 
Strachan in 1989, suggesting a relationship between atopy, family size and birth 
order (Strachan 1989).  In particular, the following risk factors may be of interest: 
 
Sibship size and birth order: It has been postulated that the risk of lymphoma 
may be related to delayed exposure to infection during childhood.  Absence 
of exposures to infections may lead to an immune system skewed towards 
T-helper 2 (Th2) type of immune response instead of Th1.  A Danish 
population cohort study reported that the risk of HL decreases with 
increasing sibship size (RR 0.91, 95%CI 0.81-1.03) and birth order (RR 
0.85, 95%CI 0.71-1.01) in young adults over 15 years of age (Westergaard 
et al. 1997).  However, the association was not supported by other studies, 
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which suggested it was a biased due to low SES effect (Grulich et al. 2010; 
Mensah et al. 2007) 
 
Atopy: Atopy is a predisposition towards developing allergic hypersensitivity to 
environmental allergens, and characterized by an immune-response that is 
skewed toward a Th2-dominant response (Grulich et al. 2007a).  Previous 
studies suggested a reduced NHL risk is associated with a history of atopy 
due to immune dysregulation.  In the analysis of 13 case-control studies in 
InterLymph, asthma and hay fever was associated with 10% and 20% 
reduction in NHL risk respectively (Vajdic et al. 2009).  
 
Autoimmune disease: Systematic autoimmune disease may increase the risk 
of lymphoma due to its association with Th1 dominated immune response.  
SLE, psoriasis and rheumatoid arthritis have a higher risk of developing 
NHL and HL (Ekstrom Smedby et al. 2008; Smitten et al. 2008; Soderberg 
et al. 2006). Other studies reported null association (Smedby et al. 2006; 
Tavani et al. 2000). 
 
Hepatitis B / C virus (HBV/HCV): Infectious virus will induce chronic immune 
stimulation and persistently activate lymphocytes (Engels 2007).  HCV 
infection is strongly associated with benign B-cell lymphoproliferative 
disorder (Charles & Dustin 2009).  In a meta-analysis of 23 studies, HCV 
infection was associated with close to 6-fold increased NHL risk (Matsuo et 
al. 2004).  Similarly, HBV is a common hepatotrophic and lymphotrophic 
virus.  In studies involving countries where hepatitis infection is endemic, 
those who were hepatitis B service antigen (HBsAg) seropositive had a 
relative risk for NHL ranging from 1.7 to 4.1 fold, as compared with those 
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with HBsAg sero-negative (Engels et al. 2010; Fwu et al. 2011; Nath et al. 
2010). 
 
Type 2 diabetes mellitus (DM): Type 2 DM is associated with altered immune 
function.  In two independent meta-analysis of diabetes with NHL, a 
moderately elevated (~20%) risk was reported (Chao & Page 2008; Mitri et 
al. 2008). 
 
Blood transfusion: Due to the immunogenic effects of red blood cells, 
allogeneic transfusions have been suggested as a risk factor for 
development of lymphoma.  In a meta-analysis of 9 case-control and 5 
cohort studies, the relative risk of developing NHL was 1.2 (95%CI 1.07-




Further, it has long been speculated that common polymorphic variation 
contributed to the susceptibility of cancers.  No definite susceptibility alleles 
have been identified so far.  With the advanced molecular technique, genome-
wide association study (GWAS) is a powerful approach for identification of 
common, low-penetrance loci without a priori knowledge about the function.  We 
can then incorporate the genetic profile, with the lifestyle factors collected by the 
traditional epidemiological studies, to investigate the link between them.  From 
previous studies in the West on GWAS or genotyping analysis, the followings 
are the areas suggested to be associated with lymphoma in inflammatory or 
immune-related systems, and hence these are some suggestions for future 
work in the Asian populations: 
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Proinflammatory cytokine gene: A study on the polymorphisms in immune 
system-related genes, tumour necrosis factor (TNF) and interleukin-10 (IL-10), 
was associated with NHL risk as reported by InterLymph based on 7,999 NHL 
cases and 8,452 controls (Skibola et al. 2010).  A 3-folded increase in NHL risk 
was observed in TNF polymorphism in the Chinese study (Zhang et al. 2012). 
 
Human Leukocyte antigen (HLA): People with a history of autoimmune 
disease have increased risk of NHL.  GWAS studies showed the single 
nucleotide polymorphisms (SNPs) at the HLA class II region (chromosome 
6p21.32) were significantly associated with nodular sclerosis HL (Cozen et al. 
2012) and follicular lymphoma (Conde et al. 2011).  The same region was 
possibly sharing genetic aetiology with DLBCL subtypes as suggested by the 
Swedish study (Smedby et al. 2011). 
 
Cytokine polymorphism: Chen et al (2011) reported a case-control study on 
common genetic variation in Th1 and Th2 cytokine genes.  Connecticut women 
with BMI ≥25kg/m2 had elevated NHL risk in those who carried IFNGR2 AA, IL5 
CT/TT, IL7R AA and TNF CC genotype. 
 
Interleukin 2 (IL2) gene: IL2 plays an important role in proliferation of T- and 
NK-cell.  Song et al (2012) examine the effects of polymorphism of IL2 with the 
risk of NHL in China.  The prevalence of -330G/+114T haplotype was 
associated with NHL (OR 1.45, 95% CI 1.12-1.88).  
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In conclusion, as the first multi-ethnic lymphoma study in Asia, our 
results have contributed to a missing piece in the bigger puzzle.  With the 
findings collected from traditional epidemiology studies over the years across 
the world, and the new knowledge at molecular level by the genome-wide 
studies, our future directions entail a new melting pot to put these information 
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Appendix 1 - Schematic diagrams of changes in classification of 
lymphoma and leukaemia 
 
Traditional understanding of haematopoietic malignancies: 
 
 
WHO classification 4th Edition (2008)  (Swerdlow et al. 2008) :  
 
Appendix – ICD codes 
1 International Classification of Diseases. Available from http://www.wolfbane.com/icd/index.html (last 
update on 7 April 2007), accessed in 2011. 
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Appendix 2 – International Classification of Diseases (ICD) for lymphatic 
and haematopoietic diseases 1 
 
ICD, Revision 6 (1948) 
 
(200-205) Neoplasms of lymphatic and 
haematopoietic tissues 
200 Lymphosarcoma and reticulosarcoma 
201 Hodgkin's disease 
202 Other forms of lymphoma (reticulosis) 
203 Multiple myeloma (plasmocytoma) 
204 Leukaemia and aleukaemia 
205 Mycosis fungoides 
 
ICD, Revision 7 (1955) 
 
(200-207) Neoplasms of lymphatic and 
haematopoietic tissues 
200 Lymphosarcoma and reticulosarcoma 
201 Hodgkin's disease 
202 Other forms of lymphoma (reticulosis) 
203 Multiple myeloma (plasmocytoma) 
204 Leukaemia and aleukaemia 
205 Mycosis fungoides 
206 Lymphatic system 
207 Haematopoietic system 
 
ICD, Revision 8 (1965) 
 
(200-209) Neoplasms of lymphatic and 
haematopoietic tissue 
200 Lymphosarcoma and reticulum-cell 
sarcoma 
201 Hodgkin's disease 
202 Other neoplasms of lymphoid tissue 
203 Multiple myeloma 
204 Lymphatic leukaemia 
205 Myeloid leukaemia 
206 Monocytic leukaemia 
207 Other and unspecified leukaemia 






ICD, Revision 9 (1975) 
 
(200-208) Malignant neoplasm of lymphatic 
and haematopoietic tissue 
200 Lymphosarcoma and reticulosarcoma 
201 Hodgkin's disease 
202 Other malignant neoplasm of 
lymphoid and histiocytic tissue 
203 Multiple myeloma and 
immunoproliferative neoplasms 
204 Lymphoid leukaemia 
205 Myeloid leukaemia 
206 Monocytic leukaemia 
207 Other specified leukaemia 
208 Leukaemia of unspecified cell type 
 
ICD, Revision 10 (1990) 
 
(C81-C96) Malignant neoplasm of lymphoid, 
haematopoietic and related 
tissue 
C81 Hodgkin's disease 
C82 Follicular [nodular] non-Hodgkin's 
lymphoma 
C83 Diffuse non-Hodgkin's lymphoma 
C84 Peripheral and cutaneous T-cell 
lymphomas 
C85 Other and unspecified types of non-
Hodgkin's lymphoma 
C88 Malignant immunoproliferative 
diseases 
C90 Multiple myeloma and malignant 
plasma cell neoplasms 
C91 Lymphoid leukaemia 
C92 Myeloid leukaemia 
C93 Monocytic leukaemia 
C94 Other leukaemias of specified cell 
type 
C95 Leukaemia of unspecified cell type 
C96 Other and unspecified malignant 
neoplasms of lymphoid, 
haematopoietic and related tissue 
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Appendix 3 – International Classification of Diseases for Oncology: 
Morphology of Neoplasms (ICD-O) for lymphatic and 
haematopoietic systems 1 
ICD-O, Edition 1 (1975)  
 
(M959-M963) Lymphomas, NOS or diffuse 
M9590/0 Lymphomatous tumour, benign 
M9590/3 Malignant lymphoma NOS 
M9591/3 Malignant lymphoma, non-
Hodgkin's type 
M9600/3 Malignant lymphoma, 
undifferentiated cell type NOS 
M9601/3 Malignant lymphoma, stem cell 
type 
M9602/3 Malignant lymphoma, 
convoluted cell type NOS 
M9610/3 Lymphosarcoma NOS 
M9611/3 Malignant lymphoma, 
lymphoplasmacytoid type 
M9612/3 Malignant lymphoma, 
immunoblastic type 
M9613/3 Malignant lymphoma, mixed 
lymphocytic-histiocytic NOS 
M9614/3 Malignant lymphoma, 
centroblastic-centrocytic, 
diffuse 
M9615/3 Malignant lymphoma, follicular 
centre cell NOS 
M9620/3 Malignant lymphoma, 
lymphocytic, well differentiated 
NOS 
M9621/3 Malignant lymphoma, 
lymphocytic, intermediate 
differentiation NOS 
M9622/3 Malignant lymphoma, 
centrocytic 
M9623/3 Malignant lymphoma, follicular 
centre cell, cleaved NOS 
M9630/3 Malignant lymphoma, 
lymphocytic, poorly 
differentiated NOS 
M9631/3 Prolymphocytic lymphosarcoma 
M9632/3 Malignant lymphoma, 
centroblastic type NOS 
M9633/3 Malignant lymphoma, follicular 
centre cell, noncleaved NOS 
 
(M964-M964) Reticulosarcomas 
M9640/3 Reticulosarcoma NOS 
M9641/3 Reticulosarcoma, pleomorphic 
cell type 
M9642/3 Reticulosarcoma, nodular 
 
 
(M965-M966) Hodgkin's disease 
M9650/3 Hodgkin's disease NOS 
M9651/3 Hodgkin's disease, lymphocytic 
predominance 
M9652/3 Hodgkin's disease, mixed 
cellularity 
M9653/3 Hodgkin's disease, lymphocytic 
depletion NOS 
M9654/3 Hodgkin's disease, lymphocytic 
depletion, diffuse fibrosis 
M9655/3 Hodgkin's disease, lymphocytic 
depletion, reticular type 
M9656/3 Hodgkin's disease, nodular 
sclerosis NOS 
M9657/3 Hodgkin's disease, nodular 
sclerosis, cellular phase 
M9660/3 Hodgkin's paragranuloma 
M9661/3 Hodgkin's granuloma 
M9662/3 Hodgkin's sarcoma 
 
(M969-M969) Lymphomas, nodular or 
follicular 
M9690/3 Malignant lymphoma, nodular 
NOS 
M9691/3 Malignant lymphoma, mixed 
lymphocytic-histiocytic, nodular 
M9692/3 Malignant lymphoma, 
centroblastic-centrocytic, 
follicular 
M9693/3 Malignant lymphoma, 
lymphocytic, well differentiated, 
nodular 
M9694/3 Malignant lymphoma, 
lymphocytic, intermediate 
differentiation, nodular 
M9695/3 Malignant lymphoma, follicular 
centre cell, cleaved, follicular 
M9696/3 Malignant lymphoma, 
lymphocytic, poorly 
differentiated, nodular 
M9697/3 Malignant lymphoma, 
centroblastic type, follicular 
M9698/3 Malignant lymphoma, follicular 
centre cell, noncleaved, 
follicular 
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(M970-M970) Mycosis fungoides 
M9700/3 Mycosis fungoides 






M9720/3 Malignant histiocytosis 
M9721/3 Histiocytic medullary 
reticulosis 
M9722/3 Letterer-Siwe's disease 
 
(M973-M973) Plasma cell tumours 
M9730/3 Plasma cell myeloma 
M9731/0 Plasma cell tumour, benign 
M9731/1 Plasmacytoma NOS 
M9731/3 Plasma cell tumour, malignant 
 
(M974-M974) Mast cell tumours 
M9740/1 Mastocytoma NOS 
M9740/3 Mast cell sarcoma 
M9741/3 Malignant mastocytosis 
 
(M975-M975) Burkitt's tumour 
M9750/3 Burkitt's tumour 
 
(M980-M980) Leukaemias NOS 
M9800/3 Leukaemia NOS 
M9801/3 Acute leukaemia NOS 
M9802/3 Subacute leukaemia NOS 
M9803/3 Chronic leukaemia NOS 
M9804/3 Aleukaemic leukaemia NOS 
 
(M981-M981) Compound leukaemias 
M9810/3 Compound leukaemia 
 
(M982-M982) Lymphoid leukaemias 
M9820/3 Lymphoid leukaemia NOS 
M9821/3 Acute lymphoid leukaemia 
M9822/3 Subacute lymphoid leukaemia 
M9823/3 Chronic lymphoid leukaemia 
M9824/3 Aleukaemic lymphoid 
leukaemia 
M9825/3 Prolymphocytic leukaemia 
 
(M983-M983) Plasma cell leukaemias 




M9841/3 Acute erythraemia 
M9842/3 Chronic erythraemia 
(M985-M985) Lymphosarcoma cell 
leukaemias 
M9850/3 Lymphosarcoma cell 
leukaemia 
 
(M986-M986) Myeloid leukaemias 
M9860/3 Myeloid leukaemia NOS 
M9861/3 Acute myeloid leukaemia 
M9862/3 Subacute myeloid leukaemia 
M9863/3 Chronic myeloid leukaemia 
M9864/3 Aleukaemic myeloid 
leukaemia 
M9865/3 Neutrophilic leukaemia 
M9866/3 Acute promyelocytic 
leukaemia 
 
(M987-M987) Basophilic leukaemias 
M9870/3 Basophilic leukaemia 
 
(M988-M988) Eosinophilic leukaemias 
M9880/3 Eosinophilic leukaemia 
 
(M989-M989) Monocytic leukaemias 
M9890/3 Monocytic leukaemia NOS 
M9891/3 Acute monocytic leukaemia 
M9892/3 Subacute monocytic 
leukaemia 
M9893/3 Chronic monocytic leukaemia 
M9894/3 Aleukaemic monocytic 
leukaemia 
 
(M990-M994) Miscellaneous leukaemias 
M9900/3 Mast cell leukaemia 
M9910/3 Megakaryocytic leukaemia 
M9920/3 Megakaryocytic myelosis 
M9930/3 Myeloid sarcoma 






M9950/1 Polycythaemia vera 
M9951/1 Acute panmyelosis 
M9960/1 Chronic myeloproliferative 
disease 
M9961/1 Myelosclerosis with myeloid 
metaplasia 
M9962/1 Idiopathic thrombocythaemia 
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ICD-O, Edition 2 (1990) 
 
(M965-M966) Hodgkin's disease 
M9650/3 Hodgkin's disease NOS 
M9652/3 Hodgkin's disease, mixed 
cellularity NOS 
M9653/3 Hodgkin's disease, 
lymphocytic depletion NOS 
M9654/3 Hodgkin's disease, 
lymphocytic depletion, diffuse 
fibrosis 
M9655/3 Hodgkin's disease, 
lymphocytic depletion, 
reticular 
M9657/3 Hodgkin's disease, 
lymphocytic predominance 
NOS 
M9658/3 Hodgkin's disease, 
lymphocytic predominance, 
diffuse 
M9659/3 Hodgkin's disease, 
lymphocytic predominance, 
nodular 
M9660/3 Hodgkin's paragranuloma 
NOS 
M9661/3 Hodgkin's granuloma 
M9662/3 Hodgkin's sarcoma 
M9663/3 Hodgkin's disease, nodular 
sclerosis NOS 
M9664/3 Hodgkin's disease, nodular 
sclerosis, cellular phase 
M9665/3 Hodgkin's disease, nodular 
sclerosis, lymphocytic 
predominance 
M9666/3 Hodgkin's disease, nodular 
sclerosis, mixed cellularity 




(M967-M968) Malignant lymphoma, 
diffuse or NOS, specified 
type 
M9670/3 Malignant lymphoma, small 
lymphocytic NOS 
M9671/3 Malignant lymphoma, 
lymphoplasmacytic 
M9672/3 Malignant lymphoma, small 
cleaved cell, diffuse 
M9673/3 Malignant lymphoma, 
lymphocytic, intermediate 
differentiation, diffuse 
M9674/3 Malignant lymphoma, 
centrocytic 
M9675/3 Malignant lymphoma, mixed 
small and large cell, diffuse 
M9676/3 Malignant lymphoma, 
centroblastic-centrocytic, 
diffuse 
M9677/3 Malignant lymphomamatous 
polyposis 
M9680/3 Malignant lymphoma, large 
cell, diffuse NOS 
M9681/3 Malignant lymphoma, large 
cell, cleaved, diffuse 
M9682/3 Malignant lymphoma, large 
cell, noncleaved, diffuse 
M9683/3 Malignant lymphoma, 
centroblastic, diffuse 
M9684/3 Malignant lymphoma, 
immunoblastic NOS 
M9685/3 Malignant lymphoma, 
lymphoblastic 
M9686/3 Malignant lymphoma, small 
cell, noncleaved, diffuse 
M9687/3 Burkitt's lymphoma NOS 
 
(M969-M969) Malignant lymphoma, 
follicular or nodular, with or 
without diffuse areas 
M9690/3 Malignant lymphoma, follicular 
NOS 
M9691/3 Malignant lymphoma, mixed 
small cleaved and large cell, 
follicular 
M9692/3 Malignant lymphoma, 
centroblastic-centrocytic, 
follicular 
M9693/3 Malignant lymphoma, 
lymphocytic, well 
differentiated, nodular 
M9694/3 Malignant lymphoma, 
lymphocytic, intermediate 
differentiation, nodular 
M9695/3 Malignant lymphoma, small 
cleaved cell, follicular 
M9696/3 Malignant lymphoma, 
lymphocytic, poorly 
differentiated, nodular 
M9697/3 Malignant lymphoma, 
centroblastic, follicular 
M9698/3 Malignant lymphoma, large 
cell, follicular NOS 
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(M970-M970) Specified cutaneous and 
peripheral T-cell 
lymphomas 
M9700/3 Mycosis fungoides 
M9701/3 Sézary's disease 
M9702/3 Peripheral T-cell lymphoma 
NOS 
M9703/3 T-zone lymphoma 
M9704/3 Lymphoepithelioid lymphoma 




M9706/3 Peripheral T-cell lymphoma, 
pleomorphic small cell 
M9707/3 Peripheral T-cell lymphoma, 
pleomorphic medium and 
large cell 
M9709/3 Cutaneous lymphoma 
 
(M971-M971) Other specified non-
Hodgkin's lymphomas 
M9711/3 Monocytoid B-cell lymphoma 
M9712/3 Angioendotheliomatosis 
M9713/3 Angiocentric T-cell lymphoma 
M9714/3 Large cell (Ki-1+) lymphoma 
 
(M972-M972) Other lymphoreticular 
neoplasms 
M9720/3 Malignant histiocytosis 
M9722/3 Letterer-Siwe disease 
M9723/3 True histiocytic lymphoma 
 
(M973-M973) Plasma cell tumours 
M9731/3 Plasmacytoma NOS 
M9732/3 Multiple myeloma 
 
(M974-M974) Mast cell tumours 
M9740/1 Mastocytoma NOS 
M9740/3 Mast cell sarcoma 








M9762/3 Alpha heavy chain disease 
M9763/3 Gamma heavy chain disease 
M9764/3 Immunoproliferative small 
intestinal disease 





M9768/1 T-gamma lymphoproliferative 
disease 
 
(M980-M980) Leukaemias NOS 
M9800/3 Leukaemia NOS 
M9801/3 Acute leukaemia NOS 
M9802/3 Subacute leukaemia NOS 
M9803/3 Chronic leukaemia NOS 
M9804/3 Aleukaemic leukaemia NOS 
 
(M982-M982) Lymphoid leukaemias 
M9820/3 Lymphoid leukaemia NOS 
M9821/3 Acute lymphoblastic 
leukaemia NOS 
M9822/3 Subacute lymphoid leukaemia 
M9823/3 Chronic lymphocytic 
leukaemia 
M9824/3 Aleukaemic lymphoid 
leukaemia 
M9825/3 Prolymphocytic leukaemia 
M9826/3 Burkitt's cell leukaemia 
M9827/3 Adult T-cell 
leukaemia/lymphoma 
 
(M983-M983) Plasma cell leukaemia 




M9841/3 Acute erythraemia 
M9842/3 Chronic erythraemia 
 
(M985-M985) Lymphosarcoma cell 
leukaemia 
M9850/3 Lymphosarcoma cell 
leukaemia 
 
(M986-M986) Myeloid (granulocytic) 
leukaemias 
M9860/3 Myeloid leukaemia NOS 
M9861/3 Acute myeloid leukaemia 
M9862/3 Subacute myeloid leukaemia 
M9863/3 Chronic myeloid leukaemia 
M9864/3 Aleukaemic myeloid 
leukaemia 
M9866/3 Acute promyelocytic 
leukaemia 
M9867/3 Acute myelomonocytic 
leukaemia 
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M9868/3 Chronic myelomonocytic 
leukaemia 
 
(M987-M987) Basophilic leukaemia 
M9870/3 Basophilic leukaemia 
 
(M988-M988) Eosinophilic leukaemia 
M9880/3 Eosinophilic leukaemia 
 
(M989-M989) Monocytic leukaemias 
M9890/3 Monocytic leukaemia NOS 
M9891/3 Acute monocytic leukaemia 
M9892/3 Subacute monocytic 
leukaemia 
M9893/3 Chronic monocytic leukaemia 
M9894/3 Aleukaemic monocytic 
leukaemia 
 
(M990-M994) Other leukaemias 
M9900/3 Mast cell leukaemia 
M9910/3 Acute megakaryoblastic 
leukaemia 
M9930/3 Myeloid sarcoma 
M9931/3 Acute panmyelosis 
M9932/3 Acute myelofibrosis 








M9950/1 Polycythaemia vera 
M9960/1 Chronic myeloproliferative 
disease 
M9961/1 Myelosclerosis with myeloid 
metaplasia 
M9962/1 Idiopathic thrombocythaemia 
M9970/1 Lymphoproliferative disease 
 
(M998-M998) Myelodysplastic syndrome 
M9980/1 Refractory anaemia NOS 
M9981/1 Refractory anaemia without 
sideroblasts 
M9982/1 Refractory anaemia with 
sideroblasts 
M9983/1 Refractory anaemia with 
excess of blasts 
M9984/1 Refractory anaemia with 
excess of blasts with 
transformation 









ICD-O, Edition 3 (2000) 
 
(M959-M959) Malignant lymphomas, 
NOS or diffuse 
M9590/3 Malignant lymphoma, NOS 
M9591/3 Malignant lymphoma, non-
Hodgkin's, NOS 
M9596/3 Composite Hodgkin's and 
non-Hodgkin's lymphoma 
 
(M965-M966) Hodgkin's lymphoma 
M9650/3 Hodgkin's lymphoma, NOS 
M9651/3 Hodgkin's lymphoma, 
lymphocyte-rich 
M9652/3 Hodgkin's lymphoma, mixed 
cellularity, NOS 
M9653/3 Hodgkin's lymphoma, 
lymphocyte depletion, NOS 
M9654/3 Hodgkin's lymphoma, 
lymphocyte depletion, diffuse 
fibrosis 
M9655/3 Hodgkin's lymphoma, 
lymphocyte depletion, 
reticular 
M9659/3 Hodgkin's lymphoma, nodular 
lymphocyte predominance 
M9661/3 Hodgkin's granuloma (obs) 
M9662/3 Hodgkin's sarcoma (obs) 
M9663/3 Hodgkin's lymphoma, nodular 
sclerosis, NOS 
M9664/3 Hodgkin's lymphoma, nodular 
sclerosis, cellular phase 
M9665/3 Hodgkin's lymphoma, nodular 
sclerosis, grade 1 
M9667/3 Hodgkin's lymphoma, nodular 
sclerosis, grade 2 
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(M967-M969) Mature B-cell lymphomas 
M9670/3 Malignant lymphoma, small B 
lymphocytic, NOS (see also 
M9823/3) 
M9671/3 Malignant lymphoma, 
lymphoplasmacytic (see also 
M9761/3) 
M9673/3 Mantle cell lymphoma 
M9675/3 Malignant lymphoma, mixed 
small and large cell, diffuse 
(obs) (see also M9690/3) 
M9678/3 Primary effusion lymphoma 
M9679/3 Mediastinal large B-cell 
lymphoma (C38.3) 
M9680/3 Malignant lymphoma, large 
B-cell, diffuse, NOS 
M9684/3 Malignant lymphoma, large 
B-cell, diffuse, immunoblastic, 
NOS 
M9687/3 Burkitt's lymphoma, NOS 
(see also M9826/3) 
M9689/3 Splenic marginal B-zone 
lymphoma (C42.2) 
M9690/3 Follicular lymphoma, NOS 
(see also M9675/3) 
M9691/3 Follicular lymphoma, grade 2 
M9695/3 Follicular lymphoma, grade 1 
M9698/3 Follicular lymphoma, grade 3 
M9699/3 Marginal zone B-cell 
lymphoma, NOS 
 
(M970-M971) Mature T- and NK-cell 
lymphomas 
M9700/3 Mycosis fungoides (C44._) 
M9701/3 Sézary's syndrome 
M9702/3 Mature T-cell lymphoma, 
NOS 
M9705/3 Angioimmunoblastic T-cell 
lymphoma 
M9708/3 Subcutaneous panniculitis-
like T-cell lymphoma 
M9709/3 Cutaneous T-cell lymphoma, 
NOS (C44._) 
M9714/3 Anaplastic large cell 
lymphoma, T-cell and Null 
cell type 
M9716/3 Hepatosplenic gamma-delta 
cell lymphoma 
M9717/3 Intestinal T-cell lymphoma 
M9718/3 Primary cutaneous CD30+ T-
cell lymphoproliferative 
disorder (C44._) 
M9719/3 NK/T-cell lymphoma, nasal 
and nasal-type 
 
(M972-M972) Precursor cell 
lymphoblastic lymphoma 
M9727/3 Precursor cell lymphoblastic 
lymphoma, NOS (see also 
M9835/3) 
M9728/3 Precursor B-cell 
lymphoblastic lymphoma 
(see also M9836/3) 
M9729/3 Precursor T-cell 
lymphoblastic lymphoma 
(see also M9837/3) 
 
(M973-M973) Plasma cell tumours 
M9731/3 Plasmacytoma, NOS 
M9732/3 Multiple myeloma (C42.1) 
M9733/3 Plasma cell leukaemia 
(C42.1) 
M9734/3 Plasmacytoma, 
extramedullary (not occurring 
in bone) 
 
(M974-M974) Mast cell tumours 
M9740/1 Mastocytoma, NOS 
M9740/3 Mast cell sarcoma 
M9741/3 Malignant mastocytosis 
M9742/3 Mast cell leukaemia (C42.1) 
 
(M975-M975) Neoplasms of histiocytes 
and accessory lymphoid 
cells 
M9750/3 Malignant histiocytosis 
M9751/1 Langerhans cell histiocytosis, 
NOS 
M9752/1 Langerhans cell histiocytosis, 
unifocal 
M9753/1 Langerhans cell histiocytosis, 
multifocal 
M9754/3 Langerhans cell histiocytosis, 
disseminated 
M9755/3 Histiocytic sarcoma 
M9756/3 Langerhans cell sarcoma 
M9757/3 Interdigitating dendritic cell 
sarcoma 





M9760/3 Immunoproliferative disease, 
NOS 




(see also M9671/3) 
M9762/3 Heavy chain disease, NOS 
M9764/3 Immunoproliferative small 
intestinal disease (C17._) 






M9768/1 T-gamma lymphoproliferative 
disease 
M9769/1 Immunoglobulin deposition 
disease 
 
(M980-M980) Leukaemias, NOS (C42.1) 
M9800/3 Leukaemia, NOS 
M9801/3 Acute leukaemia, NOS 
M9805/3 Acute biphenotypic 
leukaemia 
 
(M982-M983) Lymphoid leukaemias 
(C42.1) 
M9820/3 Lymphoid leukaemia, NOS 
M9823/3 B-cell chronic leukaemia / 
small lymphocytic lymphoma 
(see also M9670/3) 
M9826/3 Burkitt's cell leukaemia (see 
also M9687/3) 
M9827/3 Adult T-cell 
leukaemia/lymphoma (HTLV-
1 positive) 
M9831/1 T-cell large granular 
lymphocytic leukaemia 
M9832/3 Prolymphocytic leukaemia, 
NOS 
M9833/3 Prolymphocytic leukaemia, B-
cell type 
M9834/3 Prolymphocytic leukaemia, T-
cell type 
M9835/3 Precursor cell lymphoblastic 
leukaemia, NOS (see also 
M9727/3) 
M9836/3 Precursor B-cell 
lymphoblastic leukaemia 
(see also M9728/3) 
M9837/3 Precursor T-cell 
lymphoblastic leukaemia 
(see also M9729/3) 
 
 
(M984-M993) Myeloid leukaemias (C42.1) 
M9840/3 Acute myeloid leukaemia, M6 
type 
M9860/3 Myeloid leukaemia, NOS 
M9861/3 Acute myeloid leukaemia, 
NOS (FAB or WHO type not 
specified) (see also M9930/3) 
M9863/3 Chronic myeloid leukaemia, 
NOS 
M9866/3 Acute promyelocytic 
leukaemia, t(15;17)(q22;q11-
12) 
M9867/3 Acute myelomonocytic 
leukaemia 
M9870/3 Acute basophilic leukaemia 
M9871/3 Acute myeloid leukaemia with 
abnormal marrow eosinophils 
M9872/3 Acute myeloid leukaemia, 
minimal differentiation 
M9873/3 Acute myeloid leukaemia 
without maturation 
M9874/3 Acute myeloid leukaemia with 
maturation 
M9875/3 Chronic myelogenous 
leukaemia, BCR/ABL positive 
M9876/3 Atypical chronic myeloid 
leukaemia, BCR/ABL 
negative 
M9891/3 Acute monocytic leukaemia 
M9895/3 Acute myeloid leukaemia with 
multilineage dysplasia 
M9896/3 Acute myeloid leukaemia, 
t(8;21)(q22;q22) 
M9897/3 Acute myeloid leukaemia, 
11q23 abnormalities 
M9910/3 Acute megakaryoblastic 
leukaemia 
M9920/3 Therapy-related acute 
myeloid leukaemia, NOS 
M9930/3 Myeloid sarcoma (see also 
M9861/3) 
M9931/3 Acute panmyelosis with 
myelofibrosis (C42.1) 
 
(M994-M994) Other leukaemias (C42.1) 
M9940/3 Hairy cell leukaemia (C42.1) 
M9945/3 Chronic myelomonocytic 
leukaemia, NOS 
M9946/3 Juvenile myelomonocytic 
leukaemia 
M9948/3 Aggressive NK-cell 
leukaemia 
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(M995-M996) Chronic myeloproliferative 
disorders (C42.1) 
M9950/3 Polycythaemia vera 
M9960/3 Chronic myeloproliferative 
disease, NOS 
M9961/3 Myelosclerosis with myeloid 
metaplasia 
M9962/3 Essential thrombocythaemia 
M9963/3 Chronic neutrophilic 
leukaemia 
M9964/3 Hypereosinophilic syndrome 
 
(M997-M997) Other haematological 
disorders 
M9970/1 Lymphoproliferative disorder, 
NOS 





M9980/3 Refractory anaemia 
M9982/3 Refractory anaemia with 
sideroblasts 
M9983/3 Refractory anaemia with 
excess blasts 
M9984/3 Refractory anaemia with 
excess blasts in 
transformation (obs) 
M9985/3 Refractory cytopenia with 
multilineage dysplasia 
M9986/3 Myelodysplastic syndrome 
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Dr Wong Gee Chuan Dept of Haematology, SGH 
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Appendix 5 
SINGAPORE LYMPHOMA STUDY QUESTIONNAIRE (Version 2.6b.) 
   
 
 
Questionnaire on Health, Genes and Environment 
健康，基因 与 环境问卷调查 
Serial No.: -- 
 
Content : 
Part I. Personal particulars / job history   个人及就业资料 3 
Part II. Personal Medical History   个人病历 8 
A. Self-rated health   自我健康评估 8 
B. Vaccination   预防针 8 
C. Medical history   病历 9 
D. X-rays   X光照片 11 
E. Antibiotic use   抗生素 11 
F. Long term medication / treatment   长期医药治療  12 
G. Blood transfusion   捐血/输血 13 
H. Hospitalization and surgical history   住院及手术资料 13 
Part III. Lifestyles   生活习惯 14 
A. Residence abroad   国外生活 14 
B. Usual physical activity in the past year   经常性体能活动 14 
C. Outdoor leisure activities   室外閒暇运动 15 
D. Skin colour and solar radiation   皮肤颜色与太阳辐射 15 
E. Use of Hair dye   使用头发染料 16 
F. Diet   饮食 17 
G. Beverages, dairy product and supplement use   饮料品种, 奶类制品及补充剂 21 
H. Smoking   吸烟习惯 23 
I. Tattoo / acupuncture   纹身及针炙 24 
Part IV. Family history   家庭资料 25 
A. Family Medical history   家庭病历 25 
B. Residential history   居住简历 27 









1 Date of interview   受访日期  /  /    d     d (日)      m    m (月)     y      y      y     y (年) 
2 Name of interviewee   受访者姓名  
3 NRIC Number   身份证号码 -- 
4 Sex   性别    Male       男                      Female    女 




Address   居住地址 
Block no. 大牌 :   
Street name  街道名:    
Unit no. 单位 :  
Postal code 邮政号码 :  
 
PLACE of interview   NUH   SGH   NCC  NSC  TTSH 
Ward / Clinic   
For controls (tick all that apply) : 
Diagnosis    
The current admission   Not for diagnosis or suspicion of malignancy  
 Not asthma, atopic eczema or allergy 
 Not for immune-related disorder (e.g. SLE, Crohn’s, RA) 
 Not for peptic ulcer disease 
 Not for viral hepatitis or tuberculosis 
In addition  No history of organ transplantation 
 Not known to be positive for HIV/AIDS 
 
ECOG SCORE AT DIAGNOSIS (rate activity of patients / controls  immediately prior to 
treatment)  
 0.  Fully active, able to carry on all pre-disease performance without restriction 
1.   
 
Restricted in physically strenuous activity but ambulatory, able to carry out light 
house or office work 
2.  
 
Ambulatory, able to self-care but unable to work. Up and about >50% of waking 
hours  
3.  Capable of limited self-care, confined to bed/chair >50% of waking hours  
4.  Completely disabled.  Cannot carry on self-care.  Totally confined to bed or chair  
9. Unknown 
 
INTERVIEWER       Name   Signature 
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Serial No.: --  DOB：         (M/F) Ethnic:  
PART I. PERSONAL PARTICULARS / JOB HISTORY  个人及就业资料 
A. Ethnic group and birth place  族裔及出生地 
1A.1 What is your Ethnic group  您的族裔 ?  1.  Chinese 华裔   2.  Malay  馬來裔   3.  Indian  印度裔    4. Others   其它族裔 
1A.2 What is your Father’s Ethnic group  您父親的族裔 ? 1.  Chinese 华裔   2.  Malay  馬來裔   3.  Indian  印度裔    4. Others   其它族裔 
1A.3 What is your Mother’s Ethnic group  您母親的族裔? 1.  Chinese 华裔   2.  Malay  馬來裔   3.  Indian  印度裔    4. Others   其它族裔 
1A.4 
Where were you born? 您在那里出生？ 
 1.  Singapore  新加坡  2.  Malaysia  马来西亚    3.  Hong Kong / Taiwan  香港 / 台湾   
 4. PR China 中国大陆 (Province ___________ 省)   5. Other 其它(Specify 请具体说明: _______) 
1A.5 
If not born in Singapore, at what age did you come to live in Singapore? 
如果您不在新加坡出生, 您几岁开始住在新加坡？ 
_____________
_  years old岁 
B. Siblings兄弟姐妹 (excluded adopted and half siblings 同父异母/同母异父/领养的除外) 
1B.1 What is the order number that you are within your siblings?   您在家里排第几？ _______ / Don’t know 
1B.2 How many brothers do you have?  您有多少个兄弟  _______ / Don’t know 
1B.3 How many sisters do you have?  您有多少个姐妹 _______ / Don’t know 
C. Marital status  婚姻状况 
1C.1 
Are you ….? 您现在是? 
 1.  never married     2.  currently married  3.  separated / widowed or divorced 
        没有结过婚             目前已婚          分居 / 丧偶 / 离异 
 Question 1C.1a & b for women only : 
1C.1a Have you ever been pregnant?   您有没有曾经怀孕?  1.  Yes 有    2.  No  没有 
1C.1b How many children (live births) have you had?  您总共有生过几个孩子? ______________ 
D. Housing 房屋 
1D.1 
Do you currently live in….. ?  您现在住的房屋类别….. ? 
 1.  HDB or other Govt 1-3 room flat (including shop-house)      HDB /其它政府组屋 1-3房室(包括店屋) 
 2.  HDB 4-room flat    HDB 4 房室 
 3.  HDB 5-room flat    HDB 5 房室 
 4.  HDB executive       公寓式组屋 
 5.  Private / HUDC apt or condominium  私人房或公寓 
 6.  Terrace / semi-detached / bungalow  排屋 / 半独立式洋房 / 独立式洋房 
 7.  Other  其它(Specify 请具体说明: __________________) 
E. Others 其他 
1E.1a 
How many years have you attended school, in total? (from primary school) 
您总共受了多少年的在校教育 ? 
__________  years 年 
1E.1b 
How many years have you studied in kindergarten? 
您总共读了多少年的幼稚园 ? 
__________  years 年 
1E.2 
Are you currently employed?   您目前正被雇用或曾经被雇用吗? 
 1.  Yes, currently employed (includes self-employed)    目前正受雇用(包括自我雇用) 
 2.  No, previously employed / retired  曾受过雇用 / 退休 
 3.  No, never employed (e.g. homemaker / students )  从来没有被雇用(例如：家庭主妇/学生) 
1E.3 What is your usual adult height?   您平時的身高是多少？ __________  cm厘米 
1E.4 What is your usual adult weight?  您平時的体重是多少？ __________  kg 公斤 
1E.5 
Have you recently (in the past 6-12 months) lost or gained more than 5 kg of your usual adult weight? 
您最近的六到十二个月内，是否比您平時的体重减轻或加重超过 5公斤以上? 
1.  Yes 有                2.  No  没有 
F. Job History 工作记录 
1F.1 Please tell us about all the jobs you have held starting with the first job you had after leaving general 
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school.  Include all major job changes within the same company as separate jobs, (e.g. permanent moves to 
different sectors, any promotions). Ignore jobs you held for less than 1 year but include all periods 
without any job  (housekeeping, apprenticeship, military service, working on family farm/ business) if they 
were lasting at least 1 year. 
 
Job history without time gaps 
 
Job # a. Company name (optional)  公司名稱 （选择性） b. Type of Industry 行业 c. Occupation title 职业 
#1  
   




e. Year ended 
完结年份 
f. No. of hours spending outdoor 
on normal working day  
工作时共有多少时间留在室外 




小时/日  1.  Yes 有   2.  No 没有 
h. Describe your job (what you did on a typical day, and how you did it)  请说明一下您平时的工作 
 








1F.2 a. In the course of any of your jobs, did you handle any of the following? 任何的工作中，要不要接触以下的化学用品？ 




c. Total no. 
of years 
总共年期 
1F2.1 Solvents   溶劑 1. Yes 有   2. No 没有   
1F2.2 Paints   油漆 1. Yes 有   2. No 没有   
1F2.3 Paint removers   除油漆劑 1. Yes 有   2. No 没有   
1F2.4 Metal degreasing / metal cleaning agents  金属去油劑 1. Yes 有   2. No 没有   
1F2.5 Fuels   燃料 1. Yes 有   2. No 没有   
1F2.6 Ionizing radiation (e.g. X rays)    離子
化輻射能 1. Yes 有   2. No 没有   
1F2.7 Pesticides   除草劑 1. Yes 有   2. No 没有   
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PART II. PERSONAL MEDICAL HISTORY  个人病历 
A. SELF RATING HEALTH 自我健康评估 
 
Of the following sentences, which one(s) correctly best describe your childhood up to the age of 10?  (Read out 
each sentence)  在下面的句子，哪些句子是比较正确的描述您小时候 (少於 10岁) ? 
 
2A.1 I was more often sick than my schoolmates were. 
我比同学较多生病.  1.  Yes  是      2.  No  否     3.  Don’t know不知道 
2A.2 I was absent in the school more often than my school mates.   
我比同学较多请病假.  1.  Yes  是      2.  No  否     3.  Don’t know不知道 
2A.3 I used to take more medicines than my brothers/sisters. 
我比兄弟姐妹较吃更多的药.  1.  Yes  是      2.  No  否     3.  Don’t know不知道 
2A.4 I was a very healthy child.   





2B.1 When you were a child，were you vaccinated according to the official guidelines at the 
time?  (e.g . BCG + Tetanus + Poliomyelitis)  
您小時候有没有按照规定接種疫苗？(如: 肺结核 + 破伤风 +小兒麻痹症) 
 1.  Yes  是 
 2.  No  否 
 3.  Don’t know不知道 
2B.2 If no, do you know the reason?    如果没有，知道原因吗？  
 
Apart from vaccinations listed in the official guidelines,  have you ever been vaccinated for any of the followings?  
(read out all diseases) 除了规定之外，您有没有接種以下疫苗？ 
No. 
编号 i. Disease  疾病 ii. Vaccination  接種預防疫苗 iii. Age年龄 
2B.3a Hepatitis B   乙型肝炎  1.  Yes  是      2.  No  否      3.  Do not remember 沒想起來 
 
2B.3b Cholera    霍乱  1.  Yes  是      2.  No  否      3.  Do not remember 沒想起來 
 
2B.3c Small pox    天花  1.  Yes  是      2.  No  否      3.  Do not remember 沒想起來 
 
2B.3d Yellow fever   黄热病  1.  Yes  是      2.  No  否      3.  Do not remember 沒想起來 
 
2B.3e Typhoid fever   伤寒  1.  Yes  是      2.  No  否      3.  Do not remember 沒想起來 
 
2B.3f Influenza    流行性感冒  1.  Yes  是      2.  No  否      3.  Do not remember 沒想起來 
 
2B.3g Tuberculosis*   肺结核  1.  Yes  是      2.  No  否      3.  Do not remember 沒想起來 
 
2B.3h Tetanus*   破伤风  1.  Yes  是      2.  No  否      3.  Do not remember 沒想起來 
 
2B.3i Poliomyelitis*  小兒麻痹症  1.  Yes  是      2.  No  否      3.  Do not remember 沒想起來 
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C. MEDICAL HISTORY病历 
2C.1 Do you have any allergy?  您有沒有过敏症?  1.  Yes  是    2.  No  否 
2C.2 
If yes, what are you allergy to ? 
如果有，对什么敏感 ? 
a. Age at 
first time 
最初年龄 
b. Age at the last 
time 最后年龄 
c. Number of 
episodes (in a year)  
发病次数 (每年) 
2C2.1 Food products  食品    
2C2.2 Drugs  药物    
2C2.3 Pollen  花粉    
2C2.4 Dust  Mite  灰尘螨    
2C2.5 Milk (lactose intolerance) 奶类    
2C2.6 Animals 動物    
2C2.7 Others, please specify 其他, 请具体说明     
  













c. Need any 
medications? 
需要服药? 
Related to the Head  头部 
2C3.1 Allergic rhinitis  鼻敏感  1. Y    2.  N 
是         否 
 
 
2C3.2 Sinusitis  鼻窦炎   1. Y    2.  N 
是         否 
 
 
2C3.3 Herpes in the lips / cold sore  疱疹一型 (单纯疱疹)  1. Y    2.  N 
是         否 
 
 
2C3.4 Asthma  哮喘 / 气喘   1. Y    2.  N 
是         否 
 
 
Related to chest  胸部 
2C3.5 Tuberculosis   结核病  1. Y    2.  N 




Myocardial infarction / Ischaemic heart disease (heart 
disease due to blockage in the blood vessels)   
心肌梗塞 / 心绞痛 
 1. Y    2.  N 
是         否 
 
 
Related to the abdomen or pelvis 腹部 
2C3.7 Hepatitis A   甲型肝炎  1. Y    2.  N 
是         否 
 
 
2C3.8 Hepatitis B   乙型肝炎  1. Y    2.  N 
是         否 
 
 
2C3.9 Hepatitis C   丙型肝炎  1. Y    2.  N 
是         否 
 
 
2C3.10 Other Hepatitis  其他肝炎  1. Y    2.  N 
是         否 
 
 
2C3.11 Gastric ulcer / duodenal  胃溃疡 / 十二指肠的溃疡  1. Y    2.  N 
是         否 
 
 
2C3.12 Recurrent Diarrhoea 周期性發生的腹泻  1. Y    2.  N 
是         否 
 
 
2C3.13 Herpes other sites 疱疹二型 (生殖器疱疹)  1. Y    2.  N 













b. Age at first 
diagnosis 
初诊年龄 
c. Need any 
medications? 
需要服药? 
Related to bones / joints  骨/关节 
2C3.14 Rheumatoid arthritis  类风湿性关节炎  
1. Y    2.  N 
是         否 
  
2C3.15 Other arthritis (e.g. gout / non-specific arthritis)  关节炎  
1. Y    2.  N 
是         否 
  
Related to the skin 皮肤 
2C3.16 Shingles  带状疱疹 1. Y    2.  N 
是         否 
 
 
2C3.17 Eczema (child)  湿疹 (小孩) 1. Y    2.  N 
是         否 
 
 
2C3.18 Eczema (adult)  湿疹 (成人) 1. Y    2.  N 
是         否 
 
 
2C3.19 Urticaria  / Hives  荨麻疹 (风疹块) 1. Y    2.  N 
是         否 
 
 
Systemic conditions  系统性 
2C3.20 Hypertension (high blood pressure)   高血压 1. Y    2.  N 
是         否 
  
2C3.21 Hypercholesterolaemia (high blood cholesterol) 高胆固醇 1. Y    2.  N 
是         否 
  
2C3.22 Systemic Lupus Erythematosus  (SLE) 系统性红斑狼疮 
1. Y    2.  N 
是         否 
  
2C3.23 Goiter 甲状腺肿 1. Y    2.  N 
是         否 
  
2C3.24 Diabetes Mellitus (high blood sugar)   糖尿病 1. Y    2.  N 
是         否 




2C3.25 Mononucleosis   传染性单核细胞增多症  
(glandular fever 腺性热) 
1. Y    2.  N 
是         否 
  
2C3.26 Chronic Anemia 长期貧血  1. Y    2.  N 
是         否 
  
2C3.27 Cataract  白内障 1. Y    2.  N 
是         否 
  
2C3.28 Any other disease that has not been mentioned 还有其他的吗？  
1. Y    2.  N 
是         否 
  
 
2C4.1 Have you ever been told by doctor that you have a tumour or cancer?   您有否曾经诊断患上肿瘤 / 癌症 ?  1.  Yes  是      2.  No  否 
2C4.2 If yes, please specify 如果有，请具体说明 
c. Type 
類型 
d. Age at 
Diagnosis 
初诊年龄 
e. To be filled by the 
coordinator  (ICD-O) 
 
a. Site of tumour   
    肿瘤位置     
b. Hospital where it was diagnosed  
    就诊医院    
 1.  Benign良性的 
 2.  Malignant恶性的  
Years old 
      
 C  
 
  
      
2C4.3 If yes, do you remember if you were treated with : 如果有，您记得有否接受過以下治疗? 
 2C43.1 Radiotherapy  放射治疗  1.  Yes  是      2.  No  否 
 2C43.2 Chemotherapy  化学治疗  1.  Yes  是      2.  No  否 
 2C43.3 Surgery  手术治疗  1.  Yes  是      2.  No  否 
 2C43.4 Others (please specify)  其他 (请具体说明)  
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D. X-ray X光照片 
 










c. Age last  
最後年龄 
2D.1 
Abdomen with contrast (oral or enema)  
腹部 （有用造影检查)  
(口服钡剂追踪或灌肠) 
 1.  Yes  是    
 2.  No  否    
2D.2 Kidneys with Contrast  (IVU) 
肾脏 (有用造影检查) 
 1.  Yes  是     
 2.  No  否    
2D.3 
Others X-ray examination on a regular 
basis, e.g. yearly (specify) :   
其他（请具体说明）  
 1.  Yes  是    
 2.  No  否    
 
 
Age group 年龄组别   
(Enter and CIRCLE the corresponding code if interviewee is unable to give exact age).  
 
1. <10 yrs 少於 10岁 
2. 10-19 yrs old/岁 
3. 20-29 yrs old/岁 
4. 30-39 yrs old/岁 
5. 40-49 yrs old/岁 
6. 50-59 yrs old/岁 
7. ≥60 yrs old/岁以上 
 
E. ANTIBIOTICS  抗生素 
2E.1 
Have you ever taken antibiotics at any time in your life? 
您是否曾經服用抗生素 ? 
 1.  Yes  是     2.  No  否 
2E.2 How often, on average, did you need a course of antibiotics for an infection? (tick in the appropriate 
box)    平均来说，您有多少次由於感染而服用抗生素? 
  
Frequency  次数 
Never 
沒有 
Less than once 
a year 
一年少过一次 
1-3 times per 
year 
一年一到三次 
4-6 times a 
year 
一年四到六次 
More than 6 
times a year  
一年超过六次 
2E2.a Adolescence 
少年时期      
2E2.b 21 – 40 yrs old 
二十–四十岁      
2E2.c Over 40 yrs old  
超过四十岁      
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F. LONG TERM MEDICATION / TREATMENT  长期医药治療 
2F.1 
Have you ever been on any of the following treatments at least once a day for six 
months or more?  您是否曾经接受以下的医药治疗，每天至少一次，持续超
過六个月以上? 
 1.  Yes  是  








Duration  服药时期 d. Total 
months of use 
总共 (月) 
b. Age start 
初诊年齡 





 1. Y    2.  N 
是         否     
2F.3 Analgesics止痛药 
(other NSAID) 
 1. Y    2.  N 
是         否     
2F.4 Antihypertensive drug 
降高血压药 
 1. Y    2.  N 
是         否     
2F.5 Cholesterol-lowering drug 
降胆固醇药 
 1. Y    2.  N 
是         否     
2F.6 Anti-TB drug 
抗结核病药 
 1. Y    2.  N 
是         否     
2F.7 Oral hypoglycaemics  (for 
diabetes) 抗糖尿药 
 1. Y    2.  N 
是         否     
2F.8 Anti-depressive drug 
抗抑郁症药 
 1. Y    2.  N 
是         否     
2F.9 Steroids   
類固醇類药 
 1. Y    2.  N 
是         否     
2F.10 Immunosuppressants  
免疫抑制药 
 1. Y    2.  N 
是         否     
2F.11 
Medication for sleep 
disorders  睡眠失调药 
 1. Y    2.  N 
是         否     
2F.12 




 1. Y    2.  N 
是         否     
2F.13 
Traditional Chinese 
Medicine / Malay medicine 
(e.g. herbal tea etc)    
传统草药治疗/ 偏方  
(例: 中草药或马来草药) 
 1. Y    2.  N 
是         否     
2F.14 
Other long-term medication (pls specify):   
其他药类（请具体说明）     
*If ongoing, write current age. 
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G. BLOOD TRANSFUSION  捐血/输血 
2G.1 
Have you ever donated blood (including rd cells, plasma or other blood 
derivatives)?  
您有沒有曾经捐血 (包括血細胞球，血浆，或其他血制品) ? 
 1.  Yes 是   2.  No 否 
2G.2 
Have you ever received a blood transfusion (including red cells, plasma or 
other blood derivatives)? 您有沒有曾经接受输血 (包括血細胞球，血浆，
或其他血制品) ? 
 1.  Yes 是   2.  No 否 
 
2G.3 
If yes, what is the reason and how old were you when this happened? 如果有，是什么原因，几岁发
生 ? 
a. Reason  
原因 
b. Total no. of transfusions for 
this reason  总共输血次数 
c.  Age at first transfusion 
开始输血年龄 
1.   
2.   
3.   
 
 
H. HOSPITALIZATION AND SURGICAL HISTORY   住院及手术资料 
2H.1 (Apart from the current admission) Have you ever admitted to hospital ?  
(除了这次住院) 您有否曾经住进医院? 
 1.  Yes  是   2.  No  否 
 
2H.2 
If yes, do you remember whether you have ever admitted to hospital before and when was it?  
如果有，您记得以前为了什么原因住院?  哪时几岁? 





2H.3 Have you ever been operated on ? (e.g. tonsillectomy, removal of appendix, 
Caesarean section, or any other form of surgery)  您有否曾经做過手术?  
（如咽喉扁桃腺或盲肠切除手术，剖腹生产术或任何其他的手术） 
 1.  Yes  是   2.  No  否 
 
2H.4 Could you specify what type of operation and how old were you when this happened?  
您记得做過什么手术?  哪时几岁? 





Age group 年龄组别 (Enter and CIRCLE the corresponding code if interviewee is unable to give exact age).  
 
1. <10 yrs 少於 10岁 
2. 10-19 yrs old/岁 
3. 20-29 yrs old/岁 
4. 30-39 yrs old/岁 
5. 40-49 yrs old/岁 
6. 50-59 yrs old/岁 
7. ≥60 yrs old/岁以上 
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PART III. LIFESTYLE 生活习惯 
 
A  RESIDENCE ABROAD  国外生活 
3A.1 
Have you ever lived in Africa or Latin America, or other parts of Asia more 




 1. Yes 有   2.  No 没有 
3A1.1 If yes, which countries have you lived in for more than one month at a time or more than four months in a particular year?  如果有，有住在哪个国家超过一个月或一年总共超过四个月？ 
 a. Country 国家 b.  Age 年龄 c.  Duration 期间 
 1.   
 2.   
3A.2 Each time you lived abroad, did you suffer afterwards from any disease that was related to having been in that country?  您有没有曾经因住在国外而患病?  1. Yes 有   2.  No 没有 
3A2.1 If yes, what was the diagnosis?  如果有，知道诊断的结果吗？ 
 a. Diagnosis 诊断 b. Code  (ICD-9) 
 1.        
 2.        
 
B. USUAL PHYSICAL ACTIVITY IN THE PAST YEAR  经常性体能活动 
 
On the average, during the past year, how many hours in a day did you spent in the following activities, either as 
work or leisure? 在过去一年里，您平均一天做几个小时下列体能性的活动 (包括工作和娱乐) 。 
 
No. 









Vigorous Activity: digging in the garden, strenuous sports, jogging, aerobic 
dancing, tennis, squash, swimming laps,  bicycling on hills, heavy carpentry, 
moving heavy furniture, loading or unloading trucks, shoveling or equivalent 
manual work, etc 
 
剧烈活动 : 在院子挖土耕种, 伸展运动, 慢跑运动, 韵律操, 网球, 壁




Moderate Activity: heavy housework e.g mopping floor, washing clothes with 
hands, hanging clothes, light sports, regular or brisk walking, golf, yard work, 
painting, repairing things, ballroom dancing, yoga, pilate, bicycling on level 
ground,  bowling, tai chi, chi kung, etc. 
 
中等强度活动 : 繁重的家务如抹地,手洗衣物，晾衣，轻量体育运动, 
常速或快步走, 高尔夫球,亭院工作, 画画, 修理家什, 慢节奏跳舞, 在
平地上骑自行车, 保龄球, 太极, 气功. 
b f 
3B.3 
Light / Sitting Activity: leisure, light sports, light housework e.g sweeping, 
ironing, office work, driving car, strolling, personal care, standing with little 
motion, eating, reading, desk work, watching TV, listening to radio, sewing, 
playing cards etc. 
 
轻量 / 座立活动 : 轻松的家务如扫地，办公室工作, 驾车, 慢步, 自
我照顾, 有轻微运动的站立, 吃饭,读书, 在写字台前工作, 看电视, 听
广播, 缝纫, 打牌. 
c g 
3B.4 Sleeping 睡眠 d h 
 TOTAL  24 24 
  
Appendix –SLS questionnaire 
237 
C. OUTDOOR LEISURE ACTIVITIES  室外閒暇运动 
I would like you to tell me how much time you spent outdoors in different periods of your life. By definition, 
outdoors means being outside between 9am to 5pm and not under any shade.    
在不同的时期，你留在室外的时间也不同。根据定义，室外即在早上的九点到下午五点，在没有遮蓋的地
方。 
 a. School days 
学校日 




Childhood –Adolescence   小时候 - 青年期    (e.g. <20 years    少过 20岁) 
3C.1 
How many hours do you spent outdoors? 




Did you regularly practice outdoor leisure activities 
between 9am and 5pm? (e.g. swimming / sailing / 
jogging / golf / tennis etc.) 
您有常常在上午九点到下午五点做室外的閒暇运
动？(如游泳，帆船，跑步，高尔夫球 ，网球等) 
 1. Yes  有 
 2.  No  没有 
 1. Yes  有  
 2.  No  没有 
3C.3 
Were you using any sun protection? (e.g hat / sun-cream 
/ long sleeves etc. )  您有没有用任何防晒用品？(帽子 
/ 防晒露 / 長袖衣服) 
 1. Yes  有; 
(specify         ) 
 2.  No  什么也没有用 
 1. Yes  有; 
(specify       ) 






b. Non-working days 
空闲或放假日 
Adolescence – Adult    青年期 - 成年   (e.g >=20 years    20岁或以上) 
3C.4 
How many hours do you spent outdoors? 




Did you regularly practice outdoor leisure activities 
between 9am and 5pm? (e.g. swimming / sailing / 
jogging / golf / tennis etc.) 
您有常常在上午九点到下午五点做室外的閒暇运
动？(如游泳，帆船，跑步，高尔夫球 ，网球等) 
 1. Yes  有  
 2.  No  没有 
 1. Yes  有  
 2.  No  没有 
3C.6 
Were you using any sun protection? (e.g hat / sun-cream 
/ long sleeves etc. )  您有没有用任何防晒用品？(帽子 
/ 防晒露 / 長袖衣服) 
 1. Yes  有; 
(specify       ) 
 2.  No  什么也没有用 
 1. Yes  有; 
(specify       ) 
 2.  No  什么也没有用 
 
D. SKIN COLOUR AND SOLAR RADIATION 皮肤颜色与太阳辐射 
3D.1 
Which colour best describes the colour of your eyes?  您的眼睛是什么颜色? 
 1.  Black / Dark brown  黑色 / 深棕色  2. Light Brown   淡褐色  3. Other  其他 
3D.2 
What is the colour that best describes the colour of your skin with no suntan (internal part of your arm)? 
在没有晒黑以前，您的皮肤是什么颜色 ? (手臂内部的颜色) 
 1.  Very white   非常白    2.  White   白                       3.  Light tan   浅黄褐色 
 4.  Tan   黄褐色               5.  Dark brown   深棕色      6.  Black   黑色 
 7.  Albino   白化病          8.  Other   其他 
3D.3 
Have you ever had sunburn?  您至今有没有给太阳晒伤? 
 1.  Yes   有        2.  No  没有  3.  Don’t know 不知道 
                            (skip to 3D.6)          (skip to 3D.6) 
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3D.4 How old were you when you first had sunburn?  您第一次给晒伤是几岁?   Y    
3D.5 
How often have you had sunburn in your lifetime?  您有没有给太阳晒伤? 
 1.  None  从来没有      2.  Seldom (<5 times)  很少 （<5次）  
 3.  Occasionally (5-10 times)  有时（5-10次）   4. Frequently (>10 times) 常常  （>10次） 
3D.6 
What would happen to your skin if it was exposed to bright sunlight for one hour or more in the middle of the 
day without any protection?  暴露在全盛太阳下超過一小时没有保护，您的皮肤会怎么样？ 
 
 1.  Get severe sunburn with blistering  严重晒伤，起水泡 
 2.  Have painful sunburn for a few days followed by peeling 痛苦的晒伤， 会脱皮 
 3.  Get mildly burnt followed by some tanning有一点点晒伤，有晒黑 
 4.  Go brown without any sunburn  只有晒黑，没有晒伤 
 
E. USE OF HAIR DYE  使用头发染料 
3E.1 
How would you describe the original colour of your hair?  您會怎样形容你头发原来的颜色 ? 
 1.  Dark brown  深棕色  2.  Black  黑色  3.  Light brown  淺棕色 
 4.  Blonde 金黃色  5.  Red  紅色  6.   Others  其他______________ 
3E.2 
Have you ever used hair dye or any hair colouring product?  您有没有用过头发染料？ 
 1. Yes  有      2. No没有 (skip to Section F) 
 
3E.3 If yes, what type of dye did you use and in which period of your life? 如果有，常用的是哪一种染料？ 






d. Age first 
used 
最初年龄 
e. Age last 
used 
最後年龄 





 1. Permanent 持久的 
 2. Semi-permanent  半持
久的 
 3. Temporary 暂时的 
 1. Complete 
完全 
 2. Highlight 
挑染 
 1. Black  黑色 
 2. Blonde/Lt brown  金黃色 
 3. Dk Brown  深棕色 
 4. Red  紅色 
 5. Others  其他 
   
#2 
 1. Permanent 持久的 
 2. Semi-permanent  半持
久的 
 3. Temporary 暂时的 
 1. Complete
完全 
 2. Highlight 
挑染 
 1. Black  黑色 
 2. Blonde/Lt brown  金黃色 
 3. Dk Brown  深棕色 
 4. Red  紅色 
 5. Others  其他 
   
#3 
 1. Permanent 持久的 
 2. Semi-permanent  半持
久的 
 3. Temporary 暂时的 
 1. Complete
完全 
 2. Highlight 
挑染 
 1. Black  黑色 
 2. Blonde/Lt brown 金黃色 
 3. Dk Brown  深棕色 
 4. Red  紅色 
 5. Others  其他 
   
Note :  
1. Temporary : products that wash out in 1 shampoo 
2. Semi-permanent : products that wash out in 6-10 shampoos 
3. Permanent : products that do not wash out after repeated shampoos and leave a line as they grow out 
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F. DIET 饮食习惯 
 
1.) Fresh Vegetables  蔬菜品种 
I would like you to think about fresh vegetables that you consumed either by themselves, in mixed dishes with 








a. Frequency and Usual portion size  通常食用的平均次数及份量 
 
CHOOSE ONE according to photograph  请根据相片, 填上您每次所吃的份量： 
 































































































































































Pak Choi and Siew Pak Choi  (sawi 
putch)   
白菜和小白菜 
        
A / B / C 
3F1.2 
Chinese mustard (Kai Choi) 
(sawi asin)   
大头菜，芥菜 
        
A / B / C 
3F1.3 
Chinese chives and flowering Chinese 
chives   (kucai) 
韭菜，韭菜花 
        
A / B / C 
3F1.4 
Kangkong  (Ung choi) 
蕹菜 
        
A / B / C 
3F1.5 
Choi Sum  (sawi hijau) 
菜心 
        
A / B / C 
3F1.6 Spinach (Yin choi and Po choi)  (bayam) 苋菜, 菠菜, 潺菜 
        




        
A / B / C 
3F1.8 
Chinese Kale   (kailan) 
芥兰 
        
A / B / C 
3F1.9 
Other dark green leaves such as Kou Kay 
Choi, sweet potato leaves (daun keledek) 
其它深绿色菜,如枸杞菜, 蕃薯叶 
        A / B / C 
3F1.10 Head cabbage and Wong Nga Pak 椰菜 (包菜, 高丽菜), 黄芽白 (大白菜)         A / B / C 
3F1.11 Head lettuce and Chinese lettuce 玻璃生菜, 生菜         A / B / C 
3F1.12 
Broccoli  (brokoli) 
芥兰花 
        A / B / C 
3F1.13 
Cauliflower  (bunga kobis) 
椰菜花 (高丽菜花) 
        A / B / C 
 
  








a. Frequency and Usual portion size  通常食用的平均次数及份量 
 
CHOOSE ONE according to photograph  请根据相片, 填上您每次所吃的份量： 
 






























































































































































Carrots  (lobak merah) 
胡萝卜 (红萝卜) 
        A / B / C 
3F1.15 
Green beans, long beans and peas, snow 
peas, lentil, soy   
(kacang hijou / kacang pes) 
青豆类, 包括豆角 (菜豆), 荷兰豆 (豌
豆), 扁豆类, 大豆类 
        A / B / C 
3F1.16 
Bean sprout   (taugeh) 
豆芽, 大豆芽 
        A / B / C 
3F1.17 
Bitter gourd and hairy gourd 
(peria / timun bulu) 
苦瓜, 毛瓜 
        A / B / C 
3F1.18 
Potatoes (kentang puteh) 
薯仔（马铃薯) 




        
A - 2 slices/ wedges or 
less  
B - 3 or 4 slices/ wedges  
C - 5 slices/ wedges or 
more   
3F1.20 
Tomatoes, cooked or raw    
(tomato, masak atau mentah) 
蕃茄, 煮熟或生吃 
        
A - 2 slices/ wedges or 
less   
B - 3 or 4 slices/ wedges  
C - 5 slices/ wedges or 
more   
3F1.21 
Celery (Chinese & English) 
芹菜, 西洋芹菜 




        A / B / C 
3F1.23 
Eggplant / Brinjal 
茄子 
        A / B / C 
3F1.24 
Seaweed  (rumpai laut) 
紫菜 
        A / B / C 
3F1.25 
Onions, all types  (bawang) 
葱类, 包括洋葱, 青葱和小葱头 
        
A – < ½  
B – ½ onion  
C – > ½ 
3F1.26 
Corn  (jagung muda) 
粟米, 玉米, 玉蜀黍 
        
A –  ½ ear 
B – one ear  




        
A - 2 slices/ wedges or 
less   
B - 3 or 4 slices/ wedges     
C - 5 slices/ wedges or 
more   
3F1.28 Petai (Stink bean)  
臭豆 
         A / B / C 
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2.) Fruits (Fresh / Canned)   水果（新鲜或罐头） 
 
We now come to fresh or canned fruits that you consumed during the past year.  For seasonal fruits, please tell me 








a. Frequency  平均次数 
b. Usual portion size 
通常食用的份量 
 





























































































































































        A - ½ or less   一半或更少 
B - 1   一个 




        A - ½ or less   一半或更少 
B - 1   一个 




柑 (红柑)  
        A - ½ or less   一半或更少 
B - 1   一个 




        A - ½ or less   一半或更少 
B - 1   一个 




        A - ½ or less   一半或更少 
B - 1   一个 




        A - ½ or less   一半或更少 
B - 1   一个 





        
A - ½ peach or 1 apricot or less   半个桃或一个杏或
更少 
B - 1 peach or 2 apricots   1个桃 或 2个杏 
C - 2 peaches or 4 apricots or more    




        A - 6 or less    6粒或更少 
B - 7 to 12    7-12粒 




        A - ½ big or 1 small banana or less     
½个大的或一个小的或更少 
B - 1 big or 2 small bananas    一个大的或两个小的 





        A - ¼ small or ½ hawker wedge or less /¼小的或 1/2
片或更少 
B - ½ small or 1 hawker wedge  
½个小的或 1 片 





        
A - ½ hawker wedge or less    ½片或更少 
B - 1 hawker wedge    1片 




        A - ½ hawker wedge or less    ½片或更少 
B - 1 hawker wedge    1片 
C - 2 hawker wedges or more     2片或更多 
3F2.13 




        
A - 1/8 fruit or ½ rice bowl cubed pieces  or less     1/8
个或 ½片或更少 
B - ¼ fruit or 1 rice bowl cubed pieces  ¼个或 1片 





        
A - 1 hawker wedge or less   1片或更少 
B - 2 hawker wedge    2片 
C - 3 hawker wedges or more    3片或更多 
3F2.15 Other 其他          
3F2.16 
Fruit Juice  
果计 
        
             240ml cups 杯 
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3.) Meat, eggs and dairy products  肉类及蛋类食品 
 
Please tell me how often you ate each of these meats, on average, over the past one year (including food eaten at 








a. Frequency and Usual portion size  通常食用的平均次数及份量 
 
CHOOSE ONE according to photograph  请根据相片, 填上您每次所吃的份量： 
 
























































































































































 b. SIZE 
份量 
3F3.1 FISH   鱼肉类         A / B / C 
3F3.2 Pan fried fish 煎鱼         A / B / C 
3F3.3 Deep fried fish 炸鱼         A / B / C 
3F3.4 CHICKEN   鸡肉类         A / B / C 
3F3.5 Pan fried chicken 煎鸡         A / B / C 
3F3.6 Deep fried chicken 炸鸡         A / B / C 
3F3.7 PRAWNS and SQUID 虾和鱿鱼类         A / B / C 
3F3.8 DUCK   鸭肉类         A / B / C 
3F3.9 BEEF    牛肉类          A / B / C 
3F3.10 LAMB / MUTTON  羊肉类         A / B / C 
3F3.11 PORK   猪肉类          A / B / C 
3F3.12 Pan fried pork 煎猪排         A / B / C 
3F3.13 Roasted pork 烧肉         A / B / C 
3F3.14 BBQ pork 叉烧         A / B / C 
 PRESERVED FOOD 腌制类         
 
3F3.15 
Preserved meat 腌肉 (e.g. 
Sausage 肉肠, Bacon  烟肉, 
Ham  火腿, Luncheon meat 午餐
肉) 
        
A - <1 
B – 1 slice or 
piece 
C - >1 
3F3.16 Preserved fish 腌鱼 (e.g. Salted fish咸鱼, smoked fish薰鱼)         
 
3F3.17 
Preserved vegetable 腌菜 (e.g. 
pickles  泡菜, salted vegetables 
咸菜) 
        
 
3F3.18 EGGS (any form) 蛋类         
A - <1 egg 
B – 1 egg 
C - >1 egg 
 
3F3.19 
Is your diet over the past year generally similar to your normal adult diet?  
你过去一年吃的是不是平常成年的饮食习惯？ 
 
 1.  Yes  是  2.  No  不是 (give details  请具体说明  
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G. BEVERAGES, DAIRY PRODUCT AND SUPPLEMENT饮料品种, 奶类制品及补充剂 
 
Please select the category that best describes how often you drank each beverage and/or alcohol during the past 
year. I would also like to know how much you usually drank each time, including consumption at home and outside 
the home. 
请您告诉我您在过去一年里经常饮用的饮料和 / 或酒精类饮料。 同时请告诉我您每次饮用的份量（包括您在
家和外面吃的）。 
 





a. Frequency and Usual portion size  通常食用的平均次数及份量 
 
CHOOSE ONE  请任选一项 






























































































































































































Ceylon tea or western red 
tea 
锡兰茶或西式红茶 







Chinese tea中国茶:   
- black tea 黑茶(Pu’er 普
洱), 
- Oolong 乌龙茶 (Ti Kuan 
Yin铁观音) 
- white tea白茶 (Shou Mei
寿眉) 







Flower tea 花茶 
(Chrysanthemum 菊花茶, 
Jasmine茉莉茶 or other 
flower tea) 






Chinese (Lung Ching龙井) 
or Japanese Green tea 中国 / 
日本绿茶 





3G.5 Coffee (any form) 咖啡 





2) Dairy product 奶类制品 
3G.6 Fresh milk e.g with cereal  
鲜奶 






Condensed or evaporated  
milk e.g. in coffee or tea   
炼奶/淡奶 





3G.8 Yoghurt (including Lassi) 
乳酪 





3G.9 Cheese (in any form)  
芝士 
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3) Supplement use 补充剂 
 Type 类型 Duration and Frequency 年期及平均服用量 
3.G10 Multi-vitamins 多种维他命 
a. Duration of regular use  1.  0-1 years  2.  2-4 years  3.  5-9 years  4. ≥ 10 years  
b. No. taken per week  1.  ≤2  2.  3-6  3.  7 or more 
3.G11 Vitamin C 维他命 C 
a. Duration of regular use  1.  0-1 years  2.  2-4 years  3.  5-9 years  4. ≥ 10 years  
b. No. taken per week  1.  ≤2  2.  3-6  3.  7 or more 
3G.12 Folate / Folic Acid 
葉酸 
a. Duration of regular use  1.  0-1 years  2.  2-4 years  3.  5-9 years  4. ≥ 10 years  
b. No. taken per week  1.  ≤2  2.  3-6  3.  7 or more 
3G.13 Calcium 
鈣 
a. Duration of regular use  1.  0-1 years  2.  2-4 years  3.  5-9 years  4. ≥ 10 years  





a. Duration of regular use  1.  0-1 years  2.  2-4 years  3.  5-9 years  4. ≥ 10 years  
b. No. taken per week  1.  ≤2  2.  3-6  3.  7 or more 
 
4) Alcohol intake 酒精类  
3G.15 
Have you ever drunk alcohol (such as beer, rice wine, red/white wine or spirit/hard 
liquor) more than once a month, on average?  
您從来有没有喝过酒（如：啤酒，米酒, 紅/白酒烈性酒）平均超过每月一次？ 
(if no, go to Question 3.H1如果没有，直接转到问题 3.H1) 
 1. Yes 有     2. No 没有 
3G.16 How old were you when you start drinking one or more times per month?  
您从什么时候开始喝超过每月一次？   Years old岁 
  a. How often did you drink these specific types of 
alcohol ?  您多久喝一次以下的酒类？ 
b. On the day you drink, how many 
drinks, on average, did you have ?  
喝酒那天，平均喝多少？ 
3G16.1 
Beer, lager, stout, 
shandy, or cider 
啤酒类 
 1.  Never or  <1/mth从来没有 到 少于每月一次 
 2.  1/mth to <1/week 每月一次 到 少于每星期一次 
 3.   days/week   每星期 天 
  glasses/day  杯/天 
   cans/day 罐/天 
  small bottles/day小瓶/天 





 1.  Never or  <1/mth从来没有 到 少于每月一次 
 2.  1/mth to <1/week 每月一次 到 少于每星期一次 
 3.   days/week   每星期 天 
  glasses/day  杯/天 
   cans/day 罐/天 
  small bottles/day小瓶/天 
  large bottles/day 大瓶/天 
3G16.3 
Red / white wine / 
sherry 
葡萄酒类   
(紅/白酒) 
 1.  Never or  <1/mth从来没有 到 少于每月一次 
 2.  1/mth to <1/week 每月一次 到 少于每星期一次 
 3.   days/week   每星期 天 
  glasses/day  杯/天 
  small bottles/day小瓶/天 
  large bottles/day 大瓶/天 
3G16.4 




 1.  Never or  <1/mth从来没有 到 少于每月一次 
 2.  1/mth to <1/week 每月一次 到 少于每星期一次 
 3.   days/week   每星期 天 
  glasses/day  杯/天 
  small bottles/day小瓶/天 
  large bottles/day 大瓶/天 
1 drink = 330 ml of beer / 150mls of wine / 30ml of spirit = 12 – 15g of ethanol 
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H. SMOKING  吸烟习惯 
 
1). Personal smoking  个人吸烟 
3H.1 Have you ever smoked a cigarette in your lifetime?  您從来有没有曾经抽过香烟?   1. Yes 有   2. No 没有 
3H.2 
Have you ever smoked or chewed any form of tobacco apart from manufactured 
cigarettes ?  您從来有没有曾经抽过/咬过任何烟草类产品 (除了香烟)? 
(if no to both H1 and H2, go to Question 3H.11) 
 1. Yes 有   2. No没有 
3H.3 If yes, please specify 如果有，请具体说明 Type类             No. of years used   年 
3H.4 
Have you smoked at least 100 cigarettes (or any other form of tobacco) in your lifetime? 
到目前为止您抽超过 100根烟 (或其它烟草类产品) 吗?  1. Yes 有   2. No 没有 
3H.5 
Have you ever smoked at least one cigarette (or any other form of tobacco) a day for 1 
year or more? 您是否一天至少抽一根烟 (或其它烟草类产品) 长达一年或更长时间?    
(if no, go to Question 3H.11  如果没有，直接转到问题 3H.11) 
 1. Yes 有   2. No 没有 
3H.6 At what age did you start smoking?  您从几岁开始抽烟?   Years年 
3H.7 
On average, how many days per week do / did you usually smoke?  您平均一个星期抽几天烟? 
 1.  Daily  每天      2.  4-6 days a week    一个星期 4-6天   3.  2-3 days a week    一个星期 2-3 天   
 4.  Once a week    一个星期一次  5.  Less than once a week    一个星期少过一次 
3H.8 
How many sticks do you smoke in a day  (1 pack = 20 sticks)?   
您大概一天抽多少根香烟 (一包=20根) ? 
  Sticks 根 
3H.9 
Have you smoked at least one cigarette in the past 30 days? 
您是否在过去 30 天内抽过至少一根香烟? 
 1. Yes 有   2. No 没有 
3H.10 
(If 3H.9 is “No”) At what age did you stop smoking?   
(如果 3H.9没有) 您在多大年纪停止抽烟? 
  Years 年 
  
2). Passive smoking    二手烟  
Home 家庭 
3H.11 
Has any of your household members smoked cigarettes at home at least daily for 1 year or longer? 
您家里是否有成员每天在家里抽烟长达一年以上? 
 1.    Yes    是   2.  No /  not daily   否 / 不是每天  (go to Question 3.H14) 
3H.12 
Who smokes or smoked daily at home?  谁每天在家里吸烟? 
 1.    Spouse  配偶   
 2.    Others e.g. parents / in-laws / son / daughter / relatives   其他人, 如父母 / 亲家 / 儿女 / 亲戚  
 3.    Both   以上都是 
3H.13 
For how many years has at least one person living in your home smoked daily at home? 
在您家里至少有一个人每天吸烟长达多久时间? 
 1.    less than 5 years    少于 5 年   2.    5– 9 years    5-9年   3.   9– 14 years    10-14年    
 4.    15 – 19 years    15-19年   5.    20 or more years    20年或更长时间 
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Work place 工作环境 
3H.14 
Have you ever had a job where you were in close contact with, or close enough 
to smell cigarette smoke on a daily basis? 
您有没有每天在附近有人吸烟，或者可以闻到香烟气味的环境中工作过?  
 1. Yes 有       
 2. No 没有 (Go to Q3I.1) 
 3. NA (never employed 
outside home)   
3H.15 
For how many years were you in contact with cigarette smoke at work?  请问
这种情况持续多少年? 
                               Years年 
3H.16 
For how many hours a day did this occur? 
请问这种情况每天持续多少时间? 
                           Hours小时 
 
I.  Tattoo / Acupuncture  纹身及针炙  
 
3I.1 Have you ever had a permanent tattoo? (including eyebrow) 
您有没有纹身 （包括纹眉）?  1. Yes  有  2. No  没有 
3I.2 If yes, how old were you when you first started having a tattoo?   
如果有，从几岁开始? 
Age   
年龄 
                            yrs old 
岁 
3I.3 How many times have you been tattooed in your lifetime?   
您一共做过多少次? 
No. of times  
次数                            times 次 
 
3I.4 
Have you ever had acupuncture performed on you?  
您有没有做过针炙治疗? 
 1. Yes  有  2. No  没有 
3I.5 If yes, how old were you when you first had acupuncture?   
如果有，从几岁开始? 
Age   
年龄 
                            yrs old 
岁 
3I.6 How many times have you had acupuncture in your lifetime?  
您一共做过多少次? 
No. of times  
次数                            times 次 
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PART IV. Family History   家庭资料 
 
A. Family Medical History 家庭病历 
 
4A.1 
Has any of your family members (parent, sister / brother or child) ever had cancer? Note: only full 
siblings are included.   您的家庭成员 (父母, 兄弟姐妹或孩子) 中有谁得过癌症吗? 注意：只包括
亲生的兄弟姐妹 
 
 1.   no (skip to 4A.3)  没有(跳到 4A.3) 
 2.  yes, one family member has ever had cancer  有，有一位家庭成员患有癌症 
 3.  yes, two or more family members have ever had cancer  有，有两位或以上家庭成员患有癌症 
 4.A1a Father 父亲  1.  Yes  是  /   2.  No  否 /  3.  Don’t know不知道 
 4.A1b Mother 母亲  1.  Yes  是  /   2.  No  否 /  3.  Don’t know不知道 
 4.A1c Brother 兄弟  1.  Yes  是  /   2.  No  否 /  3.  Don’t know不知道 
 4.A1d Sister 姐妹  1.  Yes  是  /   2.  No  否 /  3.  Don’t know不知道 
 4.A1e Son 儿子  1.  Yes  是  /   2.  No  否 /  3.  Don’t know不知道 
 4.A1f Daughter 女儿  1.  Yes  是  /   2.  No  否 /  3.  Don’t know不知道 
 
 4.  Unknown  不知道 
 
4A.2 If yes, What type of cancer did he / she have? (if more than one, record all sites)  Please specify.  (Fill in the table below for each relative affected)  如果有，他(或她)患有何种癌症? 请具体说明。 
 a. Relatives affected 亲戚 
Cancer site癌症位置 d. Age at diagnosis 
初诊年龄 b. Site 位置 c. ICD Code 
    
    
  
    
    
  
    
    
  
    
    
  
 
4.A3 Has any of your family members (parent, sister / brother or child) ever had disease of the liver, such as 
cirrhosis or hepatitis ?   您的家庭成员 (父母,兄弟姐妹或孩子) 中有谁得过肝病，例如肝硬化或肝
炎? 
 
 1.   no (skip to next section) 没有(跳过此项到下一部分) 
 2.   yes, one family member has ever had    有，有一位家庭成员患有 
 3.   yes, two or more family members have ever had     有，有两位或以上家庭成员患有 
 4.A3a Father 父亲  1.  Yes  是  /   2.  No  否 /  3.  Don’t know不知道 
 4.A3b Mother 母亲  1.  Yes  是  /   2.  No  否 /  3.  Don’t know不知道 
 4.A3c Brother 兄弟  1.  Yes  是  /   2.  No  否 /  3.  Don’t know不知道 
 4.A3d Sister 姐妹  1.  Yes  是  /   2.  No  否 /  3.  Don’t know不知道 
 4.A3e Son 儿子  1.  Yes  是  /   2.  No  否 /  3.  Don’t know不知道 
 4.A3f Daughter 女儿  1.  Yes  是  /   2.  No  否 /  3.  Don’t know不知道 
  4.   Unknown  不知道 
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B. RESIDENTIAL HISTORY 居住简历 
 
Please try to remember the residences in which you have lived for more than a year. We will start from the first 
house you lived in after you were born. For each house, I will ask you about different aspects. 
 
请想起您从前曾经居住超过一年的房子， 我们会从您出生开始计算。 这些问题包括不同的类型。 
 
  
a. HOUSE 1 
房子一 
b. HOUSE 2 
房子二 
c. HOUSE 3 
房子三 
d. HOUSE 4 
房子四 
e. HOUSE 5 
房子五 
f. HOUSE 6 
房子六 
4B.1 Age start  最初年龄 00      
4B.2 Age end  最后年龄       
4B.3 








      
4B.4 
Nº of bed rooms    
睡房 - 房间总数 
      
4B.5 
What is the maximum number 
of people in the household? 
最多可以有多少人一起住？ 
      
4B.6 
How many family members 
shared the same bed-room with 
you? (inclusive) 
您和多少家人共睡一房间?  
      
4B.7 
Country 囯家 
District / area 地区 
      
4B.8 
Rural / Urban  
乡村的 / 都市的 
R / U R / U R / U R / U R / U R / U 
4B.9 
Water source 水源 
Pipe 水管    or  
Well/pump 井水/ 抽水 
Pp / W Pp / W Pp / W Pp / W Pp / W Pp / W 
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Did you have contact with any of the following animals?  您有沒有接触以下列出的动物? 
 
  
a. HOUSE 1 
房子一 
b. HOUSE 2 
房子二 
c. HOUSE 3 
房子三 
d. HOUSE 4 
房子四 
e. HOUSE 5 
房子五 
f. HOUSE 6 
房子六 
4B.10 
Type 1: small animals  
(e.g. dogs, cats) 
 
第一类 : 小型动物,  
狗或猫科等 
Y / N 
有 / 沒有 
Y / N 
有 / 沒有 
Y / N 
有 / 沒有 
Y / N 
有 / 沒有 
Y / N 
有 / 沒有 
Y / N 
有 / 沒有 
4B.11 
Animal lives 动物住在 : 
1. indoors 室内的 
2. outdoors 屋外的 
      
4B.12 
Contact 接触 
1. None 从来没有 
2. Occasional 有时 
3. Frequent 时常 
4. Daily 每日 
      
4B.13 
Type 2 : Birds, hens 
 
第二类 : 鸟类, 鸡类 
Y / N 
有 / 沒有 
Y / N 
有 / 沒有 
Y / N 
有 / 沒有 
Y / N 
有 / 沒有 
Y / N 
有 / 沒有 
Y / N 
有 / 沒有 
4B.14 
Animal lives 动物住在 : 
1. indoors 室内的 
2. outdoors 屋外的 
      
4B.15 
Contact 接触 
1. None 从来没有 
2. Occasional 有时 
3. Frequent 时常 
4. Daily 每日 
      
4B.16 
Type 3 : Big animals  (e.g. 
horses pigs, cows). 
 
第三类 : 大型动物,  
马, 猪, 牛  
Y / N 
有 / 沒有 
Y / N 
有 / 沒有 
Y / N 
有 / 沒有 
Y / N 
有 / 沒有 
Y / N 
有 / 沒有 
Y / N 
有 / 沒有 
4B.17 
Contact 接触 
1. None 从来没有 
2. Occasional 有时 
3. Frequent 时常 
4. Daily 每日 
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PART V. QUALITY  
 
1. Interviewer’s assessment of the reliability of the answers: 
 
 Mark rank 
 1  2  3  4  5   
 Not very reliable   Very reliable  
 
2. Has the interviewed person felt uncomfortable 
 
 Yes In which questions           
                  
 No                
 
3. Length of interview (mins) :     
 











    




Primary site   ICDO-3 C    
Nodal / Extranodal* ICDO-3 C    
 
Histological diagnosis (WHO)  M      
  
 
Grade : High / Intermediate / Low* Stage :    
 
 
Data entry by :  (Name) on  (date) 
 
Data entry checked by :  (Name) on  (date) 
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Background Some epidemiological studies have reported that teachers may be at increased risk of non-Hodgkin’s
lymphoma (NHL), but results are inconsistent.
Aims To examine the possible association between occupation and risk of NHL in the Singapore
population.
Methods A hospital-based interviewer-administered case–control study was carried out in five major hospitals
in Singapore between April 2004 and December 2008. A complete occupational history, which in-
cluded all jobs lasting over 1 year since graduation from school, was obtained for each participant. The
Singapore Standard Occupational Classification was used for coding all occupations recorded.
Results Eight hundred and thirty controls and 465 NHL cases, comprising B-cell (n5 404, 87%) as well as T-
and NK-cell (n5 61, 13%) neoplasms, were recruited. Having ever worked as a teacher was associated
with a significantly higher risk of NHL (adjusted OR 2.04, 95% CI 1.12–3.72). Teachers who had
taught for #10 years had a significantly higher risk of NHL (adjusted OR 2.44, 95% CI 1.11–5.34),
but we did not observe an elevated risk for those who reported teaching for.10 years. Among the 31
teachers with NHL, 23% taught in upper secondary schools, with equal proportions (13%) teaching
in primary and pre-primary schools, respectively. The remainder taught in other settings.
Conclusions Teachers come into frequent contact with children and may consequently have higher rates of expo-
sure to common infectious agents. Therefore, the hypothesis of an infective aetiology of NHL may be
supported by our findings.
Key words Non-Hodgkin’s lymphoma; occupation; risk factor; teacher.
Introduction
Non-Hodgkin’s lymphoma (NHL) is one of the 10 most
frequently occurring cancers in both men and women in
Singapore, and its incidence has more than doubled in the
last three decades. The age-adjusted incidence rates for
males and females (per 1 00 000) for NHL in Singapore
have increased from 3.1 and 1.9 in 1968–72 to 8.2 and 5.0
in 1998–2002, respectively [1].
Although the risk factors for NHL include inherited and
acquired immunodeficiency conditions [2], infectious,
physical and chemical agents have also been implicated
[3]. At present, no conclusive evidence of causal relations
between occupation and increased NHL risk exists. In
a recent review of occupation and risk of NHL, Boffetta
and de Vocht [4] reported significantly increased risk
among workers in the printing industry, wood workers,
farmers (especially in animal husbandry) and teachers.
Possible aetiological agents suggested were organic sol-
vents, insecticides and viral infection. The increasing in-
cidence of NHL in Singapore might be influenced by
changes in working patterns resulting from its develop-
ment from a trading port in the 1950s and 1960s to a rap-
idly industrialized society in the 1970s and beyond. This
study aimed to examine possible associations between
occupation and risk for NHL in Singapore.
Methods
The Singapore Lymphoma Study is a hospital-based
case–control study carried out in five major hospitals in
Singapore, between April 2004 and December 2008.
The study population was Singapore citizens or permanent
residents aged$18 years. The study was approved by re-
search ethics committees at each participating hospital.
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Details of the methodology have been described else-
where (Wong et al., submitted for publication). Eligible
subjects were patients with NHL diagnosed within the
past 6 months and histologically confirmed according
to the World Health’s Organization’s classification system
[5]. Hospital controls were frequency matched with cases
by recruitment centre, age (65 years) and gender, with an
approximate ratio of two controls to one case. Controls
were patients admitted primarily for acute diagnoses to
orthopaedic, internal medicine and general surgery
wards. Patients with a prior history of HIV infection were
not recruited.
Data were collected in person via a standardized
questionnaire-based interview. The questionnaire was
based on the instrument used by the Epilymph consor-
tium modified for local use in Singapore [6].
We elicited a complete occupational history that in-
cluded all jobs lasting over 1 year since graduation from
school. For every job information collected included
the year in which employment began and ended the
job title and the industry and a description of work
activities including any use of chemicals or operation of
machinery. The Singapore Standard Occupational Clas-
sification (SSOC) was used for coding occupation for all
subjects [7]. The SSOC adopts the basic framework and
principles of the International Standard Classification
of Occupations 1988 (ISCO-88). It is reviewed and
updated periodically to reflect changes in the employment
structure and the emergence of new occupations in
Singapore.
The SSOC comprises five-digit codes with each digit
giving increasing specificity regarding the individual oc-
cupation. The one-digit code represents a very broad field
of work (e.g. ‘Professional’ is coded as ‘2’), whereas the
two-digit codes provide a more specific description (e.g.
code ‘23’ denotes ‘teaching professionals’).
For this study, we used the first and longest occupa-
tions to examine the association between occupation
and NHL. The first occupation was the first job that
the subject took up after leaving school or their first
job if they had not attended school. The longest occupa-
tion was determined on the basis of the duration of each
occupation reported; if the subject took up the same job
on more than one occasion, the total duration in years was
used for this purpose.
An unconditional logistic regression model was used
to calculate odds ratio (OR) and 95% confidence intervals
(CIs) for the association between occupation and the risk
of lymphoma. All analyses were adjusted for age (as a con-
tinuous variable), gender, ethnic group (Chinese, Malay,
Indian, others), history of cancer in first-degree relatives
(yes, no) and current housing type (public housing three
or less rooms, public housing more than three rooms,
private housing, others). Analyses were performed
with STATA/SE 10.1 software (StataCorp, TX, USA,
1984–2009). All statistical tests were two sided.
Results
Eight hundred and thirty controls and 465 NHL cases
were recruited, comprising B-cell (n 5 404, 87%) as well
as T- and NK-cell (n 5 61, 13%) neoplasms. Compared
with controls, cases were more likely to be Chinese, mar-
ried, currently employed, born outside Singapore and re-
siding in larger apartments or landed property. Among
830 controls and 465 NHL cases, 760 controls and
429 NHL cases were currently employed or had retired
and 69 controls and 31 NHL cases had never been em-
ployed (e.g. students, housewives, etc.). A total of 12 con-
trols and 6 NHL cases did not disclose a detailed
occupational history and were treated as missing data.
The current analysis focused on 749 controls and 428
NHL cases who provided detailed occupational histories.
In both the first and longest occupations, using the
one-digit code of the SSOC, there was a significantly
higher percentage (9 and 8%, respectively) of professio-
nals with NHL compared to the controls (4 and 5%, re-
spectively) (Table 1). The distribution of professionals for
first and longest occupation among the cases and controls
was further examined using two-digit SSOC codes. A sig-
nificantly higher proportion of cases than controls re-
ported being a teaching professional as their longest
occupation. Teaching and ‘business professionals’ also
constituted a higher proportion of first occupations
among cases than controls. The number of business pro-
fessionals was too small (one control and nine cases) for
further analysis.
We proceeded to examine the association between
teachers and NHL. Table 2 shows the OR for those
who had ever been teachers versus other occupations.
Teachers as compared to non-teachers had a significantly
higher risk of NHL (adjusted OR 2.04, 95% CI 1.12–
3.72). Teachers who had taught for 1–10 years had signif-
icantly higher risk of NHL (adjusted OR 2.44, 95% CI
1.11–5.34), but we did not observe an elevated risk for
those who reported teaching for .10 years. Among the
31 teachers with NHL, 23% taught in upper secondary
schools, with equal proportions (13%) teaching in pri-
mary and pre-primary schools. The others were private
tutors (13%) or professionals engaged in other forms
of teaching (39%) not otherwise classified.
Discussion
We have found that teachers appear to have a 2-fold
elevated risk of NHL compared with non-teachers in
Singapore. The strength of this study, involving 465
incident cases of NHL and 830 controls, is that it is
the largest case–control study of NHL ever conducted
in an Asian country. There are, however, limitations in
our study. While we could adjust for some possible con-












considered or have information on. Compared to a na-
tional registry, the number of NHL cases in this study
was much smaller. We are currently unable to determine
the likely causative agent. In a prospective cohort study, if
biological samples were collected, it would be more fea-
sible to carry out serological analyses, e.g. the distribution
of Epstein–Barr virus titres among those who developed
NHL and those who did not.
Since 1983, there have been reports of an increased
standardized cumulative incidence ratio (SIR) for NHL
among teachers [8]. In a large registry-based analysis
in Sweden, researchers used the Swedish Cancer-
Environmental Registry to link cancer incidence during
1961–79 with occupational information from the 1960
census; this study reported an SIR among schoolteachers
of 2.1 (P , 0.05). When they included specific occupa-
tions within this industry, they found that ‘schoolteachers
in other education’ had an SIR of 3.8 (P, 0.05) [9]. The
paper does not mention what ‘other education’ involved.
This study, being registry based, had no additional
Table 1. Distribution of the first and longest occupations among the NHL cases and controls in the Singapore Lymphoma Study
SSOC Controlsa NHLa Total P-valueb
n (%) n (%) n (%)
First occupation
1 Legislators, senior officials and managers 27 (4) 20 (5) 47 (4) NS
2 Professionals 33 (4) 40 (9) 73 (6) **
3 Associate professionals and technicians 61 (8) 39 (9) 100 (8) NS
4 Clerical workers 86 (12) 57 (13) 143 (12) NS
5 Service workers and shop and market sales 132 (18) 64 (15) 196 (17) NS
6 Agricultural and fisher workers 21 (3) 17 (4) 38 (3) NS
7 Production craftsmen and related workers 96 (13) 53 (12) 149 (13) NS
8 Plant and machine operators and assemblers 142 (19) 62 (14) 204 (17) NS
9 Cleaners, labourers and related workers 137 (18) 69 (16) 206 (18) NS
10 Workers not classifiable by occupation 14 (2) 7 (2) 21 (2) NS
Total number of first occupationsa 749 (100) 428 (100) 1177 (100)
Longest occupation
1 Legislators, senior officials and managers 45 (6) 33 (8) 78 (7) NS
2 Professionals 38 (5) 35 (8) 73 (6) *
3 Associate professionals and technicians 85 (11) 52 (12) 137 (12) NS
4 Clerical workers 90 (12) 52 (12) 142 (12) NS
5 Service workers and shop and market sales 139 (19) 62 (14) 201 (17) NS
6 Agricultural and fisher workers 10 (1) 7 (2) 17 (1) NS
7 Production craftsmen and related workers 80 (11) 50 (12) 130 (11) NS
8 Plant and machine operators and assemblers 129 (17) 77 (18) 206 (18) NS
9 Cleaners, labourers and related workers 119 (16) 55 (13) 174 (15) NS
10 Workers not classifiable by occupation 12 (2) 5 (1) 17 (1) NS
Total number of longest occupationsa 747 (100) 428 (100) 1175 (100)
NS, not significant.
aTotal numbers did not add up to 830 controls and 465 NHL cases due to missing information.
bP-value from chi-square test of significance between group of interest versus others: NS, *P , 0.05, **P , 0.01.
Table 2. ORs and 95% CIs for the association between teaching and risk of NHL
Controls (n 5 749) NHL (n 5 428) Crude OR (95% CI)a P Adjusted OR (95% CI)b P
n (%) n (%)
Non-teachers 724 (97) 397 (93) 1.00 (referent) 1.00 (referent)
Ever teachers 25 (3) 31 (7) 2.26 (1.32–3.88) ** 2.04 (1.12–3.72) *
Duration
1–10 years 15 (2) 17 (4) 2.07 (1.02–4.18) * 2.44 (1.11–5.34) *
.10 years 10 (1) 14 (3) 2.55 (1.12–5.80) * 1.61 (0.66–3.93) NS
n, number of subjects; P-value: NS, *P , 0.05, **P , 0.01.
aCrude OR in logistic regression.
bAdjusted OR for age (continuous), gender (male/female), ethnicity (Chinese/Malay/Indian/others), housing type (public housing three or less rooms/public housing more
than three rooms/private housing/others) and family history of cancer in the first-degree relatives (yes/no) in multiple logistic regression model.
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information on exposures and duration of employment in
order to explore further possible causes for the associa-
tion. The authors commented that ‘whether carcinogenic
exposures occur among these workers is not clear, al-
though socioeconomic and dietary factors may also be
important’ [9]. Boffetta and de Vocht [4] conducted
a meta-analysis to provide an update on occupation
and the risk of NHL. They reported among other
occupations an increased risk for teaching (relative
risk 1.47, 95% CI 1.34–1.61). This observation was
based on 19 reported studies published up to August
2006.
Infectious agents are close to being regarded as
established aetiological agents for NHL [10]. Teachers
and childcare workers have been reported to be more at
risk of contracting infectious diseases [11,12]. Teachers
inevitably come into close contact with children fre-
quently in the course of their work. In Singapore, teacher
to student ratios could be as high as 1:40, especially in the
1960s and 1970s. However, we found no evidence of
a dose–response relationship, as those who taught for
1–10 years had a significantly higher risk of NHL (ad-
justed OR 2.44; 95% CI 1.11–5.34) compared to non-
teachers, whereas the OR for those who had taught for
.10 years was not significant when compared with
non-teachers. This observation might be consistent with
the involvement of an infectious agent, which may not re-
quire prolonged exposure (unlike for example chemical
exposure) to exert its effects on the individual’s health.
Whether we took the first occupation or the longest
occupation, teachers still appeared to be at increased risk
of NHL. Our findings are in agreement with other
studies, which also reported no statistically significant
differences between teachers in primary and secondary
education [4,13].
Among the 31 ‘ever-teachers’ cases, 48% were teach-
ing in the secondary, primary and pre-primary schools,
which covers children between 3 and 16 years old. How-
ever, 13% were private tutors and 39% professionals en-
gaged in other forms of teaching not otherwise classified.
We were not able to ascertain whether this 52% were ex-
posed to children in their adolescence and early child-
hood. If this 52% of teachers with NHL were not
exposed to children, it would weaken the hypothesis of
an association with infectious agents.
While most studies [3,4,9] have found a strong associ-
ation between NHL and farmers, we did not. This is not
surprising as Singapore is not an agricultural country and
has never been because of its small land area (710 km2).
Likewise, we did not find any association between NHL
and industrial workers (such as printers and cleaners),
which have also been reported by other studies
[4,14,15]. This is more difficult to explain, unless such
workers in Singapore have not been exposed to significant
levels of whatever specific chemicals may be capable of
contributing to the development of NHL.
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Abstract
Background Epidemiologic studies have reported an inverse
association between sun exposure and non-Hodgkin lym-
phoma (NHL), but these have been almost exclusively con-
ducted in Western populations residing in temperate locations.
We evaluated the association between personal outdoor sun
exposure and risk of malignant lymphomas in Singapore.
Methods A hospital-based case–control study of 541
incident cases of lymphoid neoplasms and 830 controls were
recruited during 2004–2008. Participants were interviewed
regarding recreational or occupational outdoor activities
during childhood and in adulthood. Basic demographics and
potential confounders were also collected. Odds ratios (OR)
and 95 % confidence intervals (CI) were calculated using
unconditional logistic regression analysis.
Results Compared with individuals who did not have
regular sun exposure, a lower risk of NHL was observed for
those who reported regular exposure on non-school days
during childhood [OR, 0.62; 95 % CI, 0.46–0.83] and non-
working days in adulthood [OR, 0.70; 95 % CI, 0.51–0.97].
The protective effect was more evident among women.
Conclusion Our findings support an inverse relationship
between intermittent sun exposure and the risk of NHL.
These findings are consistent with the growing evidence
from various countries, but further studies, especially
prospective studies, are needed in Asian populations.
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Introduction
Lymphoid neoplasm (LN), a heterogeneous group of can-
cers arising in the lymphoid tissue, is one of the least
understood and most complex group of cancers. The World
Health Organization (WHO) classification groups them
into B-cell neoplasms, T-cell neoplasms and Hodgkin
lymphoma (HL) [1]. The B- and T-cell types are com-
monly known as non-Hodgkin lymphoma (NHL).
LN is among the ten most frequent cancers in Singapore
and accounted for 6 and 4.2 % of all cancers in Singapore men
and women, respectively, in 2003–2007 [2]. In the past few
decades, the incidence and mortality rates for NHL have been
increasing substantially worldwide [3]. However, the increase
appears to have begun to level off in Europe in recent years
[4]. In Singapore where incidence rates of NHL were the
highest in south-east and east Asia, the age-standardized
incidence rates in men and women have both been rising
consistently from 3.1 and 1.9 (per 100,000 person-years) in
1968–1972 to 10.0 and 6.7 (per 100,000 person-years) in
2003–2007, respectively [5]. Only a proportion of lymphomas
are known to be related to inherited or acquired immuno-
suppression (e.g., AIDS or organ transplant procedures) [6, 7],
autoimmunity, viral infection or occupational exposures; and
they are thought to increase risk only in specific subtypes [8],
but much of the etiology remains unexplained.
Cartwright et al. reported in 1994 that in various pop-
ulations, parallel increases in the incidence of both NHL
and non-melanoma skin tumors were noted, based on an
analysis using registry data [9]. Large population-based
studies also observed an increased risk of subsequent NHL
among patients with skin cancer, or vice versa [10, 11].
These findings led to the suggestion that ultraviolet (UV)
irradiation may be a common risk factor for both these
cancers, possibly through its effects on the immune system.
The theory appeared to be supported by several ecologic
studies that found positive associations between ambient
UV radiation at various geographical latitudes and inci-
dence and mortality from NHL [12–14]. But other similar
studies did not support this association [15, 16] or reported
inverse associations instead [17–19]. Similarly, both pro-
tective [20] and risk conferring [21] effects were observed
in the prospective cohort studies examined the association
of NHL and UV radiation using area of residence.
More recently, case–control studies that evaluated
individual sun exposure levels have generally [22–24],
though not uniformly [25], supported a protective effect of
leisure-time sun exposure on NHL. In contrast, the effect of
occupational sun exposure is much less consistent [26–28].
A pooled analysis conducted by the International Lym-
phoma Epidemiology Consortium (InterLymph) [23] found
a 23 % reduction in risk for men and women in the highest
quartile of recreational sun exposure, but no association
with non-recreational sun exposure.
To date, all the epidemiologic studies have been conducted
in Caucasian populations residing in the United States, Europe,
and Australia. Singapore is a multi-ethnic Asian population
comprising 4.8 million people, of which 77 % are Chinese,
14 % Malays, and 8 % Indians. The country lies at the southern
tip of the Malayan peninsula, at a latitude of one degree north of
the equator. The aim of our study was to evaluate the associ-
ation between personal sun exposure and lymphoma risk in an
Asian population residing in a tropical location with consis-
tently high sun exposure throughout the year.
Methods
Study population
The Singapore Lymphoma Study is a hospital-based case–
control study carried out in 3 major public hospitals
(National University Hospital, Singapore General Hospital,
and Tan Tock Seng Hospital) and 2 national referral cen-
ters for skin disease (National Skin Centre) and cancer
(National Cancer Centre).
Eligible cases were all Singapore residents aged 18 years
and above with newly diagnosed lymphoid neoplasm (ICD-
O M9590-9596, M9650-9667, M9670-9699, M9700-9729,
M9731-9734, M9823-9831, and M9940-9948) including
mature B- and T-cell neoplasms and Hodgkin lymphoma.
Histological diagnosis and classification were made
according to the 2001 WHO classification system [1].
Controls were patients admitted to orthopedic, internal
medicine, and general surgery departments in the same
hospitals, and whose current admission was not for any of the
following: diagnosis or suspicion of malignancy, asthma,
atopic eczema or allergy, immune-related disorders, peptic
ulcer disease, viral hepatitis, or tuberculosis. Controls were
frequency-matched for age (±5 years), gender, study center,
and month of diagnosis. Any lymphoma patients or hospital
controls with a history of HIV/AIDS or organ transplant
were excluded. The study was approved by the Institutional
Review Board or Ethics Committee at each participating
hospital or institution. Written informed consent was
obtained from all participants.
Data collection
The questionnaire used in the Singapore Lymphoma Study
was developed with reference, in part, to the questionnaire
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originally developed and used by the EpiLymph Group,
and modified for local use. A pilot study was conducted
between April and October 2004, while the main study was
carried out between February 2005 and December 2008. A
face-to-face interview in hospital was carried out by trained
research staff. Interviews were conducted in the language
(English, Malay, or Chinese dialect) which the participant
was most familiar with and were taped for quality control
purposes with the consent of the interviewee.
In relation to sun sensitivity, participants were asked
about skin color (white or light tan, tan, dark brown, or
black on the inner side of the arm), eye color (black or dark
brown, light brown, other) and natural hair color (black,
dark brown, light brown, other). Other variables included
history of sunburn (frequency and age at first sunburn), the
use of sun protection (including hat, sun-cream, long
sleeves or umbrella), and the skin reaction to strong sun-
light without any protection (severe sunburn with blister-
ing, painful sunburn followed by peeling, mildly burnt and
some tanning, go brown without sunburn).
The number of hours spent on leisure activities under the
sun or working outdoors was used as a surrogate for sun
exposure. We asked for complete occupational histories of
jobs that lasted over 1 year. Information included the year
they started and ended each job, occupational title and
industry, and the average daily hours of exposure to the sun
for every job.
Participants were asked how many hours they spent
outdoors regularly on activities such as swimming, sailing,
jogging, playing tennis, etc. on school days or weekends in
childhood (i.e.,\20 years of age), and on working days or
rest days in adulthood (i.e., 20 years of age and above).
‘‘Outdoor’’ was defined as not under any shade and
between 9 am and 5 pm.
Detailed information on personal demographics, family
history of cancer, and other potential confounders were also
collected. These included usual adult body weight and height;
general physical activity in the past one year in terms of hours
spent on activities of (1) vigorous intensity (i.e., strenuous
sports of tennis/swimming laps, loading or unloading trucks,
shoveling or equivalent manual work), (2) moderate intensity
(i.e., heavy housework, light sports including brisk walking/
tai chi/bowling), (3) light intensity (including sitting), and (4)
sleeping on weekdays and weekends were also recorded.
Statistical analysis
Recreational sun exposure
Measures of recreational sun exposure were constructed for
the statistical analysis as follows: Daily exposure was
defined as ‘‘regular’’ if at least 30 min per day was spent on
outdoor recreational activities on a regular basis; separately
for (1) school days and (2) non-school days in childhood,
(3) working days, and (4) non-working days in adulthood.
The daily exposure was capped at 8 h per day. Weekly
exposure was calculated by adding up the daily exposure
reported over 5 school days and 2 non-school days in
childhood (i.e., childhood per week), and 5 working days
and 2 non-working days in adulthood (i.e., adult per week).
The weekly exposure was capped at 56 h per week. The
unexposed group served as the reference category.
Occupational sun exposure
For occupational sun exposure assessment, participants
were defined as outdoor workers if they had spent at least
30 min working outside under sun (between 9 am and
5 pm) in any of the jobs that lasted 1 year or more. We
categorized participants into ‘‘indoor work only’’ workers,
and those who spent all or part of their working hours
outdoors ‘‘mixed indoor ± outdoor’’ workers.
Other variables
Usual adult body height and weight were expressed as
body mass index (BMI, kg/m2). Physical activity of dif-
ferent intensities was converted to metabolic equivalent
levels (MET), defined as the ratio of work metabolic rate to
standard resting metabolic rate [29], in order to compute
the total energy expenditure per week.
An unconditional logistic regression model was used to
quantify the effect of outdoor sun exposure on the risk of
malignant lymphoma via the odds ratio (OR) estimate and its
95 % confidence interval (CI). All analyses were adjusted
for age (as a continuous variable), gender (male/female),
ethnic group (Chinese/Malay/Indian), skin color (white or
light tan/tan/dark brown or black), education level (no for-
mal education/B6 years/7–10 years/[10 years), current
housing type (public housing B3 rooms/public housing [3
rooms/private housing/others) as a surrogate for socio-eco-
nomic status, BMI (continuous), and history of any cancer in
a first-degree relative (yes/no). We further assessed the
interaction effect of sun exposure by gender in the multi-
variable model. Individuals with missing data for any vari-
ables were excluded for that analysis. All statistical tests
were evaluated assuming a two-sided test at the 0.05 level of
significance. Analyses were performed with STATA/SE
10.1 software. (StataCorp, Texas 77845 USA, 1984–2009).
Results
Of the 603 eligible cases ascertained during recruitment
period, 62 (10.3 %) did not agree to participate in the
study, leaving 541 cases (315 men and 226 women)
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(response rate 89.7 %). Among 1,330 controls ascertained
and initially confirmed as eligible, 500 (37.6 %) refused to
participate and 830 controls were used in this analysis
(response rate 62.4 %).
Descriptive characteristics of the study population are
summarized in Table 1. The average age of cases and
controls was 54.2 years (SD, 16.0) and 50.3 years (SD,
16.0), respectively, with 60 % male participants. Malays
and Indians were overrepresented among controls com-
pared with cases. As compared with controls, more cases
lived in private housing (12.9 vs. 4.9 %) and had positive
family history of any cancer in the first-degree relatives
(34.4 vs. 21.7 %). More cases were born outside Singa-
pore/Malaysia (10.1 vs. 5.3 %), only 14 cases (2.6 %) and
9 controls (1.1 %) immigrated to Singapore after age 20.
The mean usual adult BMI in the controls (25.0 kg/m2;
SD, 5.3) was higher than the cases (23.6 kg/m2; SD, 4.1).
Both groups were similar in relation to the hours spent in
various forms of activity and in total METs expended per
week.
Table 2 shows the histological subtypes of lymphoid
malignancies among cases recruited in the Singapore
Lymphoma Study. There were 404 B-cell NHL (74.7 %),
including 243 diffuse large B-cell lymphoma, 64 follicular
lymphoma, 52 marginal zone B-cell lymphoma, 13 multi-
ple myeloma, and 32 other B-cell types (e.g., CLL, SLL);
61 T-/NK-cell NHL (11.3 %), 74 HL (13.7 %), and 2
composite lymphomas (0.4 %). The distribution of sub-
types was similar between genders.
The associations between pigmentary and sun sensitivity
characteristics and malignant lymphoma are shown in
Table 3. Limited variation was observed in eye and hair
color since the majority of subjects were reported as having
black/dark brown eyes (96.3 %) and black hair (97.0 %).
Although the number of persons with natural lighter-col-
ored hair (brown, as opposed to black) was small, this
characteristic conferred a twofold risk of all lymphomas
combined (OR, 1.95; 95 % CI, 0.98–3.89). Forty percent of
the study populations have ever had sunburn in their life-
time; 20.4 % of controls and 16.9 % of cases experienced
painful/severe burn after repeated sun exposure. There was
no association between skin color and sun sensitivity
(sunburn history, age at first sunburn or skin reaction to
strong sunlight without protection) and risk of either NHL
or HL.
The prevalence of using sun protection was very low in
this study population, only 4.0 % of participants had ever
used sun protection during childhood (3.6 % used in school
days and 3.4 % in non-school days). The usage was slightly
higher in adulthood (9.1 % ever users, 6.2 % on working
days, and 7.6 % on non-working days).
Occupational sun exposure
On average, cases and controls spent 1.4 h/day (SD, 2.3)
and 1.5 h/day (SD, 2.3), respectively, working outdoors.
Participants who had ever engaged in outdoor occupations
had a decreased risk of NHL overall (OR, 0.75; 95 % CI,
Table 1 Background characteristics of cases and controls in the






No % No %
Age (years)
Range 18–87 18–90 \0.001
Mean (SD) 50.3 16.0 54.2 16.0
Gender
Male 495 59.6 315 58.2 0.60
Female 335 40.4 226 41.8
Ethnic group
Chinese 551 66.4 417 77.1 \0.001
Malay 161 19.4 89 16.5
Indian 118 14.2 35 6.5
Education
No education 77 9.3 59 11.0 0.09
B6 years 237 28.6 139 25.9
7–10 years 286 34.5 162 30.2




267 32.2 115 21.5 \0.001
Public govt housing
([3 rooms)
511 61.6 347 65.0
Private condominium/
landed property
41 4.9 69 12.9
Others (e.g., nursing
home)
11 1.3 3 0.6
Country of birth
Singapore/Malaysia 786 94.7 482 89.9 0.001
Other Asian countriesa 44 5.3 54 10.1
History of cancer in the first-degree relatives
Yes 178 21.7 177 34.4 \0.001
No 644 78.4 337 65.6
Mean adult BMI (kg/m2)
(SD)




week) in last year (SD)
264.6 51.7 260.9 52.7 0.21
SD standard deviation, BMI body mass index
* Variables were tested by chi-square test (categorical) or t test
(continuous)
a Other Asian countries including China, Taiwan, Hong Kong,
Indonesia, Philippines, India, Pakistan, and others
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0.55–1.03) and for B-cell NHL subtypes (OR, 0.73; 95 %
CI, 0.53–1.02) compared with those who only worked
indoors (Table 4). Further adjustment of hair color, skin
sensitivity, height, weight, and energy expenditure on
physical activities did not change the risk estimates mate-
rially and were not included in the final models.
Table 2 Histological subtypes of lymphoid neoplasms in the Singapore Lymphoma Study, 2004–2008
Lymphoma subtype Male Female Total
n % n % n %
Hodgkin lymphoma (HL) 46 14.6 28 12.4 74 13.7
Non-Hodgkin lymphoma (NHL) 267 84.8 198 87.6 465 86.0
B-cell neoplasms 225 71.4 179 79.2 404 74.7
Diffuse large B-cell lymphoma and Burkitt lymphoma 132 41.9 111 49.1 243 44.9
Follicular lymphoma 39 12.4 25 11.1 64 11.8
Marginal zone B-cell lymphoma 28 8.9 24 10.6 52 9.6
Multiple myeloma 7 2.2 6 2.7 13 2.4
Other B-cell typesa 19 6.0 13 5.8 32 5.9
T- cell and NK-cell neoplasms 42 13.3 19 8.4 61 11.3
Composite lymphoma (HL ? NHL) 2 0.6 0 0 2 0.4
Total (% of total) 315 58.2 226 41.8 541 100
a Other B-cell types included chronic lymphocytic leukemia/small lymphocytic lymphoma; mantle cell lymphoma; immunoblastic lymphoma;
or NHL NOS
Table 3 Association between pigmentary and sun sensitivity and risk of lymphoid malignancies in the Singapore Lymphoma Study, 2004–2008
Pigmentary and sun sensitivity
characteristics
Controls Lymphoid neoplasms Non-Hodgkin lymphoma Hodgkin lymphoma
n % n % ORa (95 % CI) n % ORa (95 % CI) n % ORa (95 % CI)
Hair color (natural)
Black 810 97.7 511 95.9 1.00 (ref) 441 96.3 1.00 (ref) 68 93.2 1.00 (ref)
Brown (dark/light) 19 2.3 22 4.1 1.95 (0.98–3.89) 17 3.7 1.98 (0.93–4.19) 5 6.9 2.16 (0.67–6.94)
Eye color
Black/dark brown 799 96.4 512 96.2 1.00 (ref) 439 96.1 1.00 (ref) 71 97.3 1.00 (ref)
Light brown 30 3.6 20 3.8 1.38 (0.68–2.78) 18 3.9 1.42 (0.67–3.00) 2 2.7 1.37 (0.30–6.24)
Skin color
White/light tan 350 42.2 263 49.4 1.00 (ref) 240 52.5 1.00 (ref) 23 31.5 1.00 (ref)
Tan 383 46.2 241 45.3 0.90 (0.69–1.19) 196 42.9 0.79 (0.59–1.06) 43 58.9 1.59 (0.89–2.86)
Dark brown/black 96 11.6 28 5.3 0.65 (0.34–1.21) 21 4.6 0.67 (0.33–1.36) 7 9.6 0.57 (0.17–1.97)
History of sunburn
Never 490 59.1 318 59.8 1.00 (ref) 281 61.5 1.00 (ref) 35 48.0 1.00 (ref)
Ever 339 40.9 214 40.2 0.97 (0.74–1.28) 176 38.5 0.98 (0.73–1.32) 38 52.1 1.00 (0.56–1.77)
Skin reaction to strong sunlight with no protection
Go brown only 614 74.2 416 78.2 1.00 (ref) 365 79.9 1.00 (ref) 49 67.1 1.00 (ref)
Mildly burnt and tanned 45 5.4 26 4.9 0.82 (0.47–1.43) 22 4.8 0.90 (0.49–1.63) 41 5.5 0.62 (0.20–1.87)
Painful burn and peeling 158 19.1 83 15.6 0.76 (0.54–1.06) 64 14.0 0.70 (0.49–1.01) 9 26.0 1.05 (0.57–1.93)
Severely burnt and blistering 11 1.3 7 1.3 0.65 (0.20–2.16) 6 1.3 0.56 (0.15–2.13) 1 1.4 1.28 (0.15–10.8)
Numbers did not add up to 830 controls and 541 cases due to missing data
ref referent, OR odds ratio, CI confidence intervals
a OR, odds ratio adjusted for age (continuous), gender (male/female), ethnic (Chinese/Malay/Indian), education (never/B6/7–10/[10 years),
housing type (public housing B3 rooms/public housing [3 rooms/private housing/others), BMI (continuous), and history of any cancer in the
first-degree relatives (yes/no) in multiple logistic regression model
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Recreational sun exposure
During childhood, cases and controls spent, on average,
11.9 h/week (SD, 15.4) and 13.1 h/week (SD, 14.6),
respectively, on recreational activities under the sun. The
amount of time was reduced substantially to 3.2 h/week
(SD, 6.9) and 4.0 h/week (SD, 7.6), respectively, during
adulthood. For all types of activities, women participants
spent less time in the sun than men. The weekly exposure
in adulthood was 4.8 h (SD, 8.2) in men and 2.8 (SD, 6.3)
in women; corresponding figures for childhood exposure
are 15.6 h (SD, 15.1) for boys and 9.4 h (SD, 13.0) for
girls.
Compared to those without regular recreational sun
exposure, those who regularly spent at least 30 min/day
outdoors on non-school days during childhood had a 38 %
reduction in risk of lymphoma. A significant association
was observed for NHL (OR, 0.62; 95 % CI, 0.46–0.83),
and for B-cell lymphoma (OR, 0.56; 95 % CI, 0.41–0.77)
in particular. Similarly, the risk of NHL among those who
reported regular recreational sun exposure in adulthood on
non-working days was also significantly reduced (OR,
0.70; 95 % CI, 0.51–0.97). For T-cell lymphoma, the
observed reduction (OR, 0.19; 95 % CI, 0.06–0.54) was
based on a small number of cases.
In terms of weekly recreational sun exposure, a signif-
icant risk reduction was observed consistently for lymphoid
neoplasms (OR, 0.73; 95 % CI, 0.55–0.96), NHL (OR,
0.73; 95 % CI, 0.54–0.99), and B-cell NHL (OR, 0.69;
95 % CI, 0.51–0.95) in childhood, but not in adulthood.
Gender differences
The protective effect of childhood sun exposure was more
evident in women (Table 5). There was a 50–60 % risk
reduction observed in women on school days (OR, 0.54;
95 % CI, 0.34–0.87), non-school days (OR, 0.38; 95 % CI,
0.23–0.61), and on combined weekly exposure (OR, 0.43;
95 % CI, 0.27–0.68).
Discussion
To our knowledge, this is the first epidemiologic study of
sun exposure and risk of malignant lymphomas conducted
both in an Asian population and in a tropical location. Our
results suggest that in this study population, regular, lei-
sure-time sun exposure in both childhood and adulthood is
associated with a reduced risk of non-Hodgkin lymphoma.
When stratified by gender, the reduction in risk conferred
by regular childhood sun exposure was stronger in women
than in men.
Recreational sun exposure
Our findings on the protective association of recreational
sun exposure are generally consistent with other studies on
personal sun exposure in the West [22, 23, 27, 28, 30–32].
A case–control study by Hughes et al. in Australia was the
first to report an inverse association between personal
ultraviolet radiation exposure and the risk of NHL. There
were reduced risks with exposure on non-working days in
adulthood, suggesting that an intermittent pattern of sun
exposure might be protective; and the protective effect of
year-round sun exposure was the greatest during childhood
[26]. The InterLymph analysis of 10 case–control studies in
the West, consisting of 8,243 cases and 9,697 controls,
reported a pooled odds ratio of 0.76 (95 % CI, 0.63–0.91)
for recreational sun exposure [23]. A recent case–control
study in Rochester [32] reported a decrease in NHL risk in
subjects who had sunbathed more than once per week
versus never (OR, 0.28; 95 % CI, 0.10–0.79) over the past
10 years. A Scandinavian study also demonstrated a
reduced risk in NHL, especially the B-cell type, with
increasing adult personal sun exposure, and among subjects
who had spent vacations in sunny southern climates [30].
In contrast, a population-based case–control study of
Connecticut women showed an increased risk of NHL
among those who reported spending time (between 9 am
and 3 pm) in strong sun during summer (OR, 1.7; 95 % CI,
1.2–2.4) [25].
The reason for a strong association in women is not
immediately clear. It is possible that the effect is greater
because of the lower baseline exposure in this group,
compared with their male counterparts. Our results were
supported by the Australian study reported by Hughes [26]
that the association of sun exposure and the NHL risk
reduction was apparently stronger in women. In our pop-
ulation, the higher exposure hours in childhood than
adulthood may be the reason for the apparently stronger
association in childhood, as suggested by the Australian
study.
Occupational sun exposure
The average occupational sun exposure reported in our
study was comparable with another study on pterygia and
sun exposure in Singapore in 1998 and 2000 [33, 34]. The
control group of 125 subjects was spending on average
1.6 h per day (SD, 1.6) currently and 1.9 h per day (SD,
1.8) at 5 years ago [33]. We detected a marginal protective
effect of occupational exposure in adults, although this was
not evident in the pooled analysis based on the InterLymph
data [23]. However, Epilymph reported a similar result,
which was only limited to the Diffuse large B-cell lym-
phoma subtype (OR, 0.72; 95 % CI, 0.54–0.97) [28]. Most
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of the studies in the West did not detect any association
between occupational sun exposure and NHL risk.
One possible explanation for the difference in the asso-
ciations observed for recreational and occupational sun
exposure is that the intermittent pattern of the former plays
a key role [23, 26]. It has also been proposed that long
periods of exposure do not result in a corresponding
increase in the active compound due to a ceiling effect [35].
Possible mechanisms of protection
It is known that ultraviolet radiation can function as a
carcinogen and has immunosuppressive functions [36] and
that skin aging and sunburn are mainly caused by DNA-
damaging UVA (95 % of UV radiation). The proposed
mechanism by which sun exposure may reduce risk of
lymphoid neoplasms is by means of vitamin D-related
pathways [37]. The main source of vitamin D (cholecal-
ciferol) production in humans is the skin, where it is syn-
thesized from 7-dehydrocholesterol following exposure to
UV-B radiation in sunlight [35]. Experimental studies have
demonstrated that the active form of vitamin D has anti-
proliferative and pro-differentiation effects on tumor cells
[38] and lymphoma cell lines [39]. Data on vitamin D
levels in Asian populations such as Singapore suggest that
vitamin D insufficiency may be prevalent among older
individuals [40–42]; to date, epidemiologic studies that
have examined the association between self-reported die-
tary vitamin D intake and NHL have all been conducted in
Western populations and have yielded null associations
[22, 31].
Strength and limitations
The primary aim of this study was to evaluate whether the
previously described effects of sun exposure on the risk of
lymphoid neoplasms can be replicated in an Asian popu-
lation living in the topics. Its strengths are that data were
collected using standardized techniques, with effort made
to maintain comparability with previous questionnaires
used in other populations. The multi-center design pro-
vided us access to a representative sample of eligible
incident cases in this country.
At the same time, we are mindful of the limitations that
are inherent in the retrospective nature of this study, and
the limited sample size. Specifically, we were unable to
make inferences about the effect of sun exposure on
Hodgkin lymphoma, and on the T-cell NHL subtypes,
although the risk estimates suggested interesting differ-
ences. The relatively low participation rate (62.4 %) in our
hospital controls may introduce a selection bias, but it is
unlikely that this is related to sun exposure in a way that
would account for the associations observed. Hospital
controls may be considered more likely to be ill than the
general population, and this would result in less, rather than
more, time spent outdoors in the sun, and hence any bias
would act conservatively. Further, in order to reduce the
effect of potential bias due to medical conditions that are
associated with higher sun exposure, not more than 10 %
of our controls had a similar admission diagnosis. We also
acknowledge that reporting and recall bias could occur in
this study, but as the hypothesis regarding sun exposure
and lymphoma risk is not widely known in the general
Table 5 The association between childhood sun exposure and non-Hodgkin lymphoma by gender
Recreational sun exposure in childhood Males Females p interaction
Nco/Nca ORa (95 % CI) Nco/Nca ORa (95 % CI)
Daily
On school days
No regular exposure 193/104 1.00 (ref) 194/136 1.00 (ref) 0.03
[30 min exposure/day 300/147 1.03 (0.71–1.49) 134/53 0.54 (0.34–0.87)**
On non-school days
No regular exposure 182/111 1.00 (ref) 203/150 1.00 (ref) 0.01
[30 min exposure/day 311/140 0.82 (0.57–1.17) 125/39 0.38 (0.23–0.61)***
Weeklyb
No regular exposure 153/84 1.00 (ref) 176/133 1.00 (ref) 0.01
[1 h exposure/week 340/167 0.97 (0.70–1.45) 152/56 0.43 (0.27–0.68)***
Numbers did not add up to 830 controls and 541 cases due to missing data
Nco no of controls, Nca no of NHL cases, ref referent, OR odds ratio, CI confidence intervals, ** p value \0.01; *** p value \0.001
a OR, odds ratio adjusted for age (continuous), ethnic (Chinese/Malay/Indian), skin color (white-light tan/tan/dark brown-black), education
(never/\6/7–10/[10 years), housing type (public housing B3 rooms/public housing [3 rooms/private housing/others), BMI (continuous), and
history of any cancer in the first-degree relatives (yes/no) in multiple logistic regression model
b Weekly sun exposure = 5 9 school days ? 2 9 non-school days (age \20 years)
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population, we would expect such a misclassification to be
non-differential.
As sun exposure (and not vitamin D) was the primary
exposure studied, we did not include dietary sources of
vitamin D. This was due to the relatively low intake of
vitamin D-rich food sources in this population, and diffi-
culties in obtaining accurate data on supplement intake,
and we recognize that this limits the extent to which we can
attribute our findings to a particular biologic mechanism.
Conclusion
In conclusion, we find that in this Asian population,
intermittent recreational sun exposure in childhood and
adulthood is inversely associated with the risk of devel-
oping non-Hodgkin lymphoma. These findings, which are
consistent with the growing evidence across various pop-
ulations, should be replicated in larger studies in other
similar contexts. The underlying mechanism, including a
possible role for vitamin D in immune modulation and
lymphomagenesis, deserves further study.
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